
<html lang="en"     class="pb-page"  data-request-id="2b3e2417-3c22-4575-aea7-982178ab184d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-14;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00369;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias" /></meta><meta name="dc.Creator" content="Ludovic  Juen" /></meta><meta name="dc.Creator" content="Marie  Brachet-Botineau" /></meta><meta name="dc.Creator" content="Cécile  Parmenon" /></meta><meta name="dc.Creator" content="Jérôme  Bourgeais" /></meta><meta name="dc.Creator" content="Olivier  Hérault" /></meta><meta name="dc.Creator" content="Fabrice  Gouilleux" /></meta><meta name="dc.Creator" content="Marie-Claude  Viaud-Massuard" /></meta><meta name="dc.Creator" content="Gildas  Prié" /></meta><meta name="dc.Description" content="Signal transducers and activators of transcription 5 (STAT5s) are crucial effectors of tyrosine kinase oncogenes in myeloid leukemias. Inhibition of STAT5 would contribute to reducing the survival ..." /></meta><meta name="Description" content="Signal transducers and activators of transcription 5 (STAT5s) are crucial effectors of tyrosine kinase oncogenes in myeloid leukemias. Inhibition of STAT5 would contribute to reducing the survival ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 12, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00369" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00369" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00369" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00369" /></link>
        
    
    

<title>New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00369" /></meta><meta property="og:title" content="New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0015.jpeg" /></meta><meta property="og:description" content="Signal transducers and activators of transcription 5 (STAT5s) are crucial effectors of tyrosine kinase oncogenes in myeloid leukemias. Inhibition of STAT5 would contribute to reducing the survival of leukemic cells and also tackling their chemoresistance. In a first screening experiment, we identified hit 13 as able to inhibit STAT5 phosphorylation and leukemic cell growth. The synthesis of 18 analogues of 13 allowed us to identify one compound, 17f, as having the most potent antileukemic effect. 17f inhibited the growth of acute and chronic myeloid leukemia cells and the phosphorylation and transcriptional activity of STAT5. Importantly, 17f had minimal effects on bone marrow stromal cells that play vital functions in the microenvironment of hematopoietic and leukemic cells. We also demonstrated that 17f inhibits STAT5 but not STAT3, AKT, or Erk1/2 phosphorylation. These results suggest that 17f might be a new lead molecule targeting STAT5 signaling in myeloid leukemias." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00369"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00369">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00369&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00369&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00369&amp;href=/doi/10.1021/acs.jmedchem.7b00369" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6119-6136</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00355" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00365" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ludovic++Juen">Ludovic Juen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marie++Brachet-Botineau">Marie Brachet-Botineau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9cile++Parmenon">Cécile Parmenon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%A9r%C3%B4me++Bourgeais">Jérôme Bourgeais</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olivier++H%C3%A9rault">Olivier Hérault</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrice++Gouilleux">Fabrice Gouilleux</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marie-Claude++Viaud-Massuard">Marie-Claude Viaud-Massuard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gildas++Pri%C3%A9">Gildas Prié</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-6369-7712" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Equipe IMT “Innovation Moléculaire et Thérapeutique”, GICC UMR 7292 CNRS, Université de Tours, Labex SYNORG, Faculté de Pharmacie, 31 avenue Monge, 37200 Tours, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Equipe LNOx “Niche leucémique & métabolisme oxidatif”, GICC UMR 7292 CNRS, Université de Tours, Faculté de Médecine, Bâtiment Dutrochet, 10bis boulevard Tonnellé, 37032 Tours, France</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">CHRU de Tours, Service d’Hématologie Biologique, 2 boulevard Tonnellé, 37044 Tours, France</span></div><div class="corresp-info"><strong>*</strong>Phone: +33-0-247366291. E-mail: <a href="/cdn-cgi/l/email-protection#8debecefffe4eee8a3eae2f8e4e1e1e8f8f5cdf8e3e4fba0f9e2f8fffea3ebff"><span class="__cf_email__" data-cfemail="06606764746f6563286169736f6a6a63737e4673686f702b7269737475286074">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Phone: +33-0-247367228. E-mail: <a href="/cdn-cgi/l/email-protection#ed8a8481898c9ec39d9f8488ad9883849bc09982989f9ec38b9f"><span class="__cf_email__" data-cfemail="b4d3ddd8d0d5c79ac4c6ddd1f4c1daddc299c0dbc1c6c79ad2c6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00369&amp;href=/doi/10.1021%2Facs.jmedchem.7b00369" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6119–6136</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 27, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 March 2017</li><li><span class="item_label"><b>Published</b> online</span>12 July 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00369" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00369</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6119%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLudovic%2BJuen%252C%2BMarie%2BBrachet-Botineau%252C%2BC%25C3%25A9cile%2BParmenon%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D14%26contentID%3Dacs.jmedchem.7b00369%26title%3DNew%2BInhibitor%2BTargeting%2BSignal%2BTransducer%2Band%2BActivator%2Bof%2BTranscription%2B5%2B%2528STAT5%2529%2BSignaling%2Bin%2BMyeloid%2BLeukemias%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6136%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00369"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1566</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00369" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ludovic&quot;,&quot;last_name&quot;:&quot;Juen&quot;},{&quot;first_name&quot;:&quot;Marie&quot;,&quot;last_name&quot;:&quot;Brachet-Botineau&quot;},{&quot;first_name&quot;:&quot;Cécile&quot;,&quot;last_name&quot;:&quot;Parmenon&quot;},{&quot;first_name&quot;:&quot;Jérôme&quot;,&quot;last_name&quot;:&quot;Bourgeais&quot;},{&quot;first_name&quot;:&quot;Olivier&quot;,&quot;last_name&quot;:&quot;Hérault&quot;},{&quot;first_name&quot;:&quot;Fabrice&quot;,&quot;last_name&quot;:&quot;Gouilleux&quot;},{&quot;first_name&quot;:&quot;Marie-Claude&quot;,&quot;last_name&quot;:&quot;Viaud-Massuard&quot;},{&quot;first_name&quot;:&quot;Gildas&quot;,&quot;last_name&quot;:&quot;Prié&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;6119-6136&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00369&quot;},&quot;abstract&quot;:&quot;Signal transducers and activators of transcription 5 (STAT5s) are crucial effectors of tyrosine kinase oncogenes in myeloid leukemias. Inhibition of STAT5 would contribute to reducing the survival of leukemic cells and also tackling their chemoresistance. In a first screening experiment, we identified hit 13 as able to inhibit STAT5 phosphorylation and leukemic cell growth. The synthesis of 18 analogues of 13 allowed us to identify one compound, 17f, as having the most potent antileukemic effect. 17f inhibited the growth of acute and chronic myeloid leukemia cells and the phosphorylation and transcriptional activity of STAT5. Importantly, 17f had minimal effects on bone marrow stromal cells that play vital functions in the microenvironment of hematopoietic and leukemic cells. We also demonstrated that 17f inhibits STAT5 but not STAT3, AKT, or Erk1/2 phosphorylation. These results suggest that 17f might be a new lead molecule targeting STAT5 signaling in myeloid leukemias.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00369&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00369" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00369&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00369" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00369&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00369" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00369&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00369&amp;href=/doi/10.1021/acs.jmedchem.7b00369" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00369" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00369" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00369%26sid%3Dliteratum%253Aachs%26pmid%3D28654259%26genre%3Darticle%26aulast%3DJuen%26date%3D2017%26atitle%3DNew%2BInhibitor%2BTargeting%2BSignal%2BTransducer%2Band%2BActivator%2Bof%2BTranscription%2B5%2B%2528STAT5%2529%2BSignaling%2Bin%2BMyeloid%2BLeukemias%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D14%26spage%3D6119%26epage%3D6136%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291594" title="Silica">Silica</a>,</li><li><a href="/action/doSearch?ConceptID=292234" title="Chromatography">Chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/jmcmar.2017.60.issue-14/20170727/jmcmar.2017.60.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Signal transducers and activators of transcription 5 (STAT5s) are crucial effectors of tyrosine kinase oncogenes in myeloid leukemias. Inhibition of STAT5 would contribute to reducing the survival of leukemic cells and also tackling their chemoresistance. In a first screening experiment, we identified hit <b>13</b> as able to inhibit STAT5 phosphorylation and leukemic cell growth. The synthesis of 18 analogues of <b>13</b> allowed us to identify one compound, <b>17f</b>, as having the most potent antileukemic effect. <b>17f</b> inhibited the growth of acute and chronic myeloid leukemia cells and the phosphorylation and transcriptional activity of STAT5. Importantly, <b>17f</b> had minimal effects on bone marrow stromal cells that play vital functions in the microenvironment of hematopoietic and leukemic cells. We also demonstrated that <b>17f</b> inhibits STAT5 but not STAT3, AKT, or Erk1/2 phosphorylation. These results suggest that <b>17f</b> might be a new lead molecule targeting STAT5 signaling in myeloid leukemias.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Signal transducers and activators of transcription factors 5A and B are two closely related STAT family members that play a major role in normal and leukemic hematopoiesis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Persistent activation of these transcription factors is frequently found in leukemias as a consequence of deregulated tyrosine kinase activity. Phosphorylation of STAT5 is triggered by tyrosine kinase oncogenes (TKO) such as Fms-like receptor tyrosine kinase 3 with internal tandem duplications (Flt3-ITD), Kit<sup>D816V</sup>, Bcr-Abl, and JAK2<sup>V617F</sup> which have been characterized in various myeloid malignancies.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6">(2-6)</a> STAT5 is a crucial effector of Bcr-Abl, the major transforming agent in chronic myeloid leukemia (CML).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> The development of Bcr-Abl tyrosine kinase inhibitors (TKI) such as imatinib mesylate (IM) has revolutionized the treatment of CML. Despite this success story, IM is not curative due to its inability to completely eradicate leukemic stem cells (LSC) that are responsible for the initiation and relapse of CML. Moreover, the occurrence of Bcr-Abl mutations during the progression of the disease promotes the resistance of CML cells to IM treatment.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Therefore, there is an urgent need for alternative therapeutic strategies to cure CML. In this regard, STAT5 fulfils all criteria of a major drug target in CML.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> High STAT5 expression levels were shown not only to enhance IM resistance in CML cells but also to trigger Bcr-Abl mutations by inducing the production of reactive oxygen species (ROS) responsible for DNA damage.<a onclick="showRef(event, 'ref8 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref8 ref11 ref12">(8, 11, 12)</a> Moreover, STAT5 was shown to play a key role in the maintenance of CML stem cells that are resistant to chemotherapy.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Several approaches have been used to target STAT5 in leukemias. Among them, cell-based screening with small molecule libraries of already approved drugs allowed the identification of pimozide as a potential STAT5 inhibitor in CML cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Although pimozide inhibits the transcriptional activity of STAT5, the use of high concentrations suggests that effects of this molecule might be indirect. More recently, salicylic acid–based molecules targeting the SH2 domain required for dimerization and transcriptional activity of STAT5 were shown to inhibit the growth of CML cells.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> One of these inhibitors binds STAT5 protein in a nanomolar range; furthermore, it induces apoptosis and inhibits tyrosine phosphorylation of STAT5 in the micromolar range. A last approach is to target STAT5 activity through the activation of peroxisome proliferator-activated receptor gamma (PPARγ). Indeed the existence of a cross-talk between protein PPAR and STAT5 has been discussed.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> For instance, antidiabetic drugs such as glitazones that are PPARγ agonists were shown to have antileukemic activity. Activation of PPARγ by glitazones decreases expression and/or phosphorylation of STAT5 in CML cells.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Importantly, Prost et al. showed that combining pioglitazone with IM triggers the apoptosis of CML stem cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The mechanism by which these leukemic stem cells are killed in response to this drug combination is not yet clear. Moreover, several reports indicated that antileukemic effects of glitazones might be dependent on “off-target” mechanisms.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a></div><div class="NLM_p">We previously described the synthesis and pharmacological evaluation of 24 PPARα/γ ligands targeting type 2 diabetes.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> All molecules synthesized during the project shared a diversely substituted 4,4-dimethyl-1,2,3,4-tetrahydroquinoline scaffold, linked to an aryl or an heteroaryl ring by an ethoxy chain. This series comprised PPARα/γ agonist, antagonist, and inactive compounds. Inhibitory effects of some representative molecules of the series were evaluated on the growth of a Bcr-Abl expressing cell line (KU812 cells) and STAT5 activity.</div><div class="NLM_p">All molecules showed no to moderate activity on KU812 cell proliferation with a maximum inhibition of 55% at 10 μM for compound <b>13</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Interestingly, the latter was the only compound to significantly inhibit STAT5 phosphorylation (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">Supporting Information</a>). We also showed that <b>13</b> was inactive on PPARα/γ suggesting that inhibition of cell growth and STAT5 phosphorylation by this molecule occurs through a PPARγ independent pathway. Therefore, pharmacological exploitation of this “off-target” effect is of interest for the development of new antileukemic molecules that are devoid of side effects associated with PPARγ activation.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hit compound <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A collection of 18 derivatives of hit compound <b>13</b> was synthesized, and a structure/activity relationship analysis was performed to determine their growth inhibitory effects on various myeloid leukemia cells. Experiments were conducted in CML cell lines (KU812 and K562) and acute myelogenous leukemia (AML) cell lines in which STAT5 is constitutively active (KG1a and MV-4-11). Among these molecules, <b>17f</b> was found to be the most active in blocking STAT5 phosphorylation and leukemic cell growth. We also demonstrated that <b>17f</b> selectively inhibits STAT5 phosphorylation but not STAT3, Erk1/2, and Akt signaling which also play a critical role in myeloid leukemia cell proliferation and survival. Interestingly, <b>17f</b> was almost inactive in inhibiting the growth of bone marrow stromal cells that are major components of the hematopoietic and leukemic microenvironment.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hit <b>13</b> scaffold was composed of indole and 4,4-dimethyl-1,2,3,4-tetrahydroquinoline rings, linked by an ethoxy chain attached by carbon C-5 of the indole and nitrogen N-1 of the tetrahydroquinoline (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). This scaffold was substituted by an acetic acid group on the nitrogen N-1 of the indole and by a cyclohexylcarbonyl group on carbon C-6 of the tetrahydroquinoline.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Previous Synthetic Route of Hit Compound <b>13</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">First, convergent synthesis of hit <b>13</b> followed the synthetic route developed in our previous PPAR project.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Acylation of intermediate CP25i with cyclohexyl carbonyl chloride in the presence of graphite<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> followed by Williamson alkylation with ethyl 2-(5-hydroxy-1<i>H</i>-indol-1-yl)acetate and further saponification led to <b>13</b>. This method had some drawbacks including poor reproducibility of the acylation step and low yield of the alkylation step (<15%). Moreover, this procedure set the central scaffold substituents from the start, making new pharmacomodulations on indole and tetrahydroquinoline rings inconvenient. In order to study SAR in our current STAT5 project, we needed to readily synthesize a series of hit <b>13</b> analogues. To do this, we designed an alternative divergent synthesis. Starting from key intermediates <b>6a</b> and <b>6b</b> obtained in satisfying yields, the central scaffold was further modified to produce the desired series (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Key Intermediates <b>6a</b> and <b>6b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) 3,3-dimethyl-acryloyl chloride, dry pyridine, 0 °C to rt, 5 h; (b) AlCl<sub>3</sub>, dry dichloromethane, 0 °C to rt, 1 h; (c) BH<sub>3</sub>·THF, dry toluene, 0 °C to reflux, 12 h; (d) NaH, BnBr, dry DMF, 0 °C to rt, 2 h; (e) CuI, 3,4,7,8-tetramethyl-1,10-phenanthroline, Cs<sub>2</sub>CO<sub>3</sub>, dry ethylene glycol, 130 °C, 72 h; (f) (1) IBX, DCE, 80 °C, 2 h; (2) filtration; (3) 4,4-dimethyl-1,2,3,4-tetrahydroquinoline or amine <b>3</b>, NaBH(AcO)<sub>3</sub>, rt, 3 h.</p></p></figure><div class="NLM_p">Synthesis of the key intermediates <b>6a</b> and <b>6b</b> started with protection of the N-1 position of 5-bromoindole by a benzyl group. The protected indole <b>4</b> was then etherified by Ullmann-type coupling. To achieve this, several ligands were tested including 8-hydroxyquinoline<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and 1,10-phenanthroline; however, the best results were obtained with electron rich 3,4,7,8-tetramethyl-1,10-phenanthroline<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> to afford <b>5</b> with a 61% yield. In order to carry out reductive amination, various reagents to oxidize alcohol <b>5</b> were assessed, including PCC, oxalyl chloride (according to Swern oxidation), Dess-Martin periodinane, and 2-iodoxybenzoic acid (IBX).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> As the aldehyde intermediate was unstable, IBX oxidation was chosen as it allowed an easy purification by simple filtration (indeed, excess of IBX and reduced byproduct 2-iodosobenzoic acid (IBA) are insoluble at rt in DCE). Moreover, the filtrate was used in the next step without further treatment since DCE is one of the best reaction solvents for reductive aminations.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> 4,4-Dimethyl-1,2,3,4-tetrahydroquinoline or 6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>3</b>, obtained from aniline or 4-bromoaniline,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> were then introduced in the presence of NaBH(AcO)<sub>3</sub> to form <b>6a</b> and <b>6b</b>, respectively, with 77% and 64% yields over two steps (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><div class="NLM_p">Conversion of aryl bromide <b>6b</b> to the corresponding nitrile <b>7</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> followed by nucleophilic addition of cyclohexylmagnesium chloride catalyzed by CuBr and subsequent hydrolysis led to ketone <b>8</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Attempts of benzyl deprotection of <b>8</b> in the presence of potassium <i>tert-</i>butoxide under air (1 atm) led to hydroxylation at the α-carbon of the ketone.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> To avoid this, several procedures were assessed to protect ketone <b>8</b> as the ketal <b>9</b>,<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> among which, the classical method using ethylene glycol and catalytic <i>p</i>-toluenesulfonic acid monohydrate with a Dean–Stark trap gave the best result, nevertheless with a low 37% yield. The long reaction time required at high temperature led to partial decomposition of the starting ketone. However, after 6 h, besides the product obtained, 34% of the starting material <b>8</b> was retrieved. Ketal <b>9</b> did undergo benzyl deprotection to afford <b>10</b> with 83% yield. Deprotection of the latter afforded ketone <b>11</b>, whereas <i>N</i>-alkylation with ethyl bromoacetate followed by saponification led to <b>13</b>. Deprotection of <b>6a</b>, conducted with potassium <i>tert-</i>butoxide under air (1 atm) in DMSO afforded <b>14</b> with 78% yield. N-Alkylation of <b>14</b> by treatment with sodium hydride and methyl iodide led to analogues <b>15a</b>. The same reaction using ethyl bromoacetate, followed by saponification led to acid <b>15c</b> with 31% yield over two steps.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Hit Compound <b>13</b> and Its Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) CuCN, DMF, reflux, 6 h; (b) (1) cyclohexylmagnesium chloride, CuBr, dry THF, reflux, 2 h; (2) H<sub>2</sub>O, H<sub>2</sub>SO<sub>4</sub> 15%; (c) <i>t</i>-BuOK, DMSO, O<sub>2</sub>, rt, 3 h; (d) ethylene glycol, <i>p</i>-toluenesulfonic acid monohydrate, toluene, reflux, 6 h; (e) 0.1 M HCl, THF, rt, 5 h; (f) NaH, ethyl bromoacetate or methyl iodide, dry DMF, 0 °C to rt, 2 h; (g) LiOH, THF/H<sub>2</sub>O, 0 °C to rt, 2 h.</p></p></figure><div class="NLM_p">Various aryl and heteroaryl groups were introduced on the tetrahydroquinoline ring of <b>16</b> using Suzuki cross-coupling, affording <b>17a</b>–<b>i</b> analogues with moderate to good yields (41–83%) (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Boronic acids used for the Suzuki coupling were commercially available except 1-methyl-4-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]sulfonyl]piperazine, which was synthesized in 2 steps from 4-bromobenzene-1-sulfonyl chloride.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Analogues <b>16</b>, <b>17a</b>–<b>i</b>, and <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) <i>t</i>-BuOK, DMSO, O<sub>2</sub>, rt, 3 h; (b) corresponding boronic acid, K<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, DMF/H<sub>2</sub>O, 90 °C, 1–14 h; (c) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf), dry dioxane, 80 °C, 21 h; (d) 2-chloropyridine, K<sub>3</sub>PO<sub>4</sub>, PdCl<sub>2</sub>(dppf), dioxane/H<sub>2</sub>O, 100 °C, 4 h.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure of Analogues <b>17a</b>–<b>i</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0014.gif" alt="" id="fx1" /></img><div></div></div><div class="NLM_p last">Challenging introduction of the 2-pyridinyl group directly from aryl bromide <b>16</b> using MIDA boronic ester<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> led to only traces of product and degradation of the starting material. As a result, we decided to convert aryl bromide <b>16</b> to the corresponding boronic acid pinacol ester, which was directly engaged in a Suzuki coupling with 2-chloropyridine to yield compound <b>18</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hit compound <b>13</b>, an inactive analogue of PPAR agonists that have been developed in our lab, was found to inhibit STAT5 phosphorylation in KU812 cells 72 h after treatment at 10 μM. However, proliferation and viability assays showed only a moderate cytotoxic efficiency on KU812 and K562 cells, with an EC<sub>50</sub> of 0.2 mM and 8 mM, respectively.</div><div class="NLM_p">As acid and ketone substituents of hit <b>13</b> were chosen in accordance with PPAR activity, we studied their relevance toward the inhibition of STAT5 activity and cytotoxic efficiency on CML cell lines, while keeping hit <b>13</b> as the central scaffold. For this purpose and in order to study structure–activity relationships, pharmacomodulations on indole and tetrahydroquinoline rings were conducted.</div><div class="NLM_p">Initial screenings were carried out to determine the growth inhibitory property of all newly synthesized compounds. KU812 and K562 cells were treated with 10 μM of each compound or DMSO as the control, and the kinetics of cell growth were determined by MTT and trypan blue dye exclusion assays (data for compounds with antiproliferative activity lower than <b>13</b> are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">On the one hand, deletion of the cyclohexyl carbonyl group on the tetrahydroquinoline led to compound <b>15c</b>, which lost antiproliferative efficiency after 48 h on K562 cells and had no effect on KU812 cells. On the other hand, removal of the acetic acid group led to compound <b>11</b>, which showed the same activity as that of <b>13</b> on K562 cells but lost it at 72 h. On KU812 cells, the antiproliferative potency of <b>11</b> could be suspected at 24 h but was lost after 48 h. Finally, we removed both terminal substituents to yield <b>14</b>, which showed a better improvement of cytotoxic efficiency on K562 and KU812 cell lines. The activity was better than <b>13</b>, and interestingly, growth inhibition was observed only after 24 h treatment (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Growth kinetics of KU812 cells treated with 10 μM of each compound as indicated or DMSO as the control. (B) Growth kinetics of K562 cells treated with each compound or DMSO as the control as in A (<i>n</i> = 3 in triplicate; data are the mean ± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate further the importance of the free indole, intermediates <b>6a</b> and <b>15b</b>, respectively, N-alkylated with a benzyl group and an acetate group, were both evaluated and found to be inactive. To rule out steric hindrance effects and to validate the importance of the free indole as hydrogen bond donor, <b>14</b> was <i>N</i>-alkylated with the minimally hindering methyl group to yield compound <b>15a</b>. As the latter showed no activity, the free nitrogen was identified as essential for the efficiency.</div><div class="NLM_p">From this point, the free nitrogen was retained on the indole, while the 6-position of the tetrahydroquinoline was investigated further. To obtain a convergent and facile route for pharmacomodulations, introduction of a bromine atom on this position yielded <b>16</b>, found to have activity similar to that of <b>13</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Growth kinetics of KU812 cells treated with 10 μM of each compound as indicated or DMSO as the control. (B) Growth kinetics of K562 cells treated with each compound or DMSO as the control as in A (<i>n</i> = 3 in triplicate; data are the mean ± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Starting from <b>16</b>, a small collection of aryl and heteroaryl substituents were introduced, i.e., phenyl, 4-fluorophenyl, 3-nitrophenyl, 3-thiophenyl, 2-furanyl, 3-pyridinyl, 6-chloropyridin-3-yl, 4-pyrininyl, and 4-((4-methylpiperazin-1-yl)sulfonyl)phenyl, which led to compounds <b>17a</b>–<b>i</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</div><div class="NLM_p"><b>17f</b> was identified as the most antiproliferative molecule in KU812 and K562 cells, while <b>17g</b> was as efficient as <b>17f</b> in the growth inhibition of KU812 cells. Compared to hit <b>13</b>, their activities were clearly increased. <b>17c</b> with a 3-nitrophenyl group possessed the same electronic distribution as <b>17f</b> but was inactive. Moreover, <b>17a</b> with the phenyl group retained the same volume as <b>17f</b> but was inactive. We assumed the hydrogen bond acceptor character of the nitrogen of the pyridine of <b>17f</b> was required for the activity. By changing the position of the nitrogen of the pyridine, from 3 to 4, the antiproliferative efficiency of <b>17h</b>, still potent, was slightly reduced compared to <b>17f</b> and <b>17g</b>. Changing the position of the nitrogen of the pyridine from 3 to 2, leading to <b>18</b>, resulted in a decrease of antiproliferative activity.</div><div class="NLM_p">Five compounds (<b>14</b>, <b>16</b>, <b>17f</b>–<b>h</b>) with similar or better antiproliferative activities than hit <b>13</b> were selected from this initial screening and tested for their capacity to induce apoptosis in KU812 cells. We observed that <b>17f</b>, <b>17g</b>, and <b>17h</b> significantly increased the number of apoptotic cells as measured by AnnexinV/7AAD staining (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative flow cytometry histogram of KU812 cells cultured for 48 h with indicated compounds (10 μM) or control DMSO. Cells were stained with FITC-Annexin V and 7-AAD, and the percentages of apoptotic cells were then evaluated by flow cytometry (<i>n</i> = 3 in triplicate; data are the mean ± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">EC<sub>50</sub> values for these molecules were also calculated and clearly indicated that <b>17f</b> was the most active inhibitor of K562 and KU812 cell growth and viability (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Apoptosis experiments with <b>17f</b> in K562 cells were also realized by AnnexinV/7AAD staining (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. EC<sub>50</sub> Values of Selected Compounds for K562 and KU812 Cells<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">K562</th><th class="colsep0 rowsep0" align="center">KU812</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">8658.96 ± 59.52</td><td class="colsep0 rowsep0" align="left">196.57 ± 16.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">78.13 ± 2.73</td><td class="colsep0 rowsep0" align="left">14.63 ± 2.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">15.58 ± 1.67</td><td class="colsep0 rowsep0" align="left">7.59 ± 0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17f</b></td><td class="colsep0 rowsep0" align="left">8.74 ± 1.54</td><td class="colsep0 rowsep0" align="left">5.38 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17g</b></td><td class="colsep0 rowsep0" align="left">13.04 ± 3.21</td><td class="colsep0 rowsep0" align="left">5.41 ± 1.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17h</b></td><td class="colsep0 rowsep0" align="left">22.65 ± 1.09</td><td class="colsep0 rowsep0" align="left">9.38 ± 1.18</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Cells were treated with concentrations ranging from 100 nM to 50 μM for 48 h. Cell viability was then determined by MTT assays, and EC<sub>50</sub> values were calculated using Origin software (<i>n</i> = 3 in triplicate; data are the mean ± SEM) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">Supporting Information</a>).</p></div></div></div><div class="NLM_p">Interestingly, this inhibitory effect was not blocked by GW9662, an antagonist of PPARγ indicating that PPARγ activation was not involved in <b>17f</b>-mediated inhibition of cell growth (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> We then addressed whether the biological effect of this molecule correlated with the suppression of STAT5 activity in KU812 and K562 cells. We first evaluated the impact of <b>17f</b> on <i>STAT5A</i> and <i>STAT5B</i> gene expression in KU812 cells by qRT-PCR experiments. Results showed that <b>17f</b> had no effect on <i>STAT5A</i> and <i>STAT5B</i> mRNA levels in KU812 cells treated for 15 h with this molecule (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). We then analyzed the phosphorylation and expression of STAT5 in KU812 and K562 cells exposed to <b>17f</b> (10 μM) for 12 h. We observed that <b>17f</b> inhibited STAT5 phosphorylation in both leukemia cell lines (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) qRT-PCR analysis of <i>STAT5A</i> and <i>STAT5B</i> transcripts in KU812 cells treated or not with <b>17f</b> (10 μM) or DMSO as the control for 15 h. Results are presented as the fold changes in gene expression in <b>17f</b>-treated cells normalized to internal control genes (<i>GAPDH</i> and <i>ACTB</i>) and relative to control cells (normalized to 1) (<i>n</i> = 3 in triplicate; data are the mean ± SEM). (B) Protein extracts from KU812 and K562 cells treated with <b>17f</b> (+) or DMSO (−) for 12 h were analyzed by Western blotting to detect P-Y-STAT5 and STAT5 protein expression (<i>n</i> = 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We then addressed whether <b>17f</b> inhibited STAT5 transcriptional activity in KU812 cells. qRT-PCR experiments were conducted to determine effects of <b>17f</b> on STAT5-dependent expression of target genes such as <i>PIM1</i>, <i>CYCLIN D1</i>, <i>C-MYC</i>, and <i>MCL-1</i>. We found that <b>17f</b> was able to downregulate <i>PIM1</i> and <i>C-MYC</i> gene expression but had weak effects on <i>CYCLIN D1</i> and <i>MCL-1</i> gene expression (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). We also compared the expression of Pim1, Cyclin D1, and Mcl-1 proteins by Western blot analysis and found that expression of Pim1 was strongly inhibited by <b>17f</b> in KU812 cells, while Cyclin D1 and Mcl-1 protein levels were less affected by this compound (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). Cyclin D1 and Mcl-1 expressions are also known to be regulated by distinct signaling pathways in Bcr-Abl-expressing cells through transcriptional and post-transcriptional mechanisms.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> We then decided to determine whether <b>17f</b> might directly interfere with the transcriptional activation of a reporter gene driven by a STAT5-specific promoter. KU812 cells were transfected with a construct containing six tandem copies of the STAT5 response element in front of the minimal TK promoter fused to the luciferase reporter gene (6x(STAT5)-TK-luc). As control, cells were also transfected with a TK-luciferase vector without STAT5 response elements (TK-luc). Luciferase activity was then determined 48 h post-transfection in cells treated or not with <b>17f</b>. As expected, constitutive STAT5 activity induced by Bcr-Abl increased luciferase activity in cells transfected with the STAT5-dependent promoter construct compared to cells transfected with the control TK-luc vector (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). This enhanced luciferase activity was selectively reduced after <b>17f</b> treatment. Collectively, these data strongly suggested that <b>17f</b> inhibits the DNA binding and transcriptional activity of STAT5 in CML cells.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) qRT-PCR analysis of <i>PIM1</i>, <i>CYCLIN D1</i>, <i>C-MYC</i>, and <i>MCL-1</i> expression in KU812 cells treated with <b>17f</b> (10 μM) or DMSO (control) for 15 h. Results are presented as the fold changes in <i>PIM1</i>, <i>CYCLIN D1</i>, <i>C-MYC</i>, and <i>MCL-1</i> gene expression in <b>17f</b> cells normalized to internal control genes (<i>GAPDH</i> and <i>ACTB</i>) and relative to untreated cells (normalized to 1) (<i>n</i> = 3 in triplicate; data are the mean ± SEM, *<i>p</i> < 0.05, and ***<i>p</i> < 0.001). (B) Expression of Pim1, Cyclin D1, and Mcl-1 proteins in KU812 cells treated with 10 μM <b>17f</b> (+) or DMSO (−) for 24 h. (C) KU812 cells transfected with a 6×(STAT5)-TK-luciferase reporter construct or a control TK-luciferase vector were treated with <b>17f</b> (10 μM) or DMSO (control) for 48 h. Luciferase activities were next determined as described in <a class="ref internalNav" href="#sec5_1_1" aria-label="Material and Methods">Material and Methods</a>. Luciferase activity (arbitrary units) in the histogram represents the relative luminescence unit (rlu) values/mg of proteins (<i>n</i> = 3 in triplicate; data are the mean ± SEM, ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">STAT5 is also constitutively phosphorylated in AML cells and particularly in myeloid leukemia cells expressing the FLT3-ITD oncogene.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> To exclude the possibility that <b>17f</b>-mediated inhibition of STAT5 and cell growth is a peculiarity of cells expressing Bcr-Abl, we evaluated effects of <b>17f</b> on STAT5 phosphorylation in two AML cell lines. MV-4-11 cells expressing FLT3-ITD and KG1a, an immature AML cell line, were exposed to <b>17f</b> for 12 h, and phosphorylation of STAT5 was then analyzed by Western blot. Results showed that <b>17f</b> strongly reduced STAT5 phosphorylation in both cell lines (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A). We then explored whether <b>17f</b> also inhibited the growth of these leukemic cells. MV-4-11 and KG1a cells were treated with <b>17f</b> (10 μM), and growth kinetics were determined by MTT and trypan blue dye exclusion assays. We found that <b>17f</b> suppressed the growth and viability of these AML cells (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). Importantly, EC<sub>50</sub> values (KG1a: 2.64 μM; MV-4-11: 3.55 μM) showed that <b>17f</b> was even more active in AML cells than in CML cells (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Interestingly enough, the EC<sub>50</sub> value obtained for <b>17f</b> in MV-4-11 cells (3.55 μM) is close to the IC<sub>50</sub> value reported for compound <b>13a</b> (3.5 μM), a STAT5-SH2 inhibitor that selectively binds to STAT5 in a nanomolar range.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In addition, we also found that <b>17f</b> induces apoptosis of KG1a and MV-4-11 cells indicating that <b>17f</b> inhibits STAT5-dependent cell survival (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Protein extracts from MV-4-11 and KG1a cells treated with <b>17f</b> (+) or DMSO (−) for 12 h were analyzed by Western blotting to detect P–Y<sup>694/699</sup>-STAT5 and STAT5 protein expression. (B) Growth kinetics of KG1a (left) and MV-4-11 (right) cells cultured in the absence (DMSO) or presence of <b>17f</b> (10 μM) were determined by MTT assays (<i>n</i> = 3 in triplicate; data are the mean ± SEM). (C) Representative flow cytometry histogram of KG1a and MV-4-11 cells cultured for 48 h with <b>17f</b> (10 μM) or DMSO (control). Cells were stained with FITC-Annexin V and 7-AAD, and the percentages of apoptotic cells were then evaluated by flow cytometry (<i>n</i> = 3 in triplicate; data are the mean ± SEM, *<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. EC<sub>50</sub> Values of <b>17f</b> for KG1a and MV-4-11 Cells<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center"><b>17f</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell lines</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KG1a</td><td class="colsep0 rowsep0" align="left">2.638 ± 0.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MV-4-11</td><td class="colsep0 rowsep0" align="left">3.549 ± 0.47</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Cells were treated with concentrations ranging from 100 nM to 50 μM for 48 h. Cell viability was then determined by MTT assays, and EC<sub>50</sub> values were calculated using Origin software (<i>n</i> = 3 in triplicate; data are the mean ± SEM) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">Supporting Information</a>).</p></div></div></div><div class="NLM_p">To determine the selectivity of <b>17f</b> on STAT5 phosphorylation, we analyzed the effects of this molecule on STAT3, Akt, and Erk1/2 signaling. KG1a, MV-4-11, and KU812 cells were treated with <b>17f</b> (10 μM) for 24 h, and the phosphorylation levels of STAT3, Akt, and Erk1/2 proteins were analyzed by Western blot analysis (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Phosphorylation levels were also determined by band intensity quantification (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">Supporting Information</a>). While phosphorylation of STAT5 was clearly inhibited by <b>17f</b> in all cell lines, effects on STAT3, Akt, and Erk1/2 phosphorylation after 24 h of treatment were almost negligible. Collectively, our findings suggest that the growth-suppressive effect of <b>17f</b> was as a result of blocking STAT5 phosphorylation in AML and CML cells.</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Protein extracts from KG1a, MV-4-11, and KU812 cells treated with <b>17f</b> (+) or DMSO (−) for 24 h were analyzed by Western blotting to detect the phosphorylated forms of STAT5, STAT3, Akt, and Erk1/2 and the total forms of these proteins (<i>n</i> = 2). Actin expression served as a loading control. Quantification of Western blot data is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Bone marrow stromal and mesenchymal stem cells (MSC) are major cellular components of the leukemic and hematopoietic microenvironment and play a vital role in the survival and chemoresistance of leukemic cells. We then analyzed the effects of <b>17f</b> on freshly isolated MSC from human bone marrow. We also included in these experiments HS-27a cells, a human bone marrow stromal cell line that shares similar biological properties with MSC. HS-27a cells constitutively express phosphorylated STAT3 but not phosphorylated STAT5 proteins, while phosphorylation of STAT5 and STAT3 are not detectable in primary MSC (data not shown). Results showed that <b>17f</b> does not significantly or weakly inhibit HS-27a and MSC cell growth with EC<sub>50</sub> values 10- to 20-fold higher than those required to inhibit leukemic cell growth (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A and <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Interestingly, we also found that <b>17f</b> does not affect the phosphorylation of STAT3 in HS-27a cells (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>B). These findings indicated that <b>17f</b> selectively inhibits myeloid leukemia cell growth while sparing normal bone marrow stromal cells of the leukemic niche.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Growth kinetics of HS-27a cells (left) and MSC (right) cultured in the absence (DMSO) or presence of <b>17f</b> (10 μM) were determined by MTT assays (<i>n</i> = 3 in triplicate; data are the mean ± SEM). (B) Extracts from HS-27a cells treated with <b>17f</b> (+) or DMSO (−) were analyzed by Western blotting to detect the phosphorylation and expression of STAT3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. EC<sub>50</sub> Values of <b>17f</b> for HS-27a and MSC Cells (3 Donors)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center"><b>17f</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cells</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HS27A</td><td class="colsep0 rowsep0" align="left">63.67 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MSC</td><td class="colsep0 rowsep0" align="left">33.65 ± 5.87</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Cells were treated with concentrations ranging from 1 μM to 100 μM for 48 h. Cell viability was then determined by MTT assays, and EC<sub>50</sub> values were calculated using Origin software (<i>n</i> = 3 in triplicate; data are the mean ± SEM) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">Supporting Information</a>).</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, among the 18 analogues of hit <b>13</b> that have been synthesized, compound <b>17f</b> was found to be the most potent inhibitor of AML and CML cell growth with encouraging EC values. Interestingly, the antileukemic effect of <b>17f</b> was even more pronounced in AML cells than in CML cells. Key structural features for the <b>17f</b>-mediated antiproliferative effect are the free nitrogen of the indole ring along with the C-6 tetrahydroquinoline 3-pyridinyl substitution.</div><div class="NLM_p">We also demonstrated that <b>17f</b> inhibits STAT5 phosphorylation in AML and CML and STAT5-dependent transcriptional activity. Importantly, we found that <b>17f</b> has no or weak impact on the major cellular components of the leukemic niche and does not affect STAT3, Akt, or Erk1/2 signaling in leukemia cells suggesting that <b>17f</b> selectively targets myeloid leukemia cells addicted to STAT5 signaling. These data also indicate that <b>17f</b> or derivatives might be of potential interest to analyze their impact on leukemia cells in contact with their stromal microenvironment.</div><div class="NLM_p last">In the aim of improving cell growth and STAT5 phosphorylation inhibition, in AML and CML cells, alternative modifications on the central scaffold of <b>17f</b> are being investigated. For instance, modification of the linker and substitution of indole by its isosteres indazole and 7-azaindole are currently undertaken.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60868" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60868" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Materials and Methods</h4><div class="NLM_p">All commercial materials were used without further purification. For anhydrous and inert reactions, the glassware was heated with a heat gun, while several vacuum-dry argon cycles were performed. The thin layer chromatography (TLC) studies were performed using commercial precoated aluminum sheets silica gel (60 Å, F<sub>254</sub>) marketed by Merck and revealed under UV 254 and 365 nm lighting. The purifications by chromatography on silica gel columns were carried out on an ISCO purification unit, Combi Flash RF 75 PSI, with Redisep flash silica gel columns (60 Å, 230–400 mesh, grade 9385). NMR spectra were measured on a Bruker Ultrashield 300 spectrometer, 300 MHz (<sup>1</sup>H), 282 MHz (<sup>19</sup>F), and 75 MHz (<sup>13</sup>C) in deuterated chloroform (CDCl<sub>3</sub>) or dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>). Chemical shifts are given in parts per million (ppm) (δ relative to the residual solvent peak for <sup>1</sup>H and <sup>13</sup>C). The notations used are δ, chemical shift (ppm); s, singlet; d, doublet; dd, doublet of doublet; t, triplet; m, multiplet; br, broad signal; <i>J</i>, coupling constant (Hz). HRMS was performed by the mass spectrometry service on a Q-Exactive spectrometer from Thermo Scientific using the electrospray ionization (ESI) technique. Melting points (mp) were taken in open capillaries on a Büchi melting point apparatus Model B-540. If necessary, the purity was determined by high performance liquid chromatography (HPLC). The purity of all final compounds was 95% or higher. HPLC analyses were carried out with a LaChrom Elite system [Hitachi L-2130 (pump) and L-2400 (UV-detector)] using 254 nm UV for detection. The column was a Phenomenex Synergi C-12, 4 μm particle size (100 mm × 4.6 mm), supported by a Phenomenex Security Guard cartridge kit C12 (4.0 mm × 3.0 mm); elution was performed with 0.2% (by volume) of TFA in water (solvent A) and acetonitrile (solvent B); gradient 35–100% of B with a flow rate of 1 mL·min<sup>–1</sup>; column temperature of 25 °C; and injection of 10 μL in DMSO.</div><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> <i>N</i>-(4-Bromophenyl)-3-methylbut-2-enamide (<b>1</b>)</h5><div class="NLM_p last">To a stirred solution of 4-bromoaniline (17.20 g, 100.00 mmol) in dry pyridine (43 mL) at 0 °C under argon was added dropwise 3,3-dimethylacryloyl chloride (13.35 mL, 120.00 mmol). The reaction mixture was stirred for 5 h at rt and then carefully poured into an Erlenmeyer flask containing 1 M HCl (750 mL) under magnetic stirring. The product was filtered, washed by water (2 × 100 mL) and heptane (2 × 100 mL), then purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (90/10) as eluent to give the title compound <b>1</b> as a white solid (24.9 g, 98%); mp 122 °C. <sup>1</sup>H NMR (DMSO, 300 MHz): δ 9.96 (s, 1H), 7.70–7.51 (m, 2H), 7.51–7.37 (m, 2H), 5.93–5.75 (m, 1H), 2.14 (d, <i>J</i> = 1.1 Hz, 3H), 1.86 (d, <i>J</i> = 1.0 Hz, 3H). <sup>13</sup>C NMR (DMSO, 75 MHz): δ 164.7, 152.0, 138.9, 131.4 (2C), 120.9 (2C), 118.9, 114.4, 27.1, 19.5. HRMS-ESI (<i>m</i>/<i>z</i>): found, 254.01618; calcd, for C<sub>11</sub>H<sub>13</sub>BrNO [M + H]<sup>+</sup> 254.01750.</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> 6-Bromo-4,4-dimethyl-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>2</b>)</h5><div class="NLM_p last">To a stirred solution of <i>N</i>-(4-bromophenyl)-3-methylbut-2-enamide <b>1</b> (24.90 g, 97.98 mmol) in dry dichloromethane (120 mL) at 0 °C under argon was added portionwise aluminum chloride (52.30 g, 391.92 mmol) over 30 min. The resulting mixture was stirred for 1 h at rt, then poured on ice and extracted with diethyl ether (5 × 100 mL). The combined organic extracts were washed with saturated aqueous NaHCO<sub>3</sub> solution (1 × 200 mL), brine (1 × 100 mL), and then dried using MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by recrystallization in ethanol to give the title compound <b>2</b> as a white solid (23.3 g, 94%); mp 176 °C. <sup>1</sup>H NMR (DMSO, 300 MHz): δ 10.26 (s, 1H), 7.40 (d, <i>J</i> = 2.2 Hz, 1H), 7.33 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 6.82 (d, <i>J</i> = 8.4 Hz, 1H), 2.35 (s, 2H), 1.21 (s, 6H). <sup>13</sup>C NMR (DMSO, 75 MHz): δ 169.2, 136.4, 134.7, 129.9, 127.1, 117.4, 114.1, 44.4, 33.8, 27.0 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 254.01628; calcd, for C<sub>11</sub>H<sub>13</sub>BrNO [M + H]<sup>+</sup> 254.01750.</div></div><div id="sec5_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> 6-Bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline (<b>3</b>)</h5><div class="NLM_p last">To a stirred solution of 6-bromo-4,4-dimethyl-3,4-dihydroquinolin-2(1<i>H</i>)-one <b>2</b> (8.60 g, 33.84 mmol) in dry toluene (65 mL) at 0 °C under argon was added dropwise a solution of 1 M BH<sub>3</sub>·THF (85 mL, 85.00 mmol). The resulting mixture was refluxed for 4 h and then quenched at 0 °C by the addition of saturated aqueous NaHCO<sub>3</sub> solution. The reaction medium was extracted with ethyl acetate (2 × 200 mL), then the combined organic extracts were washed with brine (1 × 100 mL) and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (90/10) as eluent to give the title compound <b>3</b> as a colorless oil (7.80 g, 96%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.25 (d, <i>J</i> = 2.3 Hz, 1H), 7.02 (dd, <i>J</i> = 8.5, 2.3 Hz, 1H), 6.35 (d, <i>J</i> = 8.5 Hz, 1H), 3.97 (s, 1H), 3.32–3.25 (m, 2H), 1.74–1.67 (m, 2H), 1.27 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 142.6, 132.3, 129.3, 129.2, 115.8, 108.5, 38.4, 36.8, 32.0, 30.8 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 240.03699; calcd, for C<sub>11</sub>H<sub>15</sub>BrN [M + H]<sup>+</sup> 240.03824.</div></div><div id="sec5_1_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Method A: Heterocyclic Amine Alkylation (<b>5</b>; <b>13a</b>–<b>13b</b>)</h5><div class="NLM_p last">To a stirred solution of the corresponding heterocyclic amine (1.0 equiv) in dry DMF at 0 °C was added portionwise NaH (1.2 equiv). The resulting mixture was stirred for 30 min, and then, the corresponding alkyl halide (1.2 equiv) was added dropwise. The reaction mixture was stirred at rt for 2 h, carefully hydrolyzed by water, and extracted with ethyl acetate. The combined organic extracts were washed four times with brine to remove DMF and dried using MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel.</div></div><div id="sec5_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> 1-Benzyl-5-bromo-1<i>H</i>-indole (<b>4</b>)</h5><div class="NLM_p last">The title compound was synthesized according to method A using 5-bromoindole (18.00 g, 91.82 mmol), NaH (4.42 g at 60%, 110.20 mmol), and benzyl bromide (13.11 mL, 110.20 mmol) in dry DMF (117 mL). The crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (98/2) as eluent to give the title compound <b>4</b> as a white solid (26.10 g, 99%); mp 91 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.82–7.70 (m, 1H), 7.35–7.21 (m, 4H), 7.16–7.04 (m, 4H), 6.49 (dd, <i>J</i> = 3.2, 0.8 Hz, 1H), 5.30 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 137.1, 135.1, 130.5, 129.6, 129.0 (2C), 127.9, 126.8 (2C), 124.6, 123.6, 113.0, 111.3, 101.4, 50.4. HRMS-ESI (<i>m</i>/<i>z</i>): found, 286.02133; calcd, for C<sub>15</sub>H<sub>13</sub>BrN [M + H]<sup>+</sup> 286.02259.</div></div><div id="sec5_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> 2-((1-Benzyl-1<i>H</i>-indol-5-yl)oxy)ethanol (<b>5</b>)</h5><div class="NLM_p last">In a dry 50 mL round-bottomed Schlenk flask under argon was added 1-benzyl-5-bromo-1<i>H</i>-indole <b>4</b> (3.00 g, 10.48 mmol), Cs<sub>2</sub>CO<sub>3</sub> (5.12 g, 15.72 mmol), copper(I) iodide (0.20 g, 1.05 mmol), and 3,4,7,8-tetramethyl-1,10-phenanthroline (0.50 g, 2.10 mmol). The flask was placed under vacuum and refilled with argon three times, then dry ethylene glycol (15 mL) was added as solvent. The resulting mixture was vigorously stirred at 130 °C for 72 h. The reaction mixture was filtered through a pad of dicalite and extracted with ethyl acetate. Combined organic extracts were washed with brine and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (7/3) as eluent to give the title compound <b>5</b> as a white solid (1.71 g, 61%); mp 95 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.34–7.21 (m, 3H), 7.16 (d, <i>J</i> = 8.9 Hz, 1H), 7.14–7.06 (m, 4H), 6.85 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.47 (dd, <i>J</i> = 3.1, 0.7 Hz, 1H), 5.30 (s, 2H), 4.15–4.10 (m, 2H), 4.00–3.94 (m, 2H), 2.11 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 153.1, 137.7, 132.1, 129.2, 129.2, 128.9 (2C), 127.7, 126.8 (2C), 112.6, 110.7, 104.2, 101.4, 70.2, 61.9, 50.4. HRMS-ESI (<i>m</i>/<i>z</i>): found, 268.13294; calcd, for C<sub>17</sub>H<sub>18</sub>NO<sub>2</sub> [M + H]<sup>+</sup> 268.13321.</div></div><div id="sec5_1_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Method B: Reductive Amination (<b>6a</b>–<b>b</b>)</h5><div class="NLM_p last">To a stirred solution of 2-((1-benzyl-1<i>H</i>-indol-5-yl)oxy)ethanol <b>5</b> (1.0 equiv) in dry DCE under argon was added 2-iodoxybenzoic acid (IBX) (3.0 equiv). The resulting mixture was stirred for 2 h at 80 °C and then cooled to rt. The reaction medium was filtered through a sintered glass funnel over a round-bottomed flask containing the corresponding amine (2.0 equiv) in dry DCE (10 mL). The resulting mixture was stirred for 15 min, and then, NaBH(AcO)<sub>3</sub> (1.4 equiv) was added. The reaction medium was stirred 2 h at rt and then hydrolyzed with saturated aqueous NaHCO<sub>3</sub> solution. After extraction with ethyl acetate, the combined organic extracts were washed with brine and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel.</div></div><div id="sec5_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 1-(2-((1-Benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline (<b>6a</b>)</h5><div class="NLM_p last">The title compound was synthesized according to method B using 2-((1-benzyl-1<i>H</i>-indol-5-yl)oxy)ethanol <b>5</b> (1.70 g, 6.36 mmol), IBX (5.34 g, 19.08 mmol), 4,4-dimethyl-1,2,3,4-tetrahydroquinoline (2.05 g, 12.72 mmol), and NaBH(AcO)<sub>3</sub> (1.89 g, 8.90 mmol) in dry DCE (20 mL). In this case, the purification of the crude product by flash chromatography on silica gel using cyclohexane/ethyl acetate (98/2) gave a mixture of the title compound <b>6a</b> with 4,4-dimethyl-1,2,3,4-tetrahydroquinoline. The mixture was dissolved in diethyl ether (100 mL), washed by 1 M HCl (1 × 100 mL) and brine (1 × 100 mL), dried with MgSO<sub>4</sub>, and evaporated under reduced pressure to give <b>6a</b> as a colorless oil (2.00 g, 77%). HPLC purity: 98.3%, <sup>t</sup><i>R</i> = 24.94 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.33–7.23 (m, 3H), 7.20 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.14 (d, <i>J</i> = 8.9 Hz, 1H), 7.12–7.00 (m, 5H), 6.82 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.69–6.59 (m, 2H), 6.44 (dd, <i>J</i> = 3.1, 0.8 Hz, 1H), 5.29 (s, 2H), 4.20 (t, <i>J</i> = 6.3 Hz, 2H), 3.74 (t, <i>J</i> = 6.3 Hz, 2H), 3.51–3.42 (m, 2H), 1.79–1.71 (m, 2H), 1.28 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 153.4, 143.8, 137.7, 131.9, 131.2, 129.2, 129.0, 128.9 (2C), 127.7, 127.0, 126.8 (2C), 126.2, 115.8, 112.5, 110.7, 110.6, 103.9, 101.3, 65.5, 51.0, 50.4, 46.8, 37.2, 32.1, 30.8 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 411.24285; calcd, for C<sub>28</sub>H<sub>31</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 411.24309.</div></div><div id="sec5_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 1-(2-((1-Benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline (<b>6b</b>)</h5><div class="NLM_p last">In this case, 1.5 equiv of amine <b>3</b> and 2.0 equiv of NaBH(AcO)<sub>3</sub> were used. The title compound was synthesized according to method B, using 2-((1-benzyl-1<i>H</i>-indol-5-yl)oxy)ethanol <b>5</b> (3.40 g, 12.72 mmol), IBX (10.69 g, 38.16 mmol), 6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>3</b> (4.58 g, 19.08 mmol), and NaBH(AcO)<sub>3</sub> (5.39 g, 25.44 mmol) in dry DCE (10 mL). In this case, the purification of the crude product by flash chromatography on silica gel using cyclohexane/ethyl acetate (98/2) gave a mixture of the title compound <b>6b</b> with <b>3</b>. The mixture was dissolved in diethyl ether (200 mL), washed by 3 M HCl (3 × 100 mL) and brine (1 × 100 mL), dried with MgSO<sub>4</sub>, and evaporated under reduced pressure to give <b>6b</b> as a white solid (3.98 g, 64%); mp 89 °C. HPLC purity: 99.6%, <sup>t</sup><i>R</i> = 28.82 min. <sup>1</sup>H NMR (300 MHz, DMSO) δ 7.43 (d, <i>J</i> = 3.0 Hz, 1H), 7.32–7.17 (m, 5H), 7.17–7.10 (m, 2H), 7.10–7.02 (m, 2H), 6.71 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.62 (d, <i>J</i> = 8.9 Hz, 1H), 6.36 (d, <i>J</i> = 2.6 Hz, 1H), 5.35 (s, 2H), 4.11 (t, <i>J</i> = 5.6 Hz, 2H), 3.66 (t, <i>J</i> = 5.5 Hz, 2H), 3.43–3.38 (m, 2H), 1.67–1.59 (m, 2H), 1.18 (s, 6H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 152.6, 142.7, 138.4, 133.1, 131.1, 129.7, 129.1, 128.7, 128.5 (2C), 128.0, 127.3, 126.9 (2C), 112.7, 111.6, 110.9, 106.2, 103.3, 100.6, 64.9, 50.1, 49.2, 45.8, 36.0, 31.8, 30.1 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 489.15330; calcd, for C<sub>28</sub>H<sub>30</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup> 489.15360.</div></div><div id="sec5_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 1-(2-((1-Benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline-6-carbonitrile (<b>7</b>)</h5><div class="NLM_p last">A mixture of 1-(2-((1-benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>6b</b> (1.96 g, 4.01 mmol), copper(I) cyanide (3.59 g, 40.11 mmol), and DMF (17 mL) was refluxed for 6 h. After cooling to rt, the mixture was diluted with 30% aqueous NaCN solution (80 mL), and the resulting solution was extracted with ethyl acetate (3 × 100 mL). The combined organic extracts were washed with brine (4 × 100 mL) and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (96/4) as eluent to give the title compound <b>7</b> as a greenish oil (1.20 g, 69%). <sup>1</sup>H NMR (300 MHz, DMSO) δ 7.45 (d, <i>J</i> = 2.0 Hz, 1H), 7.43 (d, <i>J</i> = 3.0 Hz, 1H), 7.36–7.09 (m, 7H), 7.05 (d, <i>J</i> = 2.3 Hz, 1H), 6.78 (d, <i>J</i> = 8.8 Hz, 1H), 6.70 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 6.36 (d, <i>J</i> = 2.9 Hz, 1H), 5.35 (s, 2H), 4.14 (t, <i>J</i> = 5.3 Hz, 2H), 3.76 (t, <i>J</i> = 5.3 Hz, 2H), 3.54–3.46 (m, 2H), 1.67–1.59 (m, 2H), 1.18 (s, 6H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 152.5, 147.0, 138.4, 131.2, 131.1 (2C), 129.7, 129.2, 128.7, 128.5 (2C), 127.3, 126.9 (2C), 120.9, 111.5, 110.9, 110.8, 103.3, 100.6, 95.3, 65.0, 49.9, 49.2, 46.1, 35.2, 31.5, 29.5 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 436.23811; calcd, for C<sub>29</sub>H<sub>30</sub>N<sub>3</sub>O [M + H]<sup>+</sup>436.23834.</div></div><div id="sec5_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> (1-(2-((1-Benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-6-yl)(cyclohexyl)methanone (<b>8</b>)</h5><div class="NLM_p last">To a stirred solution of 1-(2-((1-benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline-6-carbonitrile <b>7</b> (2.14 g, 4.91 mmol) in dry THF (30 mL) under argon were added cyclohexylmagnesium chloride (2 M solution in diethyl ether, 3.7 mL, 7.37 mmol) and copper(I) bromide (14 mg, 0.098 mmol). The resulting mixture was refluxed for 45 min. After cooling to rt, water (2.5 mL) was carefully added, followed by an aqueous solution of H<sub>2</sub>SO<sub>4</sub> (20 mL, 15%). After stirring for 20 h, the reaction mixture was extracted with dichloromethane (3 × 100 mL), the combined organic extracts were washed with saturated aqueous NaHCO<sub>3</sub> solution (1 × 100 mL) and brine (1 × 100 mL), and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel using petroleum ether/ethyl acetate (90/10) as eluent to give the title compound <b>8</b> as a yellowish solid (1.71 g, 67%); mp 69 °C. HPLC purity: 98.9%, <sup>t</sup><i>R</i> = 28.90 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.91 (d, <i>J</i> = 2.1 Hz, 1H), 7.69 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 7.35–7.19 (m, 3H), 7.14 (d, <i>J</i> = 8.9 Hz, 1H), 7.12–6.96 (m, 4H), 6.80 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.63 (d, <i>J</i> = 8.8 Hz, 1H), 6.45 (d, <i>J</i> = 3.0 Hz, 1H), 5.29 (s, 2H), 4.23 (t, <i>J</i> = 5.9 Hz, 2H), 3.81 (t, <i>J</i> = 5.8 Hz, 2H), 3.61–3.50 (m, 2H), 3.26–3.13 (m, 1H), 1.90–1.68 (m, 7H), 1.60–1.33 (m, 5H), 1.31 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 202.1, 153.1, 147.6, 137.7, 131.9, 130.8, 129.2, 129.2, 128.9 (2C), 128.6, 127.7, 126.8 (3C), 124.1, 112.4, 110.6, 109.4, 104.0, 101.3, 65.5, 51.0, 50.4, 47.1, 44.9, 36.3, 32.0, 30.2 (2C), 29.9 (2C), 26.2, 26.2 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 521.31702; calcd, for C<sub>35</sub>H<sub>41</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 521.31625.</div></div><div id="sec5_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 1-(2-((1-Benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-6-(2-cyclohexyl-1,3-dioxolan-2-yl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline (<b>9</b>)</h5><div class="NLM_p last">To a stirred solution of (1-(2-((1-benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-6-yl)(cyclohexyl)methanone <b>8</b> (0.50 g, 0.96 mmol) in dry toluene (11 mL) under argon were added dry ethylene glycol (2.15 mL, 38.40 mmol) and <i>p</i>-toluenesulfonic acid monohydrate (6 mg, 0.03 mmol). The biphasic mixture was vigorously stirred at reflux with a Dean–Stark trap for 6 h. After cooling to rt, the mixture was washed with saturated aqueous NaHCO<sub>3</sub> solution (2 × 50 mL) and brine (2 × 50 mL), and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (96/4) as eluent to give the title compound <b>9</b> as a pale yellow solid (0.20 g, 37%); mp 66 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ 7.43 (d, <i>J</i> = 3.0 Hz, 1H), 7.32–7.17 (m, 4H), 7.17–7.11 (m, 2H), 7.06 (d, <i>J</i> = 1.7 Hz, 2H), 6.90 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 6.72 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 6.59 (d, <i>J</i> = 8.6 Hz, 1H), 6.34 (d, <i>J</i> = 3.0 Hz, 1H), 5.35 (s, 2H), 4.12 (t, <i>J</i> = 5.6 Hz, 2H), 3.84 (t, <i>J</i> = 6.8 Hz, 2H), 3.65 (t, <i>J</i> = 5.6 Hz, 2H), 3.57 (t, <i>J</i> = 6.7 Hz, 2H), 3.44–3.38 (m, 2H), 1.75–1.47 (m, 8H), 1.18 (s, 6H), 1.14–0.82 (m, 5H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 152.7, 142.9, 138.4, 131.1, 129.6, 129.4, 128.7, 128.5 (2C), 127.4, 127.3, 126.9 (2C), 124.7, 123.7, 111.6, 111.3, 110.8, 109.7, 103.3, 100.6, 65.1, 63.8 (2C), 50.2, 49.2, 46.6, 45.9, 36.5, 31.5, 30.7 (2C), 26.8 (2C), 26.0, 25.7 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 565.34142; calcd, for C<sub>37</sub>H<sub>45</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 565.34247.</div></div><div id="sec5_1_1_10_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Method C: Heterocyclic Amine Debenzylation (<b>10</b>, <b>14</b>, and <b>16</b>)</h5><div class="NLM_p last">To a stirred solution of the benzyl indole (1.0 equiv) in DMSO at rt was added <i>t</i>-BuOK (7.0 equiv). Dry air was then bubbled into the solution and stirred 2 h at rt. The reaction mixture was quenched with saturated aqueous NH<sub>4</sub>Cl solution, extracted with ethyl acetate, washed with brine and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel.</div></div><div id="sec5_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-6-(2-cyclohexyl-1,3-dioxolan-2-yl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline (<b>10</b>)</h5><div class="NLM_p last">In this case, 14.0 equiv of <i>t</i>-BuOK were used. The title compound was synthesized according to method C using 1-(2-((1-benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-6-(2-cyclohexyl-1,3-dioxolan-2-yl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>9</b> (180 mg, 0.32 mmol) and <i>t</i>-BuOK (502 mg, 4.47 mmol) in DMSO (30 mL). The crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (90/10) as eluent to give <b>10</b> as a white solid (126 mg, 83%); mp 71 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ 10.91 (s, 1H), 7.35–7.20 (m, 2H), 7.07 (d, <i>J</i> = 1.9 Hz, 1H), 7.04 (d, <i>J</i> = 2.1 Hz, 1H), 6.91 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.72 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 6.60 (d, <i>J</i> = 8.6 Hz, 1H), 6.32–6.26 (m, 1H), 4.13 (t, <i>J</i> = 5.5 Hz, 2H), 3.84 (t, <i>J</i> = 6.8 Hz, 2H), 3.66 (t, <i>J</i> = 5.5 Hz, 2H), 3.58 (t, <i>J</i> = 6.7 Hz, 2H), 3.46–3.38 (m, 2H), 1.75–1.50 (m, 8H), 1.19 (s, 6H), 1.14–0.87 (m, 5H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 152.4, 142.9, 131.1, 129.4, 128.0, 127.4, 125.8, 124.7, 123.6, 112.0, 111.5, 111.4, 109.7, 102.7, 100.8, 65.1, 63.8 (2C), 50.3, 46.6, 45.9, 36.5, 31.5, 30.7 (2C), 26.8 (2C), 26.0, 25.7 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 475.29434; calcd, for C<sub>30</sub>H<sub>38</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 475.29552.</div></div><div id="sec5_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> (1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-6-yl)(cyclohexyl)methanone (<b>11</b>)</h5><div class="NLM_p last">To a stirred solution of 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-(2-cyclohexyl-1,3-dioxolan-2-yl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>10</b> (60 mg, 0.126 mmol) in THF (10 mL) under argon was added HCl (1 M solution in water, 2.5 mL, 2.50 mmol). The resulting mixture was stirred at rt for 2 h. After evaporation of the solvent under reduced pressure, the residue was extracted with ethyl acetate. The combined organic extracts were washed with saturated aqueous NaHCO<sub>3</sub> solution (1 × 50 mL), brine (1 × 50 mL), and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (85/15) as eluent to give the title compound <b>11</b> as a white solid (41 mg, 76%); mp 77 °C. HPLC purity: 99.5%, <sup>t</sup><i>R</i> = 24.00 min. <sup>1</sup>H NMR (300 MHz, DMSO) δ 10.91 (s, 1H), 7.72 (d, <i>J</i> = 2.0 Hz, 1H), 7.64 (dd, <i>J</i> = 8.8, 1.9 Hz, 1H), 7.29–7.22 (m, 2H), 7.03 (d, <i>J</i> = 2.2 Hz, 1H), 6.76–6.67 (m, 2H), 6.31–6.27 (m, 1H), 4.17 (t, <i>J</i> = 5.4 Hz, 2H), 3.79 (t, <i>J</i> = 5.3 Hz, 2H), 3.57–3.50 (m, 2H), 3.29–3.19 (m, 1H), 1.79–1.59 (m, 7H), 1.35 (m, 5H), 1.22 (s, 6H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 200.3, 152.3, 147.5, 131.2, 130.0, 128.3, 128.0, 125.9, 125.7, 122.7, 112.0, 111.4, 109.6, 102.8, 100.8, 65.0, 50.1, 46.2, 43.4, 35.6, 31.5, 29.8 (2C), 29.5 (2C), 25.7, 25.3 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 431.27000; calcd, for C<sub>28</sub>H<sub>35</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 431.26930.</div></div><div id="sec5_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Ethyl 2-(5-(2-(6-(cyclohexanecarbonyl)-4,4-dimethyl-3,4-dihydroquinolin-1(<i>2H</i>)-yl)ethoxy)-1<i>H</i>-indol-1-yl)acetate (<b>12</b>)</h5><div class="NLM_p last">The title compound was synthesized according to method A using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-(2-cyclohexyl-1,3-dioxolan-2-yl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>10</b> (85 mg, 0.179 mmol), NaH (9 mg at 60%, 0.215 mmol), and ethyl bromoacetate (24 μL, 0.215 mmol) in dry DMF (2 mL). After treatment, the crude product was treated by HCl (1 M solution in water, 0.9 mL, 0.90 mmol) in THF (5 mL) under argon and stirred at rt for 3 h. After evaporation of the solvent under reduced pressure, the residue was extracted with ethyl acetate. The combined organic extracts were washed with saturated aqueous NaHCO<sub>3</sub> solution (1 × 50 mL) and brine (1 × 50 mL), and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel using cyclohexane/acetone (94/6) as eluent to give the title compound <b>12</b> as a colorless oil (21 mg, 23%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.72 (d, <i>J</i> = 1.5 Hz, 1H), 7.64 (d, <i>J</i> = 8.8 Hz, 1H), 7.30–7.21 (m, 2H), 7.05 (d, <i>J</i> = 1.8 Hz, 1H), 6.80–6.68 (m, 2H), 6.33 (d, <i>J</i> = 2.3 Hz, 1H), 5.05 (s, 2H), 4.23–4.05 (m, 4H), 3.85–3.75 (m, 2H), 3.58–3.48 (m, 2H), 3.24 (s, 1H), 1.79–1.59 (m, 7H), 1.46–1.24 (m, 5H), 1.25–1.12 (m, 9H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 200.3, 169.1, 152.7, 147.5, 131.8, 130.2, 130.0, 128.5, 128.3, 125.7, 122.7, 111.5, 110.5, 109.6, 103.3, 100.9, 65.1, 60.8, 50.0, 47.1, 46.2, 43.5, 35.6, 31.5, 29.8 (2C), 29.5 (2C), 25.7, 25.3 (2C), 14.1. HRMS-ESI (<i>m</i>/<i>z</i>): found, 517.30665; calcd, for C<sub>32</sub>H<sub>41</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 517.30608.</div></div><div id="sec5_1_1_13_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Method D: Ester Saponification (<b>13</b> and <b>15c</b>)</h5><div class="NLM_p last">To a stirred solution of the ester (1.0 equiv) in THF and water (1/1) at rt was added LiOH (4.0 equiv). The reaction medium was stirred for 2 h at rt. After THF was removed by evaporation under reduced pressure, 1 M HCl (20 mL) was added, and the aqueous phase was extracted with dichloromethane (3 × 20 mL). The combined organic extracts were washed with brine (1 × 100 mL) and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel.</div></div><div id="sec5_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 2-(5-(2-(6-(Cyclohexanecarbonyl)-4,4-dimethyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethoxy)-1<i>H</i>-indol-1-yl)acetic acid (<b>13</b>)</h5><div class="NLM_p last">The title compound was synthesized according to method D using ethyl 2-(5-(2-(6-(cyclohexanecarbonyl)-4,4-dimethyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethoxy)-1<i>H</i>-indol-1-yl)acetate <b>12</b> (18 mg, 0.035 mmol), LiOH (6 mg, 0.14 mmol), THF (1 mL), and water (1 mL). After treatment, the crude product was purified by flash chromatography on silica gel using dichloromethane/methanol (80/20) as eluent to give the title compound <b>13</b> as a white solid (7 mg, 41%); mp 104 °C. HPLC purity: 95.9%, <sup>t</sup><i>R</i> = 21.25 min. <sup>1</sup>H NMR (300 MHz, DMSO) δ 7.73 (d, <i>J</i> = 1.6 Hz, 1H), 7.69–7.59 (m, 1H), 7.31–7.20 (m, 2H), 7.05 (d, <i>J</i> = 2.0 Hz, 1H), 6.80–6.68 (m, 2H), 6.31 (d, <i>J</i> = 2.9 Hz, 1H), 4.93 (s, 2H), 4.18 (t, <i>J</i> = 5.1 Hz, 2H), 3.80 (t, <i>J</i> = 4.9 Hz, 2H), 3.59–3.49 (m, 2H), 3.26–3.18 (m, 1H), 1.69 (m, 7H), 1.49–1.27 (m, 5H), 1.23 (s, 6H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 200.3, 170.6, 152.6, 147.5, 131.8, 130.3, 130.0, 128.4, 128.3, 125.7, 122.7, 111.4, 110.5, 109.5, 103.2, 100.5, 65.1, 50.0, 47.3, 46.2, 43.4, 35.6, 31.5, 29.8 (2C), 29.5 (2C), 25.7, 25.3 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 489.27545; calcd, for C<sub>30</sub>H<sub>37</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 489.27478.</div></div><div id="sec5_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline (<b>14</b>)</h5><div class="NLM_p last">The title compound was synthesized according to method C using 1-(2-((1-benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>6a</b> (186 mg, 0.45 mmol) and <i>t</i>-BuOK (356 mg, 3.17 mmol) in DMSO (5 mL). The crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (90/10) as eluent to give <b>14</b> as a white solid (30 mg, 78%); mp 140 °C. HPLC purity: 99.7%, <sup>t</sup><i>R</i> = 17.77 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.04 (s, 1H), 7.32–7.15 (m, 3H), 7.13–7.01 (m, 2H), 6.91–6.81 (m, 1H), 6.75–6.57 (m, 2H), 6.50–6.41 (m, 1H), 4.22 (t, <i>J</i> = 6.0 Hz, 2H), 3.75 (t, <i>J</i> = 6.2 Hz, 2H), 3.54–3.42 (m, 2H), 1.83–1.70 (m, 2H), 1.29 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 153.5, 143.8, 131.3, 131.2, 128.4, 127.0, 126.2, 125.0, 115.9, 112.9, 111.8, 110.7, 103.7, 102.5, 65.6, 51.1, 46.8, 37.2, 32.1, 30.8 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 321.19556; calcd, for C<sub>21</sub>H<sub>25</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 321.19614.</div></div><div id="sec5_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 4,4-Dimethyl-1-(2-((1-methyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-1,2,3,4-tetrahydroquinoline (<b>15a</b>)</h5><div class="NLM_p last">The title compound was synthesized according to method A using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>14</b> (50 mg, 0.16 mmol), NaH (8 mg at 60%, 0.19 mmol), and methyl iodide (12 μL, 0.19 mmol) in dry DMF (0.5 mL). The crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (95/5) as eluent to give the title compound <b>15a</b> as a white solid (47 mg, 89%); mp 77 °C. HPLC purity: 98.7%, <sup>t</sup><i>R</i> = 20.92 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.24–7.16 (m, 2H), 7.12–6.97 (m, 3H), 6.88 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.81–6.59 (m, 2H), 6.37 (d, <i>J</i> = 3.0 Hz, 1H), 4.30–4.17 (m, 2H), 3.76 (s, 3H), 3.76–3.70 (m, 2H), 3.53–3.44 (m, 2H), 1.84–1.71 (m, 2H), 1.29 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 153.2, 143.7, 132.4, 131.4, 129.5, 128.9, 127.1, 126.3, 116.1, 112.4, 111.0, 110.0, 103.9, 100.5, 65.6, 51.3, 46.7, 37.0, 33.1, 32.1, 30.9 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 335.21194; calcd, for C<sub>22</sub>H<sub>27</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 335.21179.</div></div><div id="sec5_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> Ethyl 2-(5-(2-(4,4-Dimethyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethoxy)-1<i>H</i>-indol-1-yl)acetate (<b>15b</b>)</h5><div class="NLM_p last">The title compound was synthesized according to method A using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>14</b> (0.77 g, 2.41 mmol), NaH (0.12 g at 60%, 2.89 mmol), and ethyl bromoacetate (0.32 mL, 2.89 mmol) in dry DMF (20 mL). The crude product was purified by flash chromatography on silica gel using cyclohexane/acetone (90/10) as eluent to give the title compound <b>15b</b> as a colorless oil (0.46 g, 47%). HPLC purity: 99.5%, <sup>t</sup><i>R</i> = 20.69 min. <sup>1</sup>H NMR (300 MHz, DMSO) δ 7.31–7.23 (m, 2H), 7.13 (dd, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.07 (d, <i>J</i> = 2.3 Hz, 1H), 7.01–6.92 (m, 1H), 6.77 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 6.66 (d, <i>J</i> = 7.9 Hz, 1H), 6.56–6.48 (m, 1H), 6.35 (d, <i>J</i> = 3.0 Hz, 1H), 5.06 (s, 2H), 4.22–4.06 (m, 4H), 3.68 (t, <i>J</i> = 5.7 Hz, 2H), 3.46–3.39 (m, 2H), 1.71–1.63 (m, 2H), 1.21 (s, 6H), 1.20 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 169.1, 152.8, 143.5, 131.7, 130.6, 130.2, 128.5, 126.6, 125.7, 115.3, 111.6, 110.6, 110.5, 103.2, 100.9, 65.1, 60.8, 50.2, 47.1, 46.0, 36.6, 31.5, 30.6 (2C), 14.1. HRMS-ESI (<i>m</i>/<i>z</i>): found, 407.23188; calcd, for C<sub>25</sub>H<sub>31</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 407.23292.</div></div><div id="sec5_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 2-(5-(2-(6-Bromo-4,4-dimethyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethoxy)-1<i>H</i>-indol-1-yl)acetic Acid (<b>15c</b>)</h5><div class="NLM_p last">The title compound was synthesized following method D using ethyl 2-(5-(2-(4,4-dimethyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethoxy)-1<i>H</i>-indol-1-yl)acetate <b>15b</b> (50 mg, 0.12 mmol), LiOH (21 mg, 0.49 mmol), THF (2.5 mL), and water (2.5 mL). The crude product was purified by flash chromatography on silica gel using dichloromethane/methanol (80/20) as eluent to give the title compound <b>15c</b> as a white solid (31 mg, 67%); mp 158 °C. HPLC purity: 99.5%, <sup>t</sup><i>R</i> = 14.71 min. <sup>1</sup>H NMR (300 MHz, DMSO) δ 12.89 (s, 1H), 7.25 (d, <i>J</i> = 8.9 Hz, 2H), 7.12 (d, <i>J</i> = 7.5 Hz, 1H), 7.08–7.02 (m, 1H), 6.99–6.90 (m, 1H), 6.75 (d, <i>J</i> = 8.7 Hz, 1H), 6.65 (d, <i>J</i> = 8.2 Hz, 1H), 6.56–6.46 (m, 1H), 6.31 (d, <i>J</i> = 2.6 Hz, 1H), 4.95 (s, 2H), 4.14 (t, <i>J</i> = 5.4 Hz, 2H), 3.68 (t, <i>J</i> = 5.2 Hz, 2H), 3.47–3.39 (m, 2H), 1.70–1.63 (m, 2H), 1.21 (s, 6H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 170.5, 152.7, 143.5, 131.7, 130.6, 130.2, 128.5, 126.6, 125.7, 115.3, 111.5, 110.6, 110.5, 103.2, 100.6, 65.1, 50.1, 47.2, 46.0, 36.6, 31.5, 30.6 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 379.19927; calcd, for C<sub>23</sub>H<sub>27</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 379.20162.</div></div><div id="sec5_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline (<b>16</b>)</h5><div class="NLM_p last">The title compound was synthesized according to method C using 1-(2-((1-benzyl-1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>6b</b> (1.83 g, 3.74 mmol) and <i>t</i>-BuOK (2.94 g, 26.18 mmol) in DMSO (10 mL). The crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (90/10) as eluent to give the title compound <b>16</b> as a white solid (1.16 g, 78%); mp 121 °C. HPLC purity: 98.7%, <sup>t</sup><i>R</i> = 23.68 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.04 (s, 1H), 7.32–7.20 (m, <i>J</i> = 8.7 Hz, 2H), 7.20–7.16 (m, 1H), 7.16–7.05 (m, 2H), 6.85 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 6.55 (d, <i>J</i> = 8.8 Hz, 1H), 6.49–6.44 (m, 1H), 4.20 (t, <i>J</i> = 6.0 Hz, 2H), 3.72 (t, <i>J</i> = 6.0 Hz, 2H), 3.56–3.34 (m, 2H), 1.84–1.57 (m, 2H), 1.27 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 153.3, 142.9, 133.5, 131.2, 129.5, 128.8, 128.4, 125.1, 112.8, 112.4, 111.8, 107.6, 103.7, 102.5, 65.4, 51.0, 46.7, 36.7, 32.3, 30.6 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 399.10624; calcd, for C<sub>21</sub>H<sub>24</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup> 399.10665.</div></div><div id="sec5_1_1_19_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> Method E: Suzuki Coupling (<b>17a</b>–<b>i</b>)</h5><div class="NLM_p last">A mixture of 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.5 equiv), the corresponding boronic acid (3.0 equiv), DMF (10 mL), and water (2 mL) was degassed with argon. Then PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.1 equiv) was added, and the resulting mixture was stirred at 90 °C. Upon completion of the reaction (monitored by TLC), the mixture was cooled to rt, filtered through a pad of dicalite, and extracted with ethyl acetate (3 × 50 mL). Combined organic extracts were washed with brine (4 × 50 mL) and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel.</div></div><div id="sec5_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-4,4-dimethyl-6-phenyl-1,2,3,4-tetrahydroquinoline (<b>17a</b>)</h5><div class="NLM_p last">The title compound was synthesized following method E using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (200 mg, 0.50 mmol), phenylboronic acid (183 mg, 1.50 mmol), K<sub>2</sub>CO<sub>3</sub> (207 mg, 1.50 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (35 mg, 0.05 mmol), DMF (10 mL), and water (2 mL). In this case, the reaction time was 1 h. The crude product was purified by flash chromatography on silica gel using petroleum ether/ethyl acetate (95/15) as eluent to give the title compound <b>17a</b> as a brownish solid (100 mg, 50%); mp 121 °C. HPLC purity: 97.7%, <sup>t</sup><i>R</i> = 24.17 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.05 (s, 1H), 7.59–7.52 (m, 2H), 7.48 (d, <i>J</i> = 2.2 Hz, 1H), 7.45–7.36 (m, <i>J</i> = 7.6 Hz, 2H), 7.33 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.30–7.22 (m, 2H), 7.20–7.16 (m, 1H), 7.12 (d, <i>J</i> = 2.2 Hz, 1H), 6.88 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.78 (d, <i>J</i> = 8.3 Hz, 1H), 6.49–6.45 (m, 1H), 4.26 (t, <i>J</i> = 6.1 Hz, 2H), 3.80 (t, <i>J</i> = 6.2 Hz, 2H), 3.57–3.49 (m, 2H), 1.86–1.78 (m, 2H), 1.36 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 153.4, 143.1, 141.8, 131.8, 131.3, 128.7 (3C), 128.4, 126.4 (2C), 126.0, 125.7, 125.1 (2C), 112.8, 111.8, 111.3, 103.7, 102.5, 65.5, 51.3, 46.8, 37.0, 32.2, 30.8 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 397.22532; calcd, for C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 397.22744.</div></div><div id="sec5_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-6-(4-fluorophenyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline (<b>17b</b>)</h5><div class="NLM_p last">The title compound was synthesized following method E using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (200 mg, 0.50 mmol), (4-fluorophenyl)boronic acid (209 mg, 1.50 mmol), K<sub>2</sub>CO<sub>3</sub> (207 mg, 1.50 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (35 mg, 0.05 mmol), DMF (10 mL), and water (2 mL). In this case, the reaction time was 2 h. The crude product was purified by flash chromatography on silica gel using petroleum ether/dichloromethane (60/40) as eluent to give the title compound <b>17b</b> as a brownish solid (165 mg, 80%); mp 123 °C. HPLC purity: 99.2%, <sup>t</sup><i>R</i> = 24.53 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.04 (s, 1H), 7.55–7.43 (m, 2H), 7.40 (d, <i>J</i> = 2.2 Hz, 1H), 7.32–7.20 (m, 2H), 7.20–7.13 (m, 1H), 7.14–7.02 (m, 3H), 6.87 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.75 (d, <i>J</i> = 8.5 Hz, 1H), 6.52–6.40 (m, 1H), 4.24 (t, <i>J</i> = 6.1 Hz, 2H), 3.79 (t, <i>J</i> = 6.1 Hz, 2H), 3.58–3.43 (m, 2H), 1.87–1.70 (m, 2H), 1.34 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 163.4, 160.1, 153.4, 143.2, 138.0, 131.7, 131.3, 128.5, 127.8, 127.7, 125.6, 125.1, 124.8, 115.6, 115.3, 112.8, 111.8, 111.2, 103.7, 102.6, 65.6, 51.1, 46.8, 37.1, 32.2, 30.8 (2C). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −118.04. HRMS-ESI (<i>m</i>/<i>z</i>): found, 415.21734; calcd, for C<sub>27</sub>H<sub>28</sub>FN<sub>2</sub>O [M + H]<sup>+</sup> 415.21802.</div></div><div id="sec5_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-4,4-dimethyl-6-(3-nitrophenyl)-1,2,3,4-tetrahydroquinoline (<b>17c</b>)</h5><div class="NLM_p last">The title compound was synthesized following method E using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (100 mg, 0.25 mmol), (3-nitrophenyl)boronic acid (125 mg, 0.75 mmol), K<sub>2</sub>CO<sub>3</sub> (104 mg, 0.75 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (21 mg, 0.03 mmol), DMF (10 mL), and water (2 mL). In this case, the reaction time was 2 h. The crude product was purified by flash chromatography on silica gel using petroleum ether/ethyl acetate (90/10) as eluent to give the title compound <b>17c</b> as an orange solid (75 mg, 68%); mp 63 °C. HPLC purity: 97.6%, <sup>t</sup><i>R</i> = 24.50 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.42–8.33 (m, 1H), 8.16–7.99 (m, 2H), 7.90–7.81 (m, 1H), 7.56–7.48 (m, 1H), 7.47 (d, <i>J</i> = 2.3 Hz, 1H), 7.35 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 1H), 7.21–7.17 (m, 1H), 7.11 (d, <i>J</i> = 2.4 Hz, 1H), 6.87 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.77 (d, <i>J</i> = 8.6 Hz, 1H), 6.48–6.44 (m, 1H), 4.25 (t, <i>J</i> = 6.1 Hz, 2H), 3.81 (t, <i>J</i> = 6.0 Hz, 2H), 3.58–3.51 (m, 2H), 1.84–1.76 (m, 2H), 1.36 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 153.4, 148.9, 144.3, 143.5, 132.0, 131.9, 131.3, 129.5, 128.4, 125.8, 125.7, 125.1, 124.7, 120.8, 120.4, 112.9, 111.9, 111.2, 103.7, 102.6, 65.6, 51.0, 46.8, 36.9, 32.3, 30.6 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 442.21305; calcd, for C<sub>27</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 442.21252.</div></div><div id="sec5_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-4,4-dimethyl-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinoline (<b>17d</b>)</h5><div class="NLM_p last">The title compound was synthesized following method E using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (200 mg, 0.50 mmol), thiophen-3-ylboronic acid (192 mg, 1.50 mmol), K<sub>2</sub>CO<sub>3</sub> (207 mg, 1.50 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (35 mg, 0.05 mmol), DMF (10 mL), and water (2 mL). In this case, the reaction time was 14 h. The crude product was purified by flash chromatography on silica gel using petroleum ether/ethyl acetate (90/10) as eluent to give the title compound <b>17d</b> as a beige solid (100 mg, 50%); mp 135 °C. HPLC purity: 99.1%, <sup>t</sup><i>R</i> = 22.84 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.05 (s, 1H), 7.45 (d, <i>J</i> = 2.2 Hz, 1H), 7.36–7.32 (m, 2H), 7.32–7.24 (m, 3H), 7.21–7.14 (m, 1H), 7.11 (d, <i>J</i> = 2.4 Hz, 1H), 6.87 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.72 (d, <i>J</i> = 8.5 Hz, 1H), 6.48–6.43 (m, 1H), 4.24 (t, <i>J</i> = 6.2 Hz, 2H), 3.78 (t, <i>J</i> = 6.2 Hz, 2H), 3.55–3.47 (m, 2H), 1.84–1.75 (m, 2H), 1.34 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 153.4, 143.2, 143.1, 131.5, 131.2, 128.4, 126.4, 125.7, 125.3, 125.1, 124.5, 124.0, 117.5, 112.9, 111.8, 111.0, 103.7, 102.6, 65.6, 51.1, 46.8, 37.1, 32.2, 30.8 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 403.18422; calcd, for C<sub>25</sub>H<sub>27</sub>N<sub>2</sub>OS [M + H]<sup>+</sup> 403.18386.</div></div><div id="sec5_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-6-(furan-2-yl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline (<b>17e</b>)</h5><div class="NLM_p last">The title compound was synthesized following method E using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (100 mg, 0.25 mmol), furan-2-ylboronic acid (84 mg, 0.75 mmol), K<sub>2</sub>CO<sub>3</sub> (104 mg, 0.75 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (21 mg, 0.03 mmol), DMF (10 mL), and water (2 mL). In this case, the reaction time was 1 h. The crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (95/5) as eluent to give the title compound <b>17e</b> as a brown solid (80 mg, 83%); mp 58 °C. HPLC purity: 98.9%, <sup>t</sup><i>R</i> = 22.74 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.04 (s, 1H), 7.52 (d, <i>J</i> = 2.1 Hz, 1H), 7.41–7.37 (m, 1H), 7.35 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 7.29 (s, 1H), 7.20–7.16 (m, 1H), 7.10 (d, <i>J</i> = 2.4 Hz, 1H), 6.86 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.68 (d, <i>J</i> = 8.6 Hz, 1H), 6.49–6.43 (m, 1H), 6.43–6.35 (m, 2H), 4.23 (t, <i>J</i> = 6.2 Hz, 2H), 3.77 (t, <i>J</i> = 6.2 Hz, 2H), 3.54–3.45 (m, 2H), 1.82–1.72 (m, 2H), 1.32 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 155.3, 153.3, 143.2, 140.6, 131.5, 131.3, 128.4, 125.1, 123.1, 122.1, 119.5, 112.8, 111.8, 111.5, 111.0, 103.7, 102.5, 101.8, 65.6, 51.2, 46.8, 36.9, 32.1, 30.7 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 387.20697; calcd, for C<sub>25</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 387.20670.</div></div><div id="sec5_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-4,4-dimethyl-6-(pyridin-3-yl)-1,2,3,4-tetrahydroquinoline (<b>17f</b>)</h5><div class="NLM_p last">The title compound was synthesized following method E using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (180 mg, 0.45 mmol), pyridin-3-ylboronic acid (166 mg, 1.35 mmol), K<sub>2</sub>CO<sub>3</sub> (187 mg, 1.35 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (31 mg, 0.045 mmol), DMF (10 mL), and water (2 mL). In this case, the reaction time was 2.5 h. The crude product was purified by flash chromatography on silica gel using cyclohexane/ethyl acetate (60/40) as eluent to give the title compound <b>17f</b> as a yellow solid (84 mg, 47%); mp 133 °C. HPLC purity: 99.2%, <sup>t</sup><i>R</i> = 11.70 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.80 (d, <i>J</i> = 2.3 Hz, 1H), 8.51–8.41 (m, 1H), 8.11 (s, 1H), 7.90–7.78 (m, 1H), 7.43 (d, <i>J</i> = 2.3 Hz, 1H), 7.36–7.27 (m, 3H), 7.21–7.16 (m, 1H), 7.11 (d, <i>J</i> = 2.2 Hz, 1H), 6.86 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.77 (d, <i>J</i> = 8.6 Hz, 1H), 6.50–6.41 (m, 1H), 4.25 (t, <i>J</i> = 6.0 Hz, 2H), 3.80 (t, <i>J</i> = 6.0 Hz, 2H), 3.59–3.48 (m, 2H), 1.85–1.74 (m, 2H), 1.34 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 153.4, 147.1, 146.4, 144.1, 137.5, 133.8, 131.9, 131.3, 128.5, 125.7, 125.1, 124.8, 124.5, 123.7, 112.9, 111.8, 111.2, 103.7, 102.6, 65.6, 51.2, 46.8, 36.9, 32.3, 30.7 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 398.22215; calcd, for C<sub>26</sub>H<sub>28</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 398.22269.</div></div><div id="sec5_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-6-(6-chloropyridin-3-yl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline (<b>17g</b>)</h5><div class="NLM_p last">The title compound was synthesized following method E using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (100 mg, 0.25 mmol), (6-chloropyridin-3-yl)boronic acid (118 mg, 0.75 mmol), K<sub>2</sub>CO<sub>3</sub> (104 mg, 0.75 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (21 mg, 0.03 mmol), DMF (10 mL), and water (2 mL). In this case, the reaction time was 1.5 h. The crude product was purified by flash chromatography on silica gel using petroleum ether/ethyl acetate (85/15) as eluent to give the title compound <b>17g</b> as a yellow solid (46 mg, 43%); mp 75 °C. HPLC purity: 99.3%, <sup>t</sup><i>R</i> = 23.14 min. <sup>1</sup>H NMR (300 MHz, DMSO) δ 10.91 (s, 1H), 8.63 (d, <i>J</i> = 2.3 Hz, 1H), 8.04 (dd, <i>J</i> = 8.4, 2.7 Hz, 1H), 7.50 (d, <i>J</i> = 2.3 Hz, 1H), 7.47 (d, <i>J</i> = 8.6 Hz, 1H), 7.36 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 7.29–7.23 (m, 2H), 7.04 (d, <i>J</i> = 2.3 Hz, 1H), 6.79 (d, <i>J</i> = 8.7 Hz, 1H), 6.72 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 6.33–6.27 (m, 1H), 4.16 (t, <i>J</i> = 5.5 Hz, 2H), 3.75 (t, <i>J</i> = 5.5 Hz, 2H), 3.53–3.46 (m, 2H), 1.74–1.67 (m, 2H), 1.28 (s, 6H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 152.8, 147.6, 147.0, 144.4, 136.7, 136.0, 131.8, 131.6, 128.4, 126.3, 125.6, 124.5, 124.5, 122.3, 112.4, 111.9, 111.7, 103.2, 101.3, 65.5, 50.5, 46.5, 36.8, 32.2, 30.7 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 432.18430; calcd, for C<sub>26</sub>H<sub>27</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup> 432.18372.</div></div><div id="sec5_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-4,4-dimethyl-6-(pyridin-4-yl)-1,2,3,4-tetrahydroquinoline (<b>17h</b>)</h5><div class="NLM_p last">The title compound was synthesized following method E using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (100 mg, 0.25 mmol), pyridin-4-ylboronic acid (92 mg, 0.75 mmol), K<sub>2</sub>CO<sub>3</sub> (104 mg, 0.75 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (17 mg, 0.025 mmol), DMF (5 mL), and water (1 mL). In this case, the reaction time was 1 h. The crude product was purified by flash chromatography on silica gel using dichloromethane/methanol (98/2) as eluent to give the title compound <b>17h</b> as a yellow solid (46 mg, 46%); mp 142 °C. HPLC purity: 98.7%, <sup>t</sup><i>R</i> = 11.72 min. <sup>1</sup>H NMR (300 MHz, DMSO) δ 10.91 (s, 1H), 8.57–8.40 (m, 2H), 7.63–7.55 (m, 3H), 7.47 (dd, <i>J</i> = 8.7, 2.2 Hz, 1H), 7.30–7.21 (m, 2H), 7.04 (d, <i>J</i> = 2.3 Hz, 1H), 6.80 (d, <i>J</i> = 8.7 Hz, 1H), 6.71 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.33–6.26 (m, 1H), 4.17 (t, <i>J</i> = 5.5 Hz, 2H), 3.77 (t, <i>J</i> = 5.4 Hz, 2H), 3.55–3.45 (m, 2H), 1.76–1.64 (m, 2H), 1.29 (s, 6H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 152.3, 149.9 (2C), 147.3, 144.7, 131.1, 131.1, 128.0, 125.8, 125.2, 123.9, 122.9, 119.6 (2C), 112.0, 111.5, 111.1, 102.8, 100.8, 65.1, 50.1, 46.0, 36.2, 31.7, 30.2 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 398.22231; calcd, for C<sub>26</sub>H<sub>28</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 398.22269.</div></div><div id="sec5_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 1-(2-((1<i>H</i>-Indol-5-yl)oxy)ethyl)-4,4-dimethyl-6-(4-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1,2,3,4-tetrahydroquinoline (<b>17i</b>)</h5><div class="NLM_p last">The title compound was synthesized following method E using 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (200 mg, 0.50 mmol), 1-methyl-4-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)piperazine (550 mg, 1.50 mmol), K<sub>2</sub>CO<sub>3</sub> (207 mg, 1.50 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (35 mg, 0.05 mmol), DMF (10 mL), and water (2 mL). In this case, the reaction time was 1.5 h. The crude product was purified by flash chromatography on silica gel using dichloromethane/methanol (99/1) as eluent to give the title compound <b>17i</b> as a white solid (117 mg, 42%); mp 205 °C. HPLC purity: 99.8%, <sup>t</sup><i>R</i> = 14.45 min. <sup>1</sup>H NMR (300 MHz, DMSO) δ 10.91 (s, 1H), 7.82 (d, <i>J</i> = 8.4 Hz, 2H), 7.68 (d, <i>J</i> = 8.4 Hz, 2H), 7.54 (d, <i>J</i> = 1.7 Hz, 1H), 7.41 (dd, <i>J</i> = 8.6, 1.5 Hz, 1H), 7.26 (dd, <i>J</i> = 5.6, 2.9 Hz, 2H), 7.05 (d, <i>J</i> = 1.8 Hz, 1H), 6.80 (d, <i>J</i> = 8.8 Hz, 1H), 6.72 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 6.35–6.24 (m, 1H), 4.17 (t, <i>J</i> = 5.2 Hz, 2H), 3.84–3.68 (m, 2H), 3.57–3.45 (m, 2H), 3.00–2.76 (m, 4H), 2.43–2.27 (m, 4H), 2.12 (s, 3H), 1.79–1.63 (m, 2H), 1.28 (s, 6H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 152.4, 145.3, 144.2, 131.1 (2C), 131.1, 128.2 (2C), 128.0, 125.8, 125.7 (2C), 125.5, 124.4, 124.3, 112.0, 111.5, 111.2, 102.8, 100.8, 65.1, 53.5 (2C), 50.1, 46.0, 45.8 (2C), 45.3, 36.3, 31.7, 30.2 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 559.27319; calcd, for C<sub>32</sub>H<sub>39</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 559.27374.</div></div><div id="sec5_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-4,4-dimethyl-6-(pyridin-2-yl)-1,2,3,4-tetrahydroquinoline (<b>18</b>)</h5><div class="NLM_p last">A mixture of 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline <b>16</b> (200 mg, 0.50 mmol), KOAc (245 mg, 2.50 mmol), bis(pinacolato)diboron (254 mg, 1.00 mmol), and dioxane (2.5 mL) was degassed with argon. Then, PdCl<sub>2</sub>(dppf) (4 mg, 0.005 mmol) was added, and the resulting mixture was stirred at 80 °C for 21.5 h. The mixture was cooled to rt, filtered through a pad of dicalite, washed with water, and extracted with ethyl acetate (3 × 50 mL). Combined organic extracts were washed with brine (50 mL) and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel using petroleum ether/ethyl acetate (85/15) as eluent to give intermediate 1-(2-((1<i>H</i>-indol-5-yl)oxy)ethyl)-4,4-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroquinoline as a brownish solid (110 mg). A mixture of the latter (103 mg, 0.23 mmol), K<sub>3</sub>PO<sub>4</sub> (98 mg, 0.46 mmol), 2-chloropyridine (24 μL, 1.10 mmol), dioxane (1.0 mL), and water (0.25 mL) was degassed with argon. Then, PdCl<sub>2</sub>(dppf) (4 mg, 0.005 mmol) was added, and the resulting mixture was stirred at 100 °C for 4.5 h. The mixture was cooled to rt, filtered through a pad of dicalite, washed with water, and extracted with ethyl acetate (3 × 50 mL). Combined organic extracts were washed with brine (50 mL) and dried with MgSO<sub>4</sub>. After evaporation under reduced pressure, the crude product was purified by flash chromatography on silica gel using dichloromethane/ethyl acetate (95/5) as eluent to give title compound <b>18</b> as a yellow solid (42 mg, 21%); mp 65 °C. HPLC purity: 98.2%, <sup>t</sup><i>R</i> = 10.88 min. <sup>1</sup>H NMR (300 MHz, DMSO) δ 10.92 (s, 1H), 8.54 (d, <i>J</i> = 4.6 Hz, 1H), 7.93 (d, <i>J</i> = 2.1 Hz, 1H), 7.81–7.67 (m, 3H), 7.26 (dd, <i>J</i> = 5.4, 2.7 Hz, 2H), 7.18–7.11 (m, 1H), 7.05 (d, <i>J</i> = 2.3 Hz, 1H), 6.77 (d, <i>J</i> = 8.8 Hz, 1H), 6.72 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.32–6.27 (m, 1H), 4.17 (t, <i>J</i> = 5.6 Hz, 2H), 3.76 (t, <i>J</i> = 5.5 Hz, 2H), 3.54–3.44 (m, 2H), 1.76–1.64 (m, 2H), 1.28 (s, 6H). <sup>13</sup>C NMR (75 MHz, DMSO) δ 156.7, 152.3, 149.0, 144.5, 136.8, 131.1, 130.5, 128.0, 125.8, 125.3, 125.1, 123.9, 120.5, 118.4, 112.0, 111.5, 110.6, 102.8, 100.8, 65.1, 50.1, 46.0, 36.3, 31.7, 30.3 (2C). HRMS-ESI (<i>m</i>/<i>z</i>): found, 398.22189; calcd, for C<sub>26</sub>H<sub>28</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 398.22269.</div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Biology</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Cell Cultures and Reagents</h4><div class="NLM_p last">KU812, K562, MV-4-11, KG1a, and HS-27a cell lines were obtained from the American Type Culture Collection (ATCC) and maintained according to the supplier’s recommendations. All cell lines were cultured in RPMI, with 10% fetal bovine serum, 1% glutamine, and 1% penicillin/streptomycin at 37 °C and 5% CO<sub>2</sub>. Bone marrow (BM) MSC from donors undergoing orthopedic surgery were isolated and cultured as described.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Informed consent was obtained before BM samples were taken. GW 9662 and rosiglitazone were purchased from Sigma-Aldrich (Lyon, France).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Cell Proliferation Assays</h4><div class="NLM_p last">Cell viability and proliferation were studied using an MTT cell proliferation assay. Briefly, 0.2 × 10<sup>5</sup> cells were incubated in 100 μL of X-Vivo red phenol free medium (Lonza, Basel, Switzerland) in 96 well plates. In initial screening assays, cells were incubated with 10 μM of each compound for 24, 48, and 72 h. To determine the concentration–effect of the molecules, cells were treated with concentrations ranging from 100 nM to 50 μM for 24 or 48 h. Cells were incubated with 10 μL of MTT working solution (5 g/L of methylthiazolyldiphenyl-tetrazolium bromide) during 4 h. Cells were then lysed overnight at 37 °C with 100 μL of 10% SDS and 0.003% HCl. Optical density (OD) at 570 nm was measured using a spectrophotometer (Dynex, Chantilly, United States). Living cells were also counted with the trypan blue dye exclusion method.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Apoptosis Analysis</h4><div class="NLM_p last">For apoptosis studies, cells were stained (10<sup>6</sup> cells) in buffer containing FITC-Annexin V and 7-amino-actinomycin D (7-AAD) (Beckmann Coulter, Fullerton, United States) for 15 min at 4 °C and then analyzed by flow cytometry (Becton Dickinson Accuri C6 flow cytometer).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Western Blot</h4><div class="NLM_p last">Cells were suspended in Laemmli’s 2× buffer, separated on SDS/PAGE, and blotted onto a nitrocellulose membrane (Bio-Rad). Blots were incubated with the following antibodies (Abs): P–Y<sup>694/699</sup>-STAT5, P–Y<sup>701</sup>-STAT3, P-T<sup>308</sup>-Akt, Akt, P-T<sup>202</sup>Y<sup>204</sup>-Erk1/2, Erk1/2, Pim1, Cyclin D1, Mcl-1, and actin (Cell signaling Technology, Danvers, USA), and STAT3 and STAT5 (BD Transduction Laboratories, Franklin Lakes, USA). Membranes were developed with the ECL chemiluminescence detection system (GE Healthcare, Little Chalfont, UK) using a specific peroxidase (HRP) conjugated to rabbit or mouse IgG antibodies (Cell signaling Technology, Danvers, USA).</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Plasmids, Transfection, and Measurement of Luciferase Activity</h4><div class="NLM_p last">The 6×(STAT5)-TK-luc containing six tandem copies of the STAT5 binding site linked to the minimal TK-luciferase reporter gene and control TK-luc plasmids were previously described.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> For transient transfection assays, cells were electroporated (270 V, 960 μF) with the different constructs (25 μg). Transfected cells were expanded for 48 h in medium, and cell extracts were next prepared in luciferase buffer according to the manufacturer’s protocol (One Glo luciferase assay kit, Promega). Luciferase activities were measured in a luminometer (Mithras LB940, Berthold).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> qRT-PCR Analysis</h4><div class="NLM_p last">RNA samples were reverse-transcribed using a SuperScriptVILO cDNA synthesis kit (Invitrogen, Carlsbad, United States) as recommended by the supplier. The resulting cDNAs were used for quantitative real-time PCR (qRT-PCR). PCR primers (<i>STAT5A</i>, for 5′-TCCCTATAACATGTACCCACA-3′, rev 5′-ATGGTCTCATCCAGGTCGAA-3′; <i>STAT5B</i>, for 5′-TGAAGGCCACCATCATCAG-3′, rev 5′-TGTTCAAGATCTCGCCACTG-3′; <i>PIM1</i>, for 5′<i>-</i>TTTCGAGCATGACGAAGAGA-3′, rev 5′<i>-</i>GGGCCAAGCACCATCTAAT-3′; <i>c-MYC</i>, for 5′-GCTGCTTAGACGCTGGATTT-3′, rev 5′-TAACGTTGAGGGGCATCG-3′; <i>MCL-1</i>, for 5′-AAGCCAATGGGCAGGTCT-3′, <i>rev</i> 5′-TGTCCAGTTTCCGAAGCAT-3′; and <i>Cyclin D1</i>, for 5′-CCATCCAGTGGAGGTTTGTC-3′, <i>rev</i> 5′-GTGGGACAGGTGGCCTTT-3′) were designed with the ProbeFinder software (Roche Applied Sciences, Basel, Switzerland) and used to amplify the RT-generated cDNAs. qRT-PCR analyses were performed on the Light Cycler 480 thermocycler II (Roche). Both <i>GAPDH</i> (glyceraldehyde-3-phosphate dehydrogenase) and <i>ACTB</i> (actin beta) were used as reference genes for normalization of qRT-PCR experiments. Each reaction condition was performed in triplicate. Relative gene expression was analyzed using the 2<sup>–</sup>ΔΔCt method.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00369">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00369" class="ext-link">10.1021/acs.jmedchem.7b00369</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Additional figures illustrating the inhibition of STAT5 phosphorylation of hit <b>13</b>, cell growth inhibition data, apoptosis experiments, dose–response curve for EC<sub>50</sub> calculation, quantification of Western Blot data, and NMR spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_001.csv">jm7b00369_si_001.csv (1.98 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf">jm7b00369_si_002.pdf (4.1 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00369" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85242" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85242" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrice Gouilleux</span> - <span class="hlFld-Affiliation affiliation">Equipe
LNOx “Niche
leucémique & métabolisme oxidatif”, GICC
UMR 7292 CNRS, Université de Tours, Faculté de Médecine,
Bâtiment Dutrochet, 10bis boulevard
Tonnellé, 37032 Tours, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f197909383989294df969e84989d9d948489b1849f9887dc859e848382df9783"><span class="__cf_email__" data-cfemail="a3c5c2c1d1cac0c68dc4ccd6cacfcfc6d6dbe3d6cdcad58ed7ccd6d1d08dc5d1">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gildas Prié</span> - <span class="hlFld-Affiliation affiliation">Equipe IMT “Innovation
Moléculaire et Thérapeutique”, GICC UMR 7292
CNRS, Université de Tours, Labex SYNORG, Faculté de
Pharmacie, 31 avenue Monge, 37200 Tours, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6369-7712" title="Orcid link">http://orcid.org/0000-0001-6369-7712</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4c2b2520282d3f623c3e25290c3922253a613823393e3f622a3e"><span class="__cf_email__" data-cfemail="086f61646c697b26787a616d487d66617e257c677d7a7b266e7a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ludovic Juen</span> - <span class="hlFld-Affiliation affiliation">Equipe IMT “Innovation
Moléculaire et Thérapeutique”, GICC UMR 7292
CNRS, Université de Tours, Labex SYNORG, Faculté de
Pharmacie, 31 avenue Monge, 37200 Tours, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie Brachet-Botineau</span> - <span class="hlFld-Affiliation affiliation">CHRU de Tours, Service
d’Hématologie Biologique, 2 boulevard Tonnellé, 37044 Tours, France</span>; 
    <span class="hlFld-Affiliation affiliation">Equipe
LNOx “Niche
leucémique & métabolisme oxidatif”, GICC
UMR 7292 CNRS, Université de Tours, Faculté de Médecine,
Bâtiment Dutrochet, 10bis boulevard
Tonnellé, 37032 Tours, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cécile Parmenon</span> - <span class="hlFld-Affiliation affiliation">Equipe IMT “Innovation
Moléculaire et Thérapeutique”, GICC UMR 7292
CNRS, Université de Tours, Labex SYNORG, Faculté de
Pharmacie, 31 avenue Monge, 37200 Tours, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jérôme Bourgeais</span> - <span class="hlFld-Affiliation affiliation">CHRU de Tours, Service
d’Hématologie Biologique, 2 boulevard Tonnellé, 37044 Tours, France</span>; 
    <span class="hlFld-Affiliation affiliation">Equipe
LNOx “Niche
leucémique & métabolisme oxidatif”, GICC
UMR 7292 CNRS, Université de Tours, Faculté de Médecine,
Bâtiment Dutrochet, 10bis boulevard
Tonnellé, 37032 Tours, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olivier Hérault</span> - <span class="hlFld-Affiliation affiliation">CHRU de Tours, Service
d’Hématologie Biologique, 2 boulevard Tonnellé, 37044 Tours, France</span>; 
    <span class="hlFld-Affiliation affiliation">Equipe
LNOx “Niche
leucémique & métabolisme oxidatif”, GICC
UMR 7292 CNRS, Université de Tours, Faculté de Médecine,
Bâtiment Dutrochet, 10bis boulevard
Tonnellé, 37032 Tours, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie-Claude Viaud-Massuard</span> - <span class="hlFld-Affiliation affiliation">Equipe IMT “Innovation
Moléculaire et Thérapeutique”, GICC UMR 7292
CNRS, Université de Tours, Labex SYNORG, Faculté de
Pharmacie, 31 avenue Monge, 37200 Tours, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>L. J. and M. B.-B. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4273-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Region Centre, the European Funds for the Economical and Regional Development (FEDER), the Laboratory of Excellence Labex SYNORG, ANR-11-LABX-0029, and La Ligue Contre le Cancer. We thank Emmanuel Pecnard for excellent technical assistance. We thank the Plateforme Scientifique et Technique Analyse des Systèmes Biologiques (PST-ASB) for analytical data.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i60" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i60"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61"> Abbreviations Used</h2><tr><td class="NLM_term">7-AAD</td><td class="NLM_def"><p class="first last">7-aminoactinomycin D</p></td></tr><tr><td class="NLM_term">ACTB</td><td class="NLM_def"><p class="first last">actin beta</p></td></tr><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">BCR-ABL</td><td class="NLM_def"><p class="first last">break point cluster-Abelson</p></td></tr><tr><td class="NLM_term">CML</td><td class="NLM_def"><p class="first last">chronic myeloid leukemia</p></td></tr><tr><td class="NLM_term">FACS</td><td class="NLM_def"><p class="first last">fluorescence-activated cell sorting</p></td></tr><tr><td class="NLM_term">FLT3-ITD</td><td class="NLM_def"><p class="first last">FMS like tyrosine kinase 3–internal tandem duplication</p></td></tr><tr><td class="NLM_term">GAPDH</td><td class="NLM_def"><p class="first last">glyceraldehyde-3-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">IBA</td><td class="NLM_def"><p class="first last">2-iodosobenzoic acid</p></td></tr><tr><td class="NLM_term">IBX</td><td class="NLM_def"><p class="first last">2-iodoxybenzoic acid</p></td></tr><tr><td class="NLM_term">IM</td><td class="NLM_def"><p class="first last">imatinib mesylate</p></td></tr><tr><td class="NLM_term">qRT-PCR</td><td class="NLM_def"><p class="first last">quantitative reverse transcription-polymerase chain reaction</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">PIM1</td><td class="NLM_def"><p class="first last">provirus integration site for moloney leukemia virus</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">RNA</td><td class="NLM_def"><p class="first last">ribonucleic acid</p></td></tr><tr><td class="NLM_term">STAT5</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 5</p></td></tr><tr><td class="NLM_term">TKI</td><td class="NLM_def"><p class="first last">tyrosine kinase inhibitor</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bunting, K. D.</span><span> </span><span class="NLM_article-title">STAT5 Signaling in Normal and Pathologic Hematopoiesis</span> <span class="citation_source-journal">Front. Biosci., Landmark Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2807</span><span class="NLM_x">–</span> <span class="NLM_lpage">2820</span><span class="refDoi"> DOI: 10.2741/2274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.2741%2F2274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=17485261" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=2807-2820&author=K.+D.+Bunting&title=STAT5+Signaling+in+Normal+and+Pathologic+Hematopoiesis&doi=10.2741%2F2274"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2741%2F2274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F2274%26sid%3Dliteratum%253Aachs%26aulast%3DBunting%26aufirst%3DK.%2BD.%26atitle%3DSTAT5%2520Signaling%2520in%2520Normal%2520and%2520Pathologic%2520Hematopoiesis%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2007%26volume%3D12%26spage%3D2807%26epage%3D2820%26doi%3D10.2741%2F2274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mizuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halfter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüning, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratz-Albers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serve, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büchner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienast, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdel, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serve, H.</span><span> </span><span class="NLM_article-title">Flt3 Mutations from Patients with Acute Myeloid Leukemia Induce Transformation of 32D Cells Mediated by the Ras and STAT5 Pathways</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3907</span><span class="NLM_x">–</span> <span class="NLM_lpage">3914</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=11090077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVGnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2000&pages=3907-3914&author=M.+Mizukiauthor=R.+Fenskiauthor=H.+Halfterauthor=I.+Matsumuraauthor=R.+Schmidtauthor=C.+M%C3%BCllerauthor=W.+Gr%C3%BCningauthor=K.+Kratz-Albersauthor=S.+Serveauthor=C.+Steurauthor=T.+B%C3%BCchnerauthor=J.+Kienastauthor=Y.+Kanakuraauthor=W.+E.+Berdelauthor=H.+Serve&title=Flt3+Mutations+from+Patients+with+Acute+Myeloid+Leukemia+Induce+Transformation+of+32D+Cells+Mediated+by+the+Ras+and+STAT5+Pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways</span></div><div class="casAuthors">Mizuki, Masao; Fenski, Regina; Halfter, Hartmut; Matsumura, Itaru; Schmidt, Rainer; Muller, Carsten; Gruning, Wolfram; Kratz-Albers, Karsten; Serve, Susanne; Steur, Claudia; Buchner, Thomas; Kienast, Joachim; Kanakura, Yuzuru; Berdel, Wolfgang E.; Serve, Hubert</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3907-3914</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Somatic mutations of the receptor tyrosine kinase Flt3 consisting of internal tandem duplications (ITD) occur in 20% of patients with acute myeloid leukemia.  They are assocd. with a poor prognosis of the disease.  In this study, we characterized the oncogenic potential and signaling properties of Flt3 mutations.  We constructed chimeric mols. that consisted of the murine Flt3 backbone and a 510-base pair human Flt3 fragment, which contained either 4 different ITD mutants or the wild-type coding sequence.  Flt3 isoforms contg. ITD mutations (Flt3-ITD) induced factor-independent growth and resistance to radiation-induced apoptosis in 32D cells.  Cells contg. Flt3-ITD, but not those contg. wild-type Flt3 (Flt3-WT), formed colonies in methyl-cellulose.  Injection of 32D/Flt3-ITD induced rapid development of a leukemia-type disease in syngeneic mice.  Flt3-ITD mutations exhibited constitutive autophosphorylation of the immature form of the Flt3 receptor.  Anal. of the involved signal transduction pathways revealed that Flt3-ITD only slightly activated the MAP kinases Erk1 and 2 and the protein kinase B (Akt) in the absence of ligand and retained ligand-induced activation of these enzymes.  However, Flt3-ITD led to strong factor-independent activation of STAT5.  The relative importance of the STAT5 and Ras pathways for ITD-induced colony formation was assessed by transfection of dominant neg. (dn) forms of these proteins: transfection of dnSTAT5 inhibited colony formation by 50%.  Despite its weak constitutive activation by Flt3-ITD, dnRas also strongly inhibited Flt3-ITD-mediated colony formation.  Taken together, Flt3-ITD mutations induce factor-independent growth and leukemogenesis of 32D cells that are mediated by the Ras and STAT5 pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5yxxtxsjVJ7Vg90H21EOLACvtfcHk0ljU9GvL12q2VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVGnurs%253D&md5=d6a3335d36a309bf17c0cf3f6d4ca6ec</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMizuki%26aufirst%3DM.%26aulast%3DFenski%26aufirst%3DR.%26aulast%3DHalfter%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DI.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DGr%25C3%25BCning%26aufirst%3DW.%26aulast%3DKratz-Albers%26aufirst%3DK.%26aulast%3DServe%26aufirst%3DS.%26aulast%3DSteur%26aufirst%3DC.%26aulast%3DB%25C3%25BCchner%26aufirst%3DT.%26aulast%3DKienast%26aufirst%3DJ.%26aulast%3DKanakura%26aufirst%3DY.%26aulast%3DBerdel%26aufirst%3DW.%2BE.%26aulast%3DServe%26aufirst%3DH.%26atitle%3DFlt3%2520Mutations%2520from%2520Patients%2520with%2520Acute%2520Myeloid%2520Leukemia%2520Induce%2520Transformation%2520of%252032D%2520Cells%2520Mediated%2520by%2520the%2520Ras%2520and%2520STAT5%2520Pathways%26jtitle%3DBlood%26date%3D2000%26volume%3D96%26spage%3D3907%26epage%3D3914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Harir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedbichler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonneck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Lanneree, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerenyi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahiaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux-Gruart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gondry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benit, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusanter-Fourt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassoued, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux, F.</span><span> </span><span class="NLM_article-title">Oncogenic Kit Controls Neoplastic Mast Cell Growth through a Stat5/PI3-Kinase Signaling Cascade</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">2463</span><span class="NLM_x">–</span> <span class="NLM_lpage">2473</span><span class="refDoi"> DOI: 10.1182/blood-2007-09-115477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1182%2Fblood-2007-09-115477" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=2463-2473&author=N.+Harirauthor=C.+Boudotauthor=K.+Friedbichlerauthor=K.+Sonneckauthor=R.+Kondoauthor=S.+Martin-Lannereeauthor=L.+Kennerauthor=M.+Kerenyiauthor=S.+Yahiaouiauthor=V.+Gouilleux-Gruartauthor=J.+Gondryauthor=L.+Benitauthor=I.+Dusanter-Fourtauthor=K.+Lassouedauthor=P.+Valentauthor=R.+Morigglauthor=F.+Gouilleux&title=Oncogenic+Kit+Controls+Neoplastic+Mast+Cell+Growth+through+a+Stat5%2FPI3-Kinase+Signaling+Cascade&doi=10.1182%2Fblood-2007-09-115477"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-09-115477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-09-115477%26sid%3Dliteratum%253Aachs%26aulast%3DHarir%26aufirst%3DN.%26aulast%3DBoudot%26aufirst%3DC.%26aulast%3DFriedbichler%26aufirst%3DK.%26aulast%3DSonneck%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DR.%26aulast%3DMartin-Lanneree%26aufirst%3DS.%26aulast%3DKenner%26aufirst%3DL.%26aulast%3DKerenyi%26aufirst%3DM.%26aulast%3DYahiaoui%26aufirst%3DS.%26aulast%3DGouilleux-Gruart%26aufirst%3DV.%26aulast%3DGondry%26aufirst%3DJ.%26aulast%3DBenit%26aufirst%3DL.%26aulast%3DDusanter-Fourt%26aufirst%3DI.%26aulast%3DLassoued%26aufirst%3DK.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DGouilleux%26aufirst%3DF.%26atitle%3DOncogenic%2520Kit%2520Controls%2520Neoplastic%2520Mast%2520Cell%2520Growth%2520through%2520a%2520Stat5%252FPI3-Kinase%2520Signaling%2520Cascade%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D2463%26epage%3D2473%26doi%3D10.1182%2Fblood-2007-09-115477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Shuai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halpern, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ten Hoeve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Constitutive Activation of STAT5 by the BCR-ABL Oncogene in Chronic Myelogenous Leukemia</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=247-254&author=K.+Shuaiauthor=J.+Halpernauthor=J.+ten+Hoeveauthor=X.+Raoauthor=C.+L.+Sawyers&title=Constitutive+Activation+of+STAT5+by+the+BCR-ABL+Oncogene+in+Chronic+Myelogenous+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShuai%26aufirst%3DK.%26aulast%3DHalpern%26aufirst%3DJ.%26aulast%3Dten%2BHoeve%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DX.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DConstitutive%2520Activation%2520of%2520STAT5%2520by%2520the%2520BCR-ABL%2520Oncogene%2520in%2520Chronic%2520Myelogenous%2520Leukemia%26jtitle%3DOncogene%26date%3D1996%26volume%3D13%26spage%3D247%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">James, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Couédic, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staerk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garçon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raslova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennaceur-Griscelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeval, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vainchenker, W.</span><span> </span><span class="NLM_article-title">A Unique Clonal JAK2 Mutation Leading to Constitutive Signalling Causes Polycythaemia Vera</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span><span class="refDoi"> DOI: 10.1038/nature03546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1038%2Fnature03546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=15793561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsF2ltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=1144-1148&author=C.+Jamesauthor=V.+Ugoauthor=J.-P.+Le+Cou%C3%A9dicauthor=J.+Staerkauthor=F.+Delhommeauauthor=C.+Lacoutauthor=L.+Gar%C3%A7onauthor=H.+Raslovaauthor=R.+Bergerauthor=A.+Bennaceur-Griscelliauthor=J.+L.+Villevalauthor=S.+N.+Constantinescuauthor=N.+Casadevallauthor=W.+Vainchenker&title=A+Unique+Clonal+JAK2+Mutation+Leading+to+Constitutive+Signalling+Causes+Polycythaemia+Vera&doi=10.1038%2Fnature03546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera</span></div><div class="casAuthors">James, Chloe; Ugo, Valerie; Le Couedic, Jean-Pierre; Staerk, Judith; Delhommeau, Francois; Lacout, Catherine; Garcon, Loic; Raslova, Hana; Berger, Roland; Bennaceur-Griscelli, Annelise; Villeval, Jean Luc; Constantinescu, Stefan N.; Casadevall, Nicole; Vainchenker, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7037</span>),
    <span class="NLM_cas:pages">1144-1148</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Myeloproliferative disorders are clonal hematopoietic stem cell malignancies characterized by independency or hypersensitivity of hematopoietic progenitors to numerous cytokines.  The mol. basis of most myeloproliferative disorders is unknown.  On the basis of the model of chronic myeloid leukemia, it is expected that a constitutive tyrosine kinase activity could be at the origin of these diseases.  Polycythemia vera is an acquired myeloproliferative disorder, characterized by the presence of polycythemia diversely assocd. with thrombocytosis, leukocytosis and splenomegaly.  Polycythemia vera progenitors are hypersensitive to erythropoietin and other cytokines.  Here, the authors describe a clonal and recurrent mutation in the JH2 pseudo-kinase domain of the Janus kinase 2 (JAK2) gene in most (>80%) polycythemia vera patients.  The mutation, a valine-to-phenylalanine substitution at amino acid position 617, leads to constitutive tyrosine phosphorylation activity that promotes cytokine hypersensitivity and induces erythrocytosis in a mouse model.  As this mutation is also found in other myeloproliferative disorders, this unique mutation will permit a new mol. classification of these disorders and novel therapeutical approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy-6NigTwc97Vg90H21EOLACvtfcHk0ljNNsbk0UXxEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsF2ltbk%253D&md5=9e9c223dd4e2da2ebf52d14edda85963</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature03546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03546%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DC.%26aulast%3DUgo%26aufirst%3DV.%26aulast%3DLe%2BCou%25C3%25A9dic%26aufirst%3DJ.-P.%26aulast%3DStaerk%26aufirst%3DJ.%26aulast%3DDelhommeau%26aufirst%3DF.%26aulast%3DLacout%26aufirst%3DC.%26aulast%3DGar%25C3%25A7on%26aufirst%3DL.%26aulast%3DRaslova%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DBennaceur-Griscelli%26aufirst%3DA.%26aulast%3DVilleval%26aufirst%3DJ.%2BL.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DCasadevall%26aufirst%3DN.%26aulast%3DVainchenker%26aufirst%3DW.%26atitle%3DA%2520Unique%2520Clonal%2520JAK2%2520Mutation%2520Leading%2520to%2520Constitutive%2520Signalling%2520Causes%2520Polycythaemia%2520Vera%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D1144%26epage%3D1148%26doi%3D10.1038%2Fnature03546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadleigh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wlodarska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelsperger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fröhling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Döhner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marynen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia, and Myeloid Metaplasia with Myelofibrosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1016/j.ccr.2005.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.ccr.2005.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=15837627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFSku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=387-397&author=R.+L.+Levineauthor=M.+Wadleighauthor=J.+Coolsauthor=B.+L.+Ebertauthor=G.+Wernigauthor=B.+J.+P.+Huntlyauthor=T.+J.+Boggonauthor=I.+Wlodarskaauthor=J.+J.+Clarkauthor=S.+Mooreauthor=J.+Adelspergerauthor=S.+Kooauthor=J.+C.+Leeauthor=S.+Gabrielauthor=T.+Mercherauthor=A.+D%E2%80%99Andreaauthor=S.+Fr%C3%B6hlingauthor=K.+D%C3%B6hnerauthor=P.+Marynenauthor=P.+Vandenbergheauthor=R.+A.+Mesaauthor=A.+Tefferiauthor=J.+D.+Griffinauthor=M.+J.+Eckauthor=W.+R.+Sellersauthor=M.+Meyersonauthor=T.+R.+Golubauthor=S.+J.+Leeauthor=D.+G.+Gilliland&title=Activating+Mutation+in+the+Tyrosine+Kinase+JAK2+in+Polycythemia+Vera%2C+Essential+Thrombocythemia%2C+and+Myeloid+Metaplasia+with+Myelofibrosis&doi=10.1016%2Fj.ccr.2005.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis</span></div><div class="casAuthors">Levine, Ross L.; Wadleigh, Martha; Cools, Jan; Ebert, Benjamin L.; Wernig, Gerlinde; Huntly, Brian J. P.; Boggon, Titus J.; Wlodarska, Iwona; Clark, Jennifer J.; Moore, Sandra; Adelsperger, Jennifer; Koo, Sumin; Lee, Jeffrey C.; Gabriel, Stacey; Mercher, Thomas; D'Andrea, Alan; Froehling, Stefan; Doehner, Konstanze; Marynen, Peter; Vandenberghe, Peter; Mesa, Ruben A.; Tefferi, Ayalew; Griffin, James D.; Eck, Michael J.; Sellers, William R.; Meyerson, Matthew; Golub, Todd R.; Lee, Stephanie J.; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-397</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors.  An internet-based protocol was used to collect clin. information and biol. specimens from patients with these diseases.  High-throughput DNA re-sequencing identified a recurrent somatic missense mutation JAK2V617F in granulocyte DNA samples of 121 of 164 PV patients, of which 41 had homozygous and 80 had heterozygous mutations.  Mol. and cytogenetic analyses demonstrated that homozygous mutations were due to duplication of the mutant allele.  JAK2V617F was also identified in granulocyte DNA samples from 37 of 115 ET and 16 of 46 MMM patients, but was not obsd. in 269 normal individuals.  In vitro anal. demonstrated that JAK2V617F is a constitutively active tyrosine kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXJNzUFm3Q3bVg90H21EOLACvtfcHk0lgxLUO0GOVVzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFSku7o%253D&md5=2a3e893867b114e8749cd6f5e55990b7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DWadleigh%26aufirst%3DM.%26aulast%3DCools%26aufirst%3DJ.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%2BP.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DWlodarska%26aufirst%3DI.%26aulast%3DClark%26aufirst%3DJ.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DAdelsperger%26aufirst%3DJ.%26aulast%3DKoo%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DMercher%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%26aulast%3DFr%25C3%25B6hling%26aufirst%3DS.%26aulast%3DD%25C3%25B6hner%26aufirst%3DK.%26aulast%3DMarynen%26aufirst%3DP.%26aulast%3DVandenberghe%26aufirst%3DP.%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DActivating%2520Mutation%2520in%2520the%2520Tyrosine%2520Kinase%2520JAK2%2520in%2520Polycythemia%2520Vera%252C%2520Essential%2520Thrombocythemia%252C%2520and%2520Myeloid%2520Metaplasia%2520with%2520Myelofibrosis%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D387%26epage%3D397%26doi%3D10.1016%2Fj.ccr.2005.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ye, D.</span><span> </span><span class="NLM_article-title">STAT5 Signaling Is Required for the Efficient Induction and Maintenance of CML in Mice</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">4917</span><span class="NLM_x">–</span> <span class="NLM_lpage">4925</span><span class="refDoi"> DOI: 10.1182/blood-2005-10-4110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1182%2Fblood-2005-10-4110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=4917-4925&author=D.+Ye&title=STAT5+Signaling+Is+Required+for+the+Efficient+Induction+and+Maintenance+of+CML+in+Mice&doi=10.1182%2Fblood-2005-10-4110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-10-4110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-10-4110%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DD.%26atitle%3DSTAT5%2520Signaling%2520Is%2520Required%2520for%2520the%2520Efficient%2520Induction%2520and%2520Maintenance%2520of%2520CML%2520in%2520Mice%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D4917%26epage%3D4925%26doi%3D10.1182%2Fblood-2005-10-4110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hoelbl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelzl, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fajmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grebien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warsch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennighausen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beug, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexl, V.</span><span> </span><span class="NLM_article-title">Stat5 Is Indispensable for the Maintenance of Bcr/abl-Positive Leukaemia</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1002/emmm.201000062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1002%2Femmm.201000062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=20201032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1ersrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=98-110&author=A.+Hoelblauthor=C.+Schusterauthor=B.+Kovacicauthor=B.+Zhuauthor=M.+Wickreauthor=M.+A.+Hoelzlauthor=S.+Fajmannauthor=F.+Grebienauthor=W.+Warschauthor=G.+Stenglauthor=L.+Hennighausenauthor=V.+Poliauthor=H.+Beugauthor=R.+Morigglauthor=V.+Sexl&title=Stat5+Is+Indispensable+for+the+Maintenance+of+Bcr%2Fabl-Positive+Leukaemia&doi=10.1002%2Femmm.201000062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Stat5 is indispensable for the maintenance of Bcr/Abl-positive leukaemia</span></div><div class="casAuthors">Hoelbl, Andrea; Schuster, Christian; Kovacic, Boris; Zhu, Bingmei; Wickre, Mark; Hoelzl, Maria A.; Fajmann, Sabine; Grebien, Florian; Warsch, Wolfgang; Stengl, Gabriele; Hennighausen, Lothar; Poli, Valeria; Beug, Hartmut; Moriggl, Richard; Sexl, Veronika</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">98-110</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tumorigenesis caused by the Bcr/Abl oncoprotein is a multi-step process proceeding from initial to tumor-maintaining events and finally results in a complex tumor-supporting network.  A key to successful cancer therapy is the identification of crit. functional nodes in an oncogenic network required for disease maintenance.  So far, the transcription factors Stat3 and Stat5a/b were implicated in bcr/abl-induced initial transformation.  However, to qualify as a potential drug target, a signalling pathway must be required for the maintenance of the leukemic state.  Data on the roles of Stat3 or Stat5a/b in leukemia maintenance are elusive.  Here, we show that both, Stat3 and Stat5 are necessary for initial transformation.  However, Stat5- but not Stat3-deletion induces G0/G1 cell cycle arrest and apoptosis of imatinib-sensitive and imatinib-resistant stable leukemic cells in vitro.  Accordingly, Stat5-abrogation led to effective elimination of myeloid and lymphoid leukemia maintenance in vivo.  Hence, we identified Stat5 as a vulnerable point in the oncogenic network downstream of Bcr/Abl representing a case of non-oncogene addiction (NOA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj_LpUINLk77Vg90H21EOLACvtfcHk0ljNpaXbAnH5aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1ersrs%253D&md5=7bd1560e2d03dd45d12f2b5d814ba929</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Femmm.201000062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201000062%26sid%3Dliteratum%253Aachs%26aulast%3DHoelbl%26aufirst%3DA.%26aulast%3DSchuster%26aufirst%3DC.%26aulast%3DKovacic%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DWickre%26aufirst%3DM.%26aulast%3DHoelzl%26aufirst%3DM.%2BA.%26aulast%3DFajmann%26aufirst%3DS.%26aulast%3DGrebien%26aufirst%3DF.%26aulast%3DWarsch%26aufirst%3DW.%26aulast%3DStengl%26aufirst%3DG.%26aulast%3DHennighausen%26aufirst%3DL.%26aulast%3DPoli%26aufirst%3DV.%26aulast%3DBeug%26aufirst%3DH.%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DSexl%26aufirst%3DV.%26atitle%3DStat5%2520Is%2520Indispensable%2520for%2520the%2520Maintenance%2520of%2520Bcr%252Fabl-Positive%2520Leukaemia%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D98%26epage%3D110%26doi%3D10.1002%2Femmm.201000062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Jilani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottmann, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albitar, M.</span><span> </span><span class="NLM_article-title">Phosphorylation Levels of BCR-ABL, CrkL, AKT and STAT5 in Imatinib-Resistant Chronic Myeloid Leukemia Cells Implicate Alternative Pathway Usage as a Survival Strategy</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span><span class="refDoi"> DOI: 10.1016/j.leukres.2007.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.leukres.2007.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=17900686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlOhsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=643-649&author=I.+Jilaniauthor=H.+Kantarjianauthor=M.+Gorreauthor=J.+Cortesauthor=O.+Ottmannauthor=K.+Bhallaauthor=F.+J.+Gilesauthor=M.+Albitar&title=Phosphorylation+Levels+of+BCR-ABL%2C+CrkL%2C+AKT+and+STAT5+in+Imatinib-Resistant+Chronic+Myeloid+Leukemia+Cells+Implicate+Alternative+Pathway+Usage+as+a+Survival+Strategy&doi=10.1016%2Fj.leukres.2007.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy</span></div><div class="casAuthors">Jilani, Iman; Kantarjian, Hagop; Gorre, Mercedes; Cortes, Jorge; Ottmann, Oliver; Bhalla, Kapil; Giles, Francis J.; Albitar, Maher</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">643-649</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ex-vivo studies have suggested that imatinib-resistance in chronic myeloid leukemia (CML) patients occurs despite adequate suppression of BCR-ABL activity.  Whether BCR-ABL phosphorylation levels differ between imatinib-sensitive and -resistant patients is not known.  We compared the phosphorylation of BCR-ABL in 54 previously untreated CML patients and 62 imatinib-resistant CML patients with progressive disease.  Resistant patients had significantly lower levels of BCR-ABL, CrkL and AKT phosphorylation than previously untreated patients, but STAT5 phosphorylation showed no difference.  These observations suggest that imatinib- resistance is not necessarily dependent on higher activity in BCR-ABL-dependent pathways, but is likely due to the activation of other pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOetTZMc1sbbVg90H21EOLACvtfcHk0ljNpaXbAnH5aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlOhsbo%253D&md5=a33e302bef69b8e1b77d9daa926af098</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2007.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2007.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DJilani%26aufirst%3DI.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DGorre%26aufirst%3DM.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DOttmann%26aufirst%3DO.%26aulast%3DBhalla%26aufirst%3DK.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DAlbitar%26aufirst%3DM.%26atitle%3DPhosphorylation%2520Levels%2520of%2520BCR-ABL%252C%2520CrkL%252C%2520AKT%2520and%2520STAT5%2520in%2520Imatinib-Resistant%2520Chronic%2520Myeloid%2520Leukemia%2520Cells%2520Implicate%2520Alternative%2520Pathway%2520Usage%2520as%2520a%2520Survival%2520Strategy%26jtitle%3DLeuk.%2520Res.%26date%3D2008%26volume%3D32%26spage%3D643%26epage%3D649%26doi%3D10.1016%2Fj.leukres.2007.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Cumaraswamy, A. a.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resetca, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Inhibitors of Stat5 Protein Signalling</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span><span class="refDoi"> DOI: 10.1039/C1MD00175B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1039%2FC1MD00175B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=22-27&author=A.+a.+Cumaraswamyauthor=A.+Todicauthor=D.+Resetcaauthor=M.+D.+Mindenauthor=P.+T.+Gunning&title=Inhibitors+of+Stat5+Protein+Signalling&doi=10.1039%2FC1MD00175B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2FC1MD00175B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1MD00175B%26sid%3Dliteratum%253Aachs%26aulast%3DCumaraswamy%26aufirst%3DA.%2Ba.%26aulast%3DTodic%26aufirst%3DA.%26aulast%3DResetca%26aufirst%3DD.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DInhibitors%2520of%2520Stat5%2520Protein%2520Signalling%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D22%26epage%3D27%26doi%3D10.1039%2FC1MD00175B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Prost, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relouzat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spentchian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouzegdouh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saliba, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massonnet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beressi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeyen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggueneau, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maneglier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chomienne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrétien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousselot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leboulch, P.</span><span> </span><span class="NLM_article-title">Erosion of the Chronic Myeloid Leukaemia Stem Cell Pool by PPARγ Agonists</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">525</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span><span class="refDoi"> DOI: 10.1038/nature15248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1038%2Fnature15248" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=380-383&author=S.+Prostauthor=F.+Relouzatauthor=M.+Spentchianauthor=Y.+Ouzegdouhauthor=J.+Salibaauthor=G.+Massonnetauthor=J.+Beressiauthor=E.+Verhoeyenauthor=V.+Raggueneauauthor=B.+Maneglierauthor=S.+Castaigneauthor=C.+Chomienneauthor=S.+Chr%C3%A9tienauthor=P.+Rousselotauthor=P.+Leboulch&title=Erosion+of+the+Chronic+Myeloid+Leukaemia+Stem+Cell+Pool+by+PPAR%CE%B3+Agonists&doi=10.1038%2Fnature15248"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature15248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature15248%26sid%3Dliteratum%253Aachs%26aulast%3DProst%26aufirst%3DS.%26aulast%3DRelouzat%26aufirst%3DF.%26aulast%3DSpentchian%26aufirst%3DM.%26aulast%3DOuzegdouh%26aufirst%3DY.%26aulast%3DSaliba%26aufirst%3DJ.%26aulast%3DMassonnet%26aufirst%3DG.%26aulast%3DBeressi%26aufirst%3DJ.%26aulast%3DVerhoeyen%26aufirst%3DE.%26aulast%3DRaggueneau%26aufirst%3DV.%26aulast%3DManeglier%26aufirst%3DB.%26aulast%3DCastaigne%26aufirst%3DS.%26aulast%3DChomienne%26aufirst%3DC.%26aulast%3DChr%25C3%25A9tien%26aufirst%3DS.%26aulast%3DRousselot%26aufirst%3DP.%26aulast%3DLeboulch%26aufirst%3DP.%26atitle%3DErosion%2520of%2520the%2520Chronic%2520Myeloid%2520Leukaemia%2520Stem%2520Cell%2520Pool%2520by%2520PPAR%25CE%25B3%2520Agonists%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D380%26epage%3D383%26doi%3D10.1038%2Fnature15248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Warsch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundschober, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gille, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerny-Reiterer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigan, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelbl-Kovacic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexl, V.</span><span> </span><span class="NLM_article-title">STAT5 Triggers BCR-ABL1 Mutation by Mediating ROS Production in Chronic Myeloid Leukaemia</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1687</span><span class="refDoi"> DOI: 10.18632/oncotarget.806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.18632%2Foncotarget.806" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1669-1687&author=W.+Warschauthor=E.+Grundschoberauthor=A.+Bergerauthor=L.+Gilleauthor=S.+Cerny-Reitererauthor=A.-S.+Tiganauthor=A.+Hoelbl-Kovacicauthor=P.+Valentauthor=R.+Morigglauthor=V.+Sexl&title=STAT5+Triggers+BCR-ABL1+Mutation+by+Mediating+ROS+Production+in+Chronic+Myeloid+Leukaemia&doi=10.18632%2Foncotarget.806"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.806%26sid%3Dliteratum%253Aachs%26aulast%3DWarsch%26aufirst%3DW.%26aulast%3DGrundschober%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DGille%26aufirst%3DL.%26aulast%3DCerny-Reiterer%26aufirst%3DS.%26aulast%3DTigan%26aufirst%3DA.-S.%26aulast%3DHoelbl-Kovacic%26aufirst%3DA.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DSexl%26aufirst%3DV.%26atitle%3DSTAT5%2520Triggers%2520BCR-ABL1%2520Mutation%2520by%2520Mediating%2520ROS%2520Production%2520in%2520Chronic%2520Myeloid%2520Leukaemia%26jtitle%3DOncotarget%26date%3D2012%26volume%3D3%26spage%3D1669%26epage%3D1687%26doi%3D10.18632%2Foncotarget.806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span> </span><span class="NLM_article-title">Inhibition of STAT5: A Therapeutic Option in BCR-ABL1-Driven Leukemia</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">9564</span><span class="NLM_x">–</span> <span class="NLM_lpage">9576</span><span class="refDoi"> DOI: 10.18632/oncotarget.2465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.18632%2Foncotarget.2465" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=9564-9576&author=A.+Bergerauthor=V.+Sexlauthor=P.+Valentauthor=R.+Moriggl&title=Inhibition+of+STAT5%3A+A+Therapeutic+Option+in+BCR-ABL1-Driven+Leukemia&doi=10.18632%2Foncotarget.2465"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2465%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DSexl%26aufirst%3DV.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DMoriggl%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520STAT5%253A%2520A%2520Therapeutic%2520Option%2520in%2520BCR-ABL1-Driven%2520Leukemia%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D9564%26epage%3D9576%26doi%3D10.18632%2Foncotarget.2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Nelson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Natan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gashin, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klitgaard, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addorio, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, D. A.</span><span> </span><span class="NLM_article-title">The STAT5 Inhibitor Pimozide Decreases Survival of Chronic Myelogenous Leukemia Cells Resistant to Kinase Inhibitors</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">3421</span><span class="NLM_x">–</span> <span class="NLM_lpage">3429</span><span class="refDoi"> DOI: 10.1182/blood-2009-11-255232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1182%2Fblood-2009-11-255232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=3421-3429&author=E.+A.+Nelsonauthor=S.+R.+Walkerauthor=E.+Weisbergauthor=M.+Bar-Natanauthor=R.+Barrettauthor=L.+B.+Gashinauthor=S.+Terrellauthor=J.+L.+Klitgaardauthor=L.+Santoauthor=M.+R.+Addorioauthor=B.+L.+Ebertauthor=J.+D.+Griffinauthor=D.+A.+Frank&title=The+STAT5+Inhibitor+Pimozide+Decreases+Survival+of+Chronic+Myelogenous+Leukemia+Cells+Resistant+to+Kinase+Inhibitors&doi=10.1182%2Fblood-2009-11-255232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-11-255232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-11-255232%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DE.%2BA.%26aulast%3DWalker%26aufirst%3DS.%2BR.%26aulast%3DWeisberg%26aufirst%3DE.%26aulast%3DBar-Natan%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DR.%26aulast%3DGashin%26aufirst%3DL.%2BB.%26aulast%3DTerrell%26aufirst%3DS.%26aulast%3DKlitgaard%26aufirst%3DJ.%2BL.%26aulast%3DSanto%26aufirst%3DL.%26aulast%3DAddorio%26aufirst%3DM.%2BR.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26atitle%3DThe%2520STAT5%2520Inhibitor%2520Pimozide%2520Decreases%2520Survival%2520of%2520Chronic%2520Myelogenous%2520Leukemia%2520Cells%2520Resistant%2520to%2520Kinase%2520Inhibitors%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26spage%3D3421%26epage%3D3429%26doi%3D10.1182%2Fblood-2009-11-255232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cumaraswamy, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geletu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laister, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muench, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1202</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span><span class="refDoi"> DOI: 10.1021/ml500165r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500165r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1202-1206&author=A.+A.+Cumaraswamyauthor=A.+M.+Lewisauthor=M.+Geletuauthor=A.+Todicauthor=D.+B.+Diazauthor=X.+R.+Chengauthor=C.+E.+Brownauthor=R.+C.+Laisterauthor=D.+Muenchauthor=K.+Kermanauthor=H.+L.+Grimesauthor=M.+D.+Mindenauthor=P.+T.+Gunning&title=Nanomolar-Potency+Small+Molecule+Inhibitor+of+STAT5+Protein&doi=10.1021%2Fml500165r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fml500165r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500165r%26sid%3Dliteratum%253Aachs%26aulast%3DCumaraswamy%26aufirst%3DA.%2BA.%26aulast%3DLewis%26aufirst%3DA.%2BM.%26aulast%3DGeletu%26aufirst%3DM.%26aulast%3DTodic%26aufirst%3DA.%26aulast%3DDiaz%26aufirst%3DD.%2BB.%26aulast%3DCheng%26aufirst%3DX.%2BR.%26aulast%3DBrown%26aufirst%3DC.%2BE.%26aulast%3DLaister%26aufirst%3DR.%2BC.%26aulast%3DMuench%26aufirst%3DD.%26aulast%3DKerman%26aufirst%3DK.%26aulast%3DGrimes%26aufirst%3DH.%2BL.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DNanomolar-Potency%2520Small%2520Molecule%2520Inhibitor%2520of%2520STAT5%2520Protein%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1202%26epage%3D1206%26doi%3D10.1021%2Fml500165r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Possinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeffler, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elstner, E.</span><span> </span><span class="NLM_article-title">Growth Inhibition and Apoptosis in Human Philadelphia Chromosome-Positive Lymphoblastic Leukemia Cell Lines by Treatment with the Dual PPARα/γ Ligand TZD18</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">3683</span><span class="NLM_x">–</span> <span class="NLM_lpage">3692</span><span class="refDoi"> DOI: 10.1182/blood-2005-05-2103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1182%2Fblood-2005-05-2103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=3683-3692&author=H.+Liuauthor=C.+Zangauthor=M.+H.+Fennerauthor=D.+Liuauthor=K.+Possingerauthor=H.+P.+Koefflerauthor=E.+Elstner&title=Growth+Inhibition+and+Apoptosis+in+Human+Philadelphia+Chromosome-Positive+Lymphoblastic+Leukemia+Cell+Lines+by+Treatment+with+the+Dual+PPAR%CE%B1%2F%CE%B3+Ligand+TZD18&doi=10.1182%2Fblood-2005-05-2103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-05-2103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-05-2103%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZang%26aufirst%3DC.%26aulast%3DFenner%26aufirst%3DM.%2BH.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DPossinger%26aufirst%3DK.%26aulast%3DKoeffler%26aufirst%3DH.%2BP.%26aulast%3DElstner%26aufirst%3DE.%26atitle%3DGrowth%2520Inhibition%2520and%2520Apoptosis%2520in%2520Human%2520Philadelphia%2520Chromosome-Positive%2520Lymphoblastic%2520Leukemia%2520Cell%2520Lines%2520by%2520Treatment%2520with%2520the%2520Dual%2520PPAR%25CE%25B1%252F%25CE%25B3%2520Ligand%2520TZD18%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D3683%26epage%3D3692%26doi%3D10.1182%2Fblood-2005-05-2103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Saiki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatta, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horie, T.</span><span> </span><span class="NLM_article-title">Pioglitazone Inhibits the Growth of Human Leukemia Cell Lines and Primary Leukemia Cells While Sparing Normal Hematopoietic Stem Cells</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span><span class="refDoi"> DOI: 10.3892/ijo.29.2.437</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.3892%2Fijo.29.2.437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=16820887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=437-443&author=M.+Saikiauthor=Y.+Hattaauthor=T.+Yamazakiauthor=T.+Itohauthor=Y.+Enomotoauthor=J.+Takeuchiauthor=U.+Sawadaauthor=S.+Aizawaauthor=T.+Horie&title=Pioglitazone+Inhibits+the+Growth+of+Human+Leukemia+Cell+Lines+and+Primary+Leukemia+Cells+While+Sparing+Normal+Hematopoietic+Stem+Cells&doi=10.3892%2Fijo.29.2.437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells</span></div><div class="casAuthors">Saiki, Minoru; Hatta, Yoshihiro; Yamazaki, Tetsuo; Itoh, Takeyoshi; Enomoto, Yuko; Takeuchi, Jin; Sawada, Umihiko; Aizawa, Shin; Horie, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">437-443</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) compose a subfamily of nuclear hormone receptors functioning as transcriptional regulators.  Originally, the PPARγ ligand known as thiazolidinedione (TZD) was used for the treatment of diabetic patients.  However, recent studies have shown that TZD also has an antitumor effect that inhibits cell growth in several types of human malignant neoplasms, including leukemia cell lines.  Since pioglitazone is the only TZD currently available in clinics in Japan and the role of TZD in normal human hematopoietic cells or primary leukemia cells has not been previously reported, the authors investigated the effect of pioglitazone on human normal hematopoietic progenitor cells, primary leukemia cells, and leukemia cell lines (HL60, K562, U937, HEL, CEM, Jurkat, and NALM1).  Pioglitazone inhibited the proliferation of leukemia cells in a dose-dependent manner.  The viable cell nos. of HL60, K562, and Jurkat leukemia cell lines were profoundly reduced when the cells were cocultured with pioglitazone.  Colony formation in the leukemia cell lines as well as the primary leukemia cells was significantly inhibited to 20-71% and 1-25% of that in control cultures by the addn. of 100 and 300 μM of pioglitazone, resp.  However, the CFU-E and CFU-GM colonies of cells obtained from healthy volunteers were not altered in the presence of 100 μM of pioglitazone.  Pioglitazone (300 μM) induced slight decrease of CFU-E and CFU-GM.  BFU-E was more sensitive to pioglitazone than CFU-E and CFU-GM.  Pioglitazone-induced growth inhibition in HL60 cells was assocd. with cell cycle arrest at the G1 phase, as has been reported for another TZD, troglitazone.  Similar levels of PPARγ protein were obsd. in both leukemia and normal bone marrow cells by Western blotting, suggesting that the expression of PPARγ protein was not assocd. with the inhibitory potency of pioglitazone.  In conclusion, the authors' results suggest that pioglitazone may offer a new therapeutic approach to aid in the treatment of leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-S6WHssFOu7Vg90H21EOLACvtfcHk0lgIYGL8qlvhoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKls7w%253D&md5=cd73257e9d9c3d272572a64f94abd2cc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3892%2Fijo.29.2.437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.29.2.437%26sid%3Dliteratum%253Aachs%26aulast%3DSaiki%26aufirst%3DM.%26aulast%3DHatta%26aufirst%3DY.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DEnomoto%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DJ.%26aulast%3DSawada%26aufirst%3DU.%26aulast%3DAizawa%26aufirst%3DS.%26aulast%3DHorie%26aufirst%3DT.%26atitle%3DPioglitazone%2520Inhibits%2520the%2520Growth%2520of%2520Human%2520Leukemia%2520Cell%2520Lines%2520and%2520Primary%2520Leukemia%2520Cells%2520While%2520Sparing%2520Normal%2520Hematopoietic%2520Stem%2520Cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2006%26volume%3D29%26spage%3D437%26epage%3D443%26doi%3D10.3892%2Fijo.29.2.437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bertz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wächter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Possinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillip Koeffler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elstner, E.</span><span> </span><span class="NLM_article-title">Compound 48, a Novel Dual PPAR α/γ Ligand, Inhibits the Growth of Human CML Cell Lines and Enhances the Anticancer-Effects of Imatinib</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1016/j.leukres.2008.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.leukres.2008.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=19131110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVajsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=686-692&author=J.+Bertzauthor=C.+Zangauthor=H.+Liuauthor=M.+W%C3%A4chterauthor=K.+Possingerauthor=H.+Phillip+Koefflerauthor=E.+Elstner&title=Compound+48%2C+a+Novel+Dual+PPAR+%CE%B1%2F%CE%B3+Ligand%2C+Inhibits+the+Growth+of+Human+CML+Cell+Lines+and+Enhances+the+Anticancer-Effects+of+Imatinib&doi=10.1016%2Fj.leukres.2008.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Compound 48, a novel dual PPAR α/γ ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib</span></div><div class="casAuthors">Bertz, Janina; Zang, Chuanbing; Liu, Hongyu; Waechter, Marlies; Possinger, Kurt; Phillip Koeffler, H.; Elstner, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">686-692</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Compd. 48 (C48) is a novel dual ligand for peroxisome proliferator-activated receptor α and γ (PPARα/γ).  Culture of imatinib-sensitive and -resistant CML cell lines with C48 resulted in a strong growth inhibition which assocd. with G0/G1 cell cycle arrest.  However, it showed no obvious toxicity to normal CD34+ hematopoietic stem cells.  Decrease of pSTATs and pAKT were noticed suggesting that interference of AKT and STATs signaling may be the mechanisms for the effects of PPARα/γ ligands.  Of more clin. importance, this ligand strongly enhanced the anticancer-effects of imatinib.  Overall, our data suggest that the PPARα/γ ligands may have potentials in the treatment of CML in an adjuvant setting either before or after the development of imatinib resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Dt8rO5BcXbVg90H21EOLACvtfcHk0lgIYGL8qlvhoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVajsr8%253D&md5=41da2590344c7c152e04d2d82f4e127c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2008.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2008.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DBertz%26aufirst%3DJ.%26aulast%3DZang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DW%25C3%25A4chter%26aufirst%3DM.%26aulast%3DPossinger%26aufirst%3DK.%26aulast%3DPhillip%2BKoeffler%26aufirst%3DH.%26aulast%3DElstner%26aufirst%3DE.%26atitle%3DCompound%252048%252C%2520a%2520Novel%2520Dual%2520PPAR%2520%25CE%25B1%252F%25CE%25B3%2520Ligand%252C%2520Inhibits%2520the%2520Growth%2520of%2520Human%2520CML%2520Cell%2520Lines%2520and%2520Enhances%2520the%2520Anticancer-Effects%2520of%2520Imatinib%26jtitle%3DLeuk.%2520Res.%26date%3D2009%26volume%3D33%26spage%3D686%26epage%3D692%26doi%3D10.1016%2Fj.leukres.2008.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Prost, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Dantec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augé, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derdouch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auregan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Déglon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relouzat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubertin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillere, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusanter-Fourt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirszenbaum, M.</span><span> </span><span class="NLM_article-title">Human and Simian Immunodeficiency Viruses Deregulate Early Hematopoiesis through a Nef/PPARγ/STAT5 Signaling Pathway in Macaques</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1765</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span><span class="refDoi"> DOI: 10.1172/JCI33037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1172%2FJCI33037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1765-1775&author=S.+Prostauthor=M.+Le+Dantecauthor=S.+Aug%C3%A9author=R.+Le+Grandauthor=S.+Derdouchauthor=G.+Aureganauthor=N.+D%C3%A9glonauthor=F.+Relouzatauthor=A.+Aubertinauthor=B.+Maillereauthor=I.+Dusanter-Fourtauthor=M.+Kirszenbaum&title=Human+and+Simian+Immunodeficiency+Viruses+Deregulate+Early+Hematopoiesis+through+a+Nef%2FPPAR%CE%B3%2FSTAT5+Signaling+Pathway+in+Macaques&doi=10.1172%2FJCI33037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1172%2FJCI33037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI33037%26sid%3Dliteratum%253Aachs%26aulast%3DProst%26aufirst%3DS.%26aulast%3DLe%2BDantec%26aufirst%3DM.%26aulast%3DAug%25C3%25A9%26aufirst%3DS.%26aulast%3DLe%2BGrand%26aufirst%3DR.%26aulast%3DDerdouch%26aufirst%3DS.%26aulast%3DAuregan%26aufirst%3DG.%26aulast%3DD%25C3%25A9glon%26aufirst%3DN.%26aulast%3DRelouzat%26aufirst%3DF.%26aulast%3DAubertin%26aufirst%3DA.%26aulast%3DMaillere%26aufirst%3DB.%26aulast%3DDusanter-Fourt%26aufirst%3DI.%26aulast%3DKirszenbaum%26aufirst%3DM.%26atitle%3DHuman%2520and%2520Simian%2520Immunodeficiency%2520Viruses%2520Deregulate%2520Early%2520Hematopoiesis%2520through%2520a%2520Nef%252FPPAR%25CE%25B3%252FSTAT5%2520Signaling%2520Pathway%2520in%2520Macaques%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D1765%26epage%3D1775%26doi%3D10.1172%2FJCI33037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Seargent, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, J. H.</span><span> </span><span class="NLM_article-title">GW9662, a Potent Antagonist of PPARγ, Inhibits Growth of Breast Tumour Cells and Promotes the Anticancer Effects of the PPARγ Agonist Rosiglitazone, Independently of PPARγ Activation</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1038%2Fsj.bjp.0705973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=15533890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFWmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=933-937&author=J.+M.+Seargentauthor=E.+A.+Yatesauthor=J.+H.+Gill&title=GW9662%2C+a+Potent+Antagonist+of+PPAR%CE%B3%2C+Inhibits+Growth+of+Breast+Tumour+Cells+and+Promotes+the+Anticancer+Effects+of+the+PPAR%CE%B3+Agonist+Rosiglitazone%2C+Independently+of+PPAR%CE%B3+Activation&doi=10.1038%2Fsj.bjp.0705973"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activation</span></div><div class="casAuthors">Seargent, Jill M.; Yates, Elisabeth A.; Gill, Jason H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">933-937</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor gamma (PPARγ), a member of the nuclear receptor superfamily, is activated by several compds., including the thiazolidinediones.  In addn. to being a therapeutic target for obesity, hypolipidemia and diabetes, perturbation of PPARγ signaling is now believed to be a strategy for treatment of several cancers, including breast.  Although differential expression of PPARγ is obsd. in tumors compared to normal tissues and PPARγ agonists have been shown to inhibit tumor cell growth and survival, the interdependence of these observations is unclear.  This study demonstrated that the potent, irreversible and selective PPARγ antagonist GW9662 prevented activation of PPARγ and inhibited growth of human mammary tumor cell lines.  Controversially, GW9662 prevented rosiglitazone-mediated PPARγ activation, but enhanced rather than reversed rosiglitazone-induced growth inhibition.  As such, these data support the existence of PPARγ-independent pathways and question the central belief that PPARγ ligands mediate their anticancer effects via activation of PPARγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7aiVWefjYtLVg90H21EOLACvtfcHk0li9k2cSh8ywXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFWmtw%253D%253D&md5=b75a4db57a7ac03225406d11314c37d7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705973%26sid%3Dliteratum%253Aachs%26aulast%3DSeargent%26aufirst%3DJ.%2BM.%26aulast%3DYates%26aufirst%3DE.%2BA.%26aulast%3DGill%26aufirst%3DJ.%2BH.%26atitle%3DGW9662%252C%2520a%2520Potent%2520Antagonist%2520of%2520PPAR%25CE%25B3%252C%2520Inhibits%2520Growth%2520of%2520Breast%2520Tumour%2520Cells%2520and%2520Promotes%2520the%2520Anticancer%2520Effects%2520of%2520the%2520PPAR%25CE%25B3%2520Agonist%2520Rosiglitazone%252C%2520Independently%2520of%2520PPAR%25CE%25B3%2520Activation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D933%26epage%3D937%26doi%3D10.1038%2Fsj.bjp.0705973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulp, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">PPARγ-Independent Antitumor Effects of Thiazolidinediones</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1016/j.canlet.2008.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.canlet.2008.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=18790559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFKjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=119-124&author=S.+Weiauthor=J.+Yangauthor=S.+Leeauthor=S.+K.+Kulpauthor=C.+Chen&title=PPAR%CE%B3-Independent+Antitumor+Effects+of+Thiazolidinediones&doi=10.1016%2Fj.canlet.2008.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">PPARγ-independent antitumor effects of thiazolidinediones</span></div><div class="casAuthors">Wei, Shuo; Yang, Jian; Lee, Su-Lin; Kulp, Samuel K.; Chen, Ching-Shih</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-124</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The thiazolidinedione (TZD) family of PPARγ agonists, esp. troglitazone and ciglitazone, induce cell cycle arrest, differentiation, and apoptosis in cancer cells.  Mounting evidence indicates that TZDs interfere with multiple signaling mechanisms independently of PPARγ activation, which affect many aspects of cellular functions governing cell cycle progression and survival of cancer cells.  Here, we review the "off-target" mechanisms that underlie the antitumor effects of TZDs with emphasis on 3 key pathways, namely, inhibition of Bcl-2/Bcl-xL function, proteasomal degrdn. of cell cycle- and apoptosis-regulatory proteins, and transcriptional repression of androgen receptor (AR) through Sp1 degrdn.  Relative to tumor cells, nonmalignant cells are resistant to these PPARγ-independent antitumor effects, which underscores the translational potential of these agents.  Furthermore, dissocn. of these antitumor effects from their PPARγ agonist activity provides a rationale for using TZDs as scaffolds for lead optimization to develop a novel class of antitumor agents with a unique mode of mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6Y4tzRlwErVg90H21EOLACvtfcHk0lgqGRlXACmx-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFKjsL8%253D&md5=fc56d3c6acc3500d8afc0b8d77b67248</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKulp%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DPPAR%25CE%25B3-Independent%2520Antitumor%2520Effects%2520of%2520Thiazolidinediones%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D276%26spage%3D119%26epage%3D124%26doi%3D10.1016%2Fj.canlet.2008.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Parmenon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennuyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinot-Bouchez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutin, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dacquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktorza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viaud-Massuard, M.-C.</span><span> </span><span class="NLM_article-title">4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline-Based PPARα/γ Agonists. Part I: Synthesis and Pharmacological Evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1617</span><span class="NLM_x">–</span> <span class="NLM_lpage">1622</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.bmcl.2008.01.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=18255290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1Ckt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1617-1622&author=C.+Parmenonauthor=J.+Guillardauthor=D.-H.+Caignardauthor=N.+Hennuyerauthor=B.+Staelsauthor=V.+Audinot-Bouchezauthor=J.-A.+Boutinauthor=C.+Dacquetauthor=A.+Ktorzaauthor=M.-C.+Viaud-Massuard&title=4%2C4-Dimethyl-1%2C2%2C3%2C4-Tetrahydroquinoline-Based+PPAR%CE%B1%2F%CE%B3+Agonists.+Part+I%3A+Synthesis+and+Pharmacological+Evaluation&doi=10.1016%2Fj.bmcl.2008.01.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARα/γ agonists. Part I: Synthesis and pharmacological evaluation</span></div><div class="casAuthors">Parmenon, Cecile; Guillard, Jerome; Caignard, Daniel-Henri; Hennuyer, Nathalie; Staels, Bart; Audinot-Bouchez, Valerie; Boutin, Jean-Albert; Dacquet, Catherine; Ktorza, Alain; Viaud-Massuard, Marie-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1617-1622</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 4,4-dimethyl-1,2,3,4-tetrahydroquinolines, e.g. I (R = H, Me), was synthesized and studied as human PPARγ selective agonists and dual PPARα/γ agonists for potential treatment of type-2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp08HKGqPuCVLVg90H21EOLACvtfcHk0lgqGRlXACmx-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1Ckt70%253D&md5=93ad385b32df02483e5cd41d979000de</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.067%26sid%3Dliteratum%253Aachs%26aulast%3DParmenon%26aufirst%3DC.%26aulast%3DGuillard%26aufirst%3DJ.%26aulast%3DCaignard%26aufirst%3DD.-H.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DAudinot-Bouchez%26aufirst%3DV.%26aulast%3DBoutin%26aufirst%3DJ.-A.%26aulast%3DDacquet%26aufirst%3DC.%26aulast%3DKtorza%26aufirst%3DA.%26aulast%3DViaud-Massuard%26aufirst%3DM.-C.%26atitle%3D4%252C4-Dimethyl-1%252C2%252C3%252C4-Tetrahydroquinoline-Based%2520PPAR%25CE%25B1%252F%25CE%25B3%2520Agonists.%2520Part%2520I%253A%2520Synthesis%2520and%2520Pharmacological%2520Evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1617%26epage%3D1622%26doi%3D10.1016%2Fj.bmcl.2008.01.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Parmenon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennuyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinot-Bouchez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutin, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dacquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktorza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viaud-Massuard, M.-C.</span><span> </span><span class="NLM_article-title">4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline-Based PPARα/γ Agonists. Part. II: Synthesis and Pharmacological Evaluation of Oxime and Acidic Head Group Structural Variations</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2683</span><span class="NLM_x">–</span> <span class="NLM_lpage">2687</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.bmcl.2009.03.143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2683-2687&author=C.+Parmenonauthor=J.+Guillardauthor=D.-H.+Caignardauthor=N.+Hennuyerauthor=B.+Staelsauthor=V.+Audinot-Bouchezauthor=J.-A.+Boutinauthor=C.+Dacquetauthor=A.+Ktorzaauthor=M.-C.+Viaud-Massuard&title=4%2C4-Dimethyl-1%2C2%2C3%2C4-Tetrahydroquinoline-Based+PPAR%CE%B1%2F%CE%B3+Agonists.+Part.+II%3A+Synthesis+and+Pharmacological+Evaluation+of+Oxime+and+Acidic+Head+Group+Structural+Variations&doi=10.1016%2Fj.bmcl.2009.03.143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.143%26sid%3Dliteratum%253Aachs%26aulast%3DParmenon%26aufirst%3DC.%26aulast%3DGuillard%26aufirst%3DJ.%26aulast%3DCaignard%26aufirst%3DD.-H.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DAudinot-Bouchez%26aufirst%3DV.%26aulast%3DBoutin%26aufirst%3DJ.-A.%26aulast%3DDacquet%26aufirst%3DC.%26aulast%3DKtorza%26aufirst%3DA.%26aulast%3DViaud-Massuard%26aufirst%3DM.-C.%26atitle%3D4%252C4-Dimethyl-1%252C2%252C3%252C4-Tetrahydroquinoline-Based%2520PPAR%25CE%25B1%252F%25CE%25B3%2520Agonists.%2520Part.%2520II%253A%2520Synthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Oxime%2520and%2520Acidic%2520Head%2520Group%2520Structural%2520Variations%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2683%26epage%3D2687%26doi%3D10.1016%2Fj.bmcl.2009.03.143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Garcia-Bates, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson-Haidaris, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sime, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, R. P.</span><span> </span><span class="NLM_article-title">Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies</span> <span class="citation_source-journal">PPAR Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1155/2008/834612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1155%2F2008%2F834612" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=1-18&author=T.+M.+Garcia-Batesauthor=G.+M.+Lehmannauthor=P.+J.+Simpson-Haidarisauthor=S.+H.+Bernsteinauthor=P.+J.+Simeauthor=R.+P.+Phipps&title=Role+of+Peroxisome+Proliferator-Activated+Receptor+Gamma+and+Its+Ligands+in+the+Treatment+of+Hematological+Malignancies&doi=10.1155%2F2008%2F834612"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1155%2F2008%2F834612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2008%252F834612%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Bates%26aufirst%3DT.%2BM.%26aulast%3DLehmann%26aufirst%3DG.%2BM.%26aulast%3DSimpson-Haidaris%26aufirst%3DP.%2BJ.%26aulast%3DBernstein%26aufirst%3DS.%2BH.%26aulast%3DSime%26aufirst%3DP.%2BJ.%26aulast%3DPhipps%26aufirst%3DR.%2BP.%26atitle%3DRole%2520of%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520Gamma%2520and%2520Its%2520Ligands%2520in%2520the%2520Treatment%2520of%2520Hematological%2520Malignancies%26jtitle%3DPPAR%2520Res.%26date%3D2008%26volume%3D2008%26spage%3D1%26epage%3D18%26doi%3D10.1155%2F2008%2F834612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kodomari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span> </span><span class="NLM_article-title">Graphite as an Effective Catalyst for Friedel–Crafts Acylation</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">1567</span><span class="NLM_x">–</span> <span class="NLM_lpage">1568</span><span class="refDoi"> DOI: 10.1039/a703947f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1039%2Fa703947f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=1567-1568&issue=16&author=M.+Kodomariauthor=Y.+Suzukiauthor=K.+Yoshida&title=Graphite+as+an+Effective+Catalyst+for+Friedel%E2%80%93Crafts+Acylation&doi=10.1039%2Fa703947f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fa703947f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa703947f%26sid%3Dliteratum%253Aachs%26aulast%3DKodomari%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DK.%26atitle%3DGraphite%2520as%2520an%2520Effective%2520Catalyst%2520for%2520Friedel%25E2%2580%2593Crafts%2520Acylation%26jtitle%3DChem.%2520Commun.%26date%3D1997%26issue%3D16%26spage%3D1567%26epage%3D1568%26doi%3D10.1039%2Fa703947f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Niu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span> </span><span class="NLM_article-title">Copper(I)-Catalyzed Aryl Bromides To Form Intermolecular and Intramolecular Carbon–Oxygen Bonds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">5075</span><span class="NLM_x">–</span> <span class="NLM_lpage">5078</span><span class="refDoi"> DOI: 10.1021/jo900600m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo900600m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVOmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=5075-5078&author=J.+Niuauthor=P.+Guoauthor=J.+Kangauthor=Z.+Liauthor=J.+Xuauthor=S.+Hu&title=Copper%28I%29-Catalyzed+Aryl+Bromides+To+Form+Intermolecular+and+Intramolecular+Carbon%E2%80%93Oxygen+Bonds&doi=10.1021%2Fjo900600m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I)-Catalyzed Aryl Bromides To Form Intermolecular and Intramolecular Carbon-Oxygen Bonds</span></div><div class="casAuthors">Niu, Jiajia; Guo, Pengran; Kang, Juntao; Li, Zhigang; Xu, Jingwei; Hu, Shaojing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5075-5078</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A highly efficient Cu-catalyzed C-O bond-forming reaction of alc. and aryl bromides has been developed.  This transformation was realized through the use of copper(I) iodide as a catalyst, 8-hydroxyquinoline as a ligand, and K3PO4 as a base.  A variety of functionalized substrates were found to react under these reaction conditions to provide products in good to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXe9h4hZl2HLVg90H21EOLACvtfcHk0li5pu5O77vSUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVOmsbo%253D&md5=b80aea2e47f5e3b9c9c9cef81794966f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo900600m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900600m%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DS.%26atitle%3DCopper%2528I%2529-Catalyzed%2520Aryl%2520Bromides%2520To%2520Form%2520Intermolecular%2520and%2520Intramolecular%2520Carbon%25E2%2580%2593Oxygen%2520Bonds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D5075%26epage%3D5078%26doi%3D10.1021%2Fjo900600m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Altman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtor, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">An Improved Cu-Based Catalyst System for the Reactions of Alcohols with Aryl Halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1021/jo702024p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo702024p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOgsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=284-286&author=R.+A.+Altmanauthor=A.+Shafirauthor=A.+Choiauthor=P.+A.+Lichtorauthor=S.+L.+Buchwald&title=An+Improved+Cu-Based+Catalyst+System+for+the+Reactions+of+Alcohols+with+Aryl+Halides&doi=10.1021%2Fjo702024p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An Improved Cu-Based Catalyst System for the Reactions of Alcohols with Aryl Halides</span></div><div class="casAuthors">Altman, Ryan A.; Shafir, Alexandr; Choi, Alice; Lichtor, Phillip A.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">284-286</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of 3,4,7,8-tetramethyl-1,10-phenanthroline (Me4Phen) as a ligand improves the Cu-catalyzed cross-coupling reactions of aryl iodides and bromides with primary and secondary aliph., benzylic, allylic, and propargylic alcs to give products, e.g., I, in good yields.  Most importantly, by employing this catalyst system, the need to use an excessive quantity of the alc. coupling partner is alleviated.  The relatively mild conditions, short reaction times, and moderately low catalyst loading allow for a wide array of functional groups to be tolerated on both the electrophilic and nucleophilic coupling partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy2UxAcp1pOrVg90H21EOLACvtfcHk0lhT4MTNcbraog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOgsrjF&md5=a99d7184c0f34e2ca688ba0796c95b70</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo702024p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo702024p%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DR.%2BA.%26aulast%3DShafir%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DA.%26aulast%3DLichtor%26aufirst%3DP.%2BA.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DAn%2520Improved%2520Cu-Based%2520Catalyst%2520System%2520for%2520the%2520Reactions%2520of%2520Alcohols%2520with%2520Aryl%2520Halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D284%26epage%3D286%26doi%3D10.1021%2Fjo702024p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">More, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finney, N. S.</span><span> </span><span class="NLM_article-title">A Simple and Advantageous Protocol for the Oxidation of Alcohols with O-Iodoxybenzoic Acid (IBX)</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3001</span><span class="NLM_x">–</span> <span class="NLM_lpage">3003</span><span class="refDoi"> DOI: 10.1021/ol026427n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol026427n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVSgtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=3001-3003&author=J.+D.+Moreauthor=N.+S.+Finney&title=A+Simple+and+Advantageous+Protocol+for+the+Oxidation+of+Alcohols+with+O-Iodoxybenzoic+Acid+%28IBX%29&doi=10.1021%2Fol026427n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple and Advantageous Protocol for the Oxidation of Alcohols with o-Iodoxybenzoic Acid (IBX)</span></div><div class="casAuthors">More, Jesse D.; Finney, Nathaniel S.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3001-3003</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Both primary and secondary alcs. were oxidized into the corresponding aldehydes in excellent yields (90-100%) by heating a soln. of an alc. with suspended 2-iodoxybenzoic acid (IBX) followed by filtration of insol. byproducts and solvent removal.  The IBX oxidant can be recycled and reused.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEUdN6GyHKIrVg90H21EOLACvtfcHk0lgElVMJ6E_sKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVSgtbo%253D&md5=c7ff04157bc298d4fce92906f321ba96</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fol026427n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol026427n%26sid%3Dliteratum%253Aachs%26aulast%3DMore%26aufirst%3DJ.%2BD.%26aulast%3DFinney%26aufirst%3DN.%2BS.%26atitle%3DA%2520Simple%2520and%2520Advantageous%2520Protocol%2520for%2520the%2520Oxidation%2520of%2520Alcohols%2520with%2520O-Iodoxybenzoic%2520Acid%2520%2528IBX%2529%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D3001%26epage%3D3003%26doi%3D10.1021%2Fol026427n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. D.</span><span> </span><span class="NLM_article-title">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3849</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span><span class="refDoi"> DOI: 10.1021/jo960057x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+Amination+of+Aldehydes+and+Ketones+with+Sodium+Triacetoxyborohydride.+Studies+on+Direct+and+Indirect+Reductive+Amination+Procedures&doi=10.1021%2Fjo960057x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0lgElVMJ6E_sKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520Amination%2520of%2520Aldehydes%2520and%2520Ketones%2520with%2520Sodium%2520Triacetoxyborohydride.%2520Studies%2520on%2520Direct%2520and%2520Indirect%2520Reductive%2520Amination%2520Procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862%26doi%3D10.1021%2Fjo960057x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Dhar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klucik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madler, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivey, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacheis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birckbichler, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benbrook, D. M.</span><span> </span><span class="NLM_article-title">Synthesis, Structure–Activity Relationships, and RARγ–Ligand Interactions of Nitrogen Heteroarotinoids</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3602</span><span class="NLM_x">–</span> <span class="NLM_lpage">3614</span><span class="refDoi"> DOI: 10.1021/jm9900974</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9900974" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3602-3614&author=A.+Dharauthor=S.+Liuauthor=J.+Klucikauthor=K.+D.+Berlinauthor=M.+M.+Madlerauthor=S.+Luauthor=R.+T.+Iveyauthor=D.+Zacheisauthor=C.+W.+Brownauthor=E.+C.+Nelsonauthor=P.+J.+Birckbichlerauthor=D.+M.+Benbrook&title=Synthesis%2C+Structure%E2%80%93Activity+Relationships%2C+and+RAR%CE%B3%E2%80%93Ligand+Interactions+of+Nitrogen+Heteroarotinoids&doi=10.1021%2Fjm9900974"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm9900974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9900974%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DKlucik%26aufirst%3DJ.%26aulast%3DBerlin%26aufirst%3DK.%2BD.%26aulast%3DMadler%26aufirst%3DM.%2BM.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DIvey%26aufirst%3DR.%2BT.%26aulast%3DZacheis%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DC.%2BW.%26aulast%3DNelson%26aufirst%3DE.%2BC.%26aulast%3DBirckbichler%26aufirst%3DP.%2BJ.%26aulast%3DBenbrook%26aufirst%3DD.%2BM.%26atitle%3DSynthesis%252C%2520Structure%25E2%2580%2593Activity%2520Relationships%252C%2520and%2520RAR%25CE%25B3%25E2%2580%2593Ligand%2520Interactions%2520of%2520Nitrogen%2520Heteroarotinoids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3602%26epage%3D3614%26doi%3D10.1021%2Fjm9900974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Weiberth, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. S.</span><span> </span><span class="NLM_article-title">Copper(I)-Activated Addition of Grignard Reagents to Nitriles. Synthesis of Ketimines, Ketones, and Amines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3901</span><span class="NLM_x">–</span> <span class="NLM_lpage">3904</span><span class="refDoi"> DOI: 10.1021/jo00226a033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00226a033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADyaL2sXlsFCjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1987&pages=3901-3904&author=F.+J.+Weiberthauthor=S.+S.+Hall&title=Copper%28I%29-Activated+Addition+of+Grignard+Reagents+to+Nitriles.+Synthesis+of+Ketimines%2C+Ketones%2C+and+Amines&doi=10.1021%2Fjo00226a033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I)-activated addition of Grignard reagents to nitriles.  Synthesis of ketimines, ketones, and amines</span></div><div class="casAuthors">Weiberth, Franz J.; Hall, Stan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3901-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The nucleophilic addn. of Grignard reagents to nitriles, esp. when using sterically demanding components, is effectively catalyzed by copper(I) salts.  Alkyl and arom. nitriles and a selection of Grignard reagents were employed to prep. sterically hindered ketimines after addn., ketones after a tandem addn.-hydrolysis procedure, and branched primary amines after a tandem addn.-redn. sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSk9wHfpw5mLVg90H21EOLACvtfcHk0lg1STTVQpl_Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlsFCjs7c%253D&md5=dcb9d089a8d4b275553ae770f089a9f7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo00226a033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00226a033%26sid%3Dliteratum%253Aachs%26aulast%3DWeiberth%26aufirst%3DF.%2BJ.%26aulast%3DHall%26aufirst%3DS.%2BS.%26atitle%3DCopper%2528I%2529-Activated%2520Addition%2520of%2520Grignard%2520Reagents%2520to%2520Nitriles.%2520Synthesis%2520of%2520Ketimines%252C%2520Ketones%252C%2520and%2520Amines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1987%26volume%3D52%26spage%3D3901%26epage%3D3904%26doi%3D10.1021%2Fjo00226a033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Haddach, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deaton-rewolinski, M. V.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">An Efficient Method for the N-Debenzylation of Aromatic Heterocycles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)02192-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2FS0040-4039%2801%2902192-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtlSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=399-402&author=A.+A.+Haddachauthor=M.+V.+Deaton-rewolinski&title=An+Efficient+Method+for+the+N-Debenzylation+of+Aromatic+Heterocycles&doi=10.1016%2FS0040-4039%2801%2902192-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient method for the N-debenzylation of aromatic heterocycles</span></div><div class="casAuthors">Haddach, Aubrey A.; Kelleman, Audrey; Deaton-Rewolinski, Melissa V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-402</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The treatment of N-benzylated heterocycles with K tert-butoxide/DMSO and O at room temp. cleanly affords N-debenzylated products in high yield.  This procedure can be used on a variety of functionalized N-contg. heterocycles such as imidazoles, benzimidazoles, pyrazoles, indazoles, carbazoles, and indoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxH_1cyKPnwLVg90H21EOLACvtfcHk0lg1STTVQpl_Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtlSg&md5=d58503d132cc29a1d75ba44ab13040c1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2902192-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252902192-X%26sid%3Dliteratum%253Aachs%26aulast%3DHaddach%26aufirst%3DA.%2BA.%26aulast%3DDeaton-rewolinski%26aufirst%3DM.%2BV.%26atitle%3DAn%2520Efficient%2520Method%2520for%2520the%2520N-Debenzylation%2520of%2520Aromatic%2520Heterocycles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D399%26epage%3D402%26doi%3D10.1016%2FS0040-4039%2801%2902192-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Liang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, N.</span><span> </span><span class="NLM_article-title">Highly Efficient C-H Hydroxylation of Carbonyl Compounds with Oxygen under Mild Conditions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">548</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span><span class="refDoi"> DOI: 10.1002/anie.201308698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1002%2Fanie.201308698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVClsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=548-552&author=Y.+F.+Liangauthor=N.+Jiao&title=Highly+Efficient+C-H+Hydroxylation+of+Carbonyl+Compounds+with+Oxygen+under+Mild+Conditions&doi=10.1002%2Fanie.201308698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Efficient C-H Hydroxylation of Carbonyl Compounds with Oxygen under Mild Conditions</span></div><div class="casAuthors">Liang, Yu-Feng; Jiao, Ning</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">548-552</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A transition-metal-free Cs2CO3-catalyzed α-hydroxylation of carbonyl compds. with O2 as the oxygen source is described.  E.g., in presence of Cs2CO3, P(OEt)3, and O2 in DMSO, α-hydroxylation of 2-methyl-1-tetralone gave 99% I.  This reaction provides an efficient approach to tertiary α-hydroxy carbonyl compds., which are highly valued chems. and widely used in the chem. and pharmaceutical industry.  The simple conditions and the use of mol. oxygen as both the oxidant and the oxygen source make this protocol very environmentally friendly and practical.  This transformation is highly efficient and highly selective for tertiary C(sp3)-H bond cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwv4f5czbDALVg90H21EOLACvtfcHk0ljeOYWiCK8Jow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVClsLvP&md5=996c3e3c8b7176daaf378db12273801e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.201308698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201308698%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%2BF.%26aulast%3DJiao%26aufirst%3DN.%26atitle%3DHighly%2520Efficient%2520C-H%2520Hydroxylation%2520of%2520Carbonyl%2520Compounds%2520with%2520Oxygen%2520under%2520Mild%2520Conditions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D548%26epage%3D552%26doi%3D10.1002%2Fanie.201308698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lucas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehdi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bélanger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breau, L.</span><span> </span><span class="NLM_article-title">Expedient Synthesis of Symmetric Aryl Ketones and of Ambient-Temperature Molten Salts of Imidazole</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span><span class="refDoi"> DOI: 10.1055/s-2000-6416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1055%2Fs-2000-6416" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2000&publication_year=2000&pages=1253-1258&author=P.+Lucasauthor=N.+Mehdiauthor=H.+A.+Hoauthor=D.+B%C3%A9langerauthor=L.+Breau&title=Expedient+Synthesis+of+Symmetric+Aryl+Ketones+and+of+Ambient-Temperature+Molten+Salts+of+Imidazole&doi=10.1055%2Fs-2000-6416"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-6416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-6416%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DP.%26aulast%3DMehdi%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DH.%2BA.%26aulast%3DB%25C3%25A9langer%26aufirst%3DD.%26aulast%3DBreau%26aufirst%3DL.%26atitle%3DExpedient%2520Synthesis%2520of%2520Symmetric%2520Aryl%2520Ketones%2520and%2520of%2520Ambient-Temperature%2520Molten%2520Salts%2520of%2520Imidazole%26jtitle%3DSynthesis%26date%3D2000%26volume%3D2000%26spage%3D1253%26epage%3D1258%26doi%3D10.1055%2Fs-2000-6416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demnitz, F. W. J.</span><span> </span><span class="NLM_article-title">An Efficient, Rapid and Highly Selective Preparation of the Wieland-Miescher Ketone-9-Ethylene Ketal</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1016/S0040-4039(96)02334-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2FS0040-4039%2896%2902334-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=389-390&author=P.+Ciceriauthor=F.+W.+J.+Demnitz&title=An+Efficient%2C+Rapid+and+Highly+Selective+Preparation+of+the+Wieland-Miescher+Ketone-9-Ethylene+Ketal&doi=10.1016%2FS0040-4039%2896%2902334-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2896%2902334-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252896%252902334-9%26sid%3Dliteratum%253Aachs%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDemnitz%26aufirst%3DF.%2BW.%2BJ.%26atitle%3DAn%2520Efficient%252C%2520Rapid%2520and%2520Highly%2520Selective%2520Preparation%2520of%2520the%2520Wieland-Miescher%2520Ketone-9-Ethylene%2520Ketal%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D389%26epage%3D390%26doi%3D10.1016%2FS0040-4039%2896%2902334-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Devine, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodring, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leed, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciotti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5537</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5522-5537&author=W.+Devineauthor=J.+L.+Woodringauthor=U.+Swaminathanauthor=E.+Amataauthor=G.+Patelauthor=J.+Erathauthor=N.+E.+Roncalauthor=P.+J.+Leeauthor=S.+E.+Leedauthor=A.+Rodriguezauthor=K.+Mensa-Wilmotauthor=R.+J.+Sciottiauthor=M.+P.+Pollastri&title=Protozoan+Parasite+Growth+Inhibitors+Discovered+by+Cross-Screening+Yield+Potent+Scaffolds+for+Lead+Discovery&doi=10.1021%2Facs.jmedchem.5b00515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Protozoan parasite growth inhibitors discovered by cross-screening yield potent scaffolds for lead discovery</span></div><div class="casAuthors">Devine, William; Woodring, Jennifer L.; Swaminathan, Uma; Amata, Emanuele; Patel, Gautam; Erath, Jessey; Roncal, Norma E.; Lee, Patricia J.; Leed, Susan E.; Rodriguez, Ana; Mensa-Wilmot, Kojo; Sciotti, Richard J.; Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5522-5537</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tropical protozoal infections are a significant cause of morbidity and mortality worldwide; four in particular (human African trypanosomiasis (HAT), Chagas disease, cutaneous leishmaniasis, and malaria) have an estd. combined burden of over 87 million disability-adjusted life years.  New drugs are needed for each of these diseases.  Building on the previous identification of NEU-617 as a potent and nontoxic inhibitor of proliferation for the HAT pathogen (Trypanosoma brucei), the authors have now tested this class of analogs against other protozoal species: T. cruzi (Chagas disease), Leishmania major (cutaneous leishmaniasis), and Plasmodium falciparum (malaria).  Based on hits identified in this screening campaign, the authors describe the prepn. of several replacements for the quinazoline scaffold and report these inhibitors' biol. activities against these parasites.  In doing this, the authors have identified several potent proliferation inhibitors for each pathogen, such as NEU-924, I, for T. cruzi and NEU-1017, II, for L. major and P. falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbrXR55ZLJ7Vg90H21EOLACvtfcHk0ljHj7QQEMudlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bN&md5=76fef909165981d8e542d28a5ee59c12</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00515%26sid%3Dliteratum%253Aachs%26aulast%3DDevine%26aufirst%3DW.%26aulast%3DWoodring%26aufirst%3DJ.%2BL.%26aulast%3DSwaminathan%26aufirst%3DU.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DG.%26aulast%3DErath%26aufirst%3DJ.%26aulast%3DRoncal%26aufirst%3DN.%2BE.%26aulast%3DLee%26aufirst%3DP.%2BJ.%26aulast%3DLeed%26aufirst%3DS.%2BE.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DProtozoan%2520Parasite%2520Growth%2520Inhibitors%2520Discovered%2520by%2520Cross-Screening%2520Yield%2520Potent%2520Scaffolds%2520for%2520Lead%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5522%26epage%3D5537%26doi%3D10.1021%2Facs.jmedchem.5b00515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Knapp, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, M. D.</span><span> </span><span class="NLM_article-title">A General Solution for Unstable Boronic Acids: Slow-Release Cross-Coupling from Air-Stable MIDA Boronates</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">6961</span><span class="NLM_x">–</span> <span class="NLM_lpage">6963</span><span class="refDoi"> DOI: 10.1021/ja901416p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja901416p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Cls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=6961-6963&author=D.+M.+Knappauthor=E.+P.+Gillisauthor=M.+D.+Burke&title=A+General+Solution+for+Unstable+Boronic+Acids%3A+Slow-Release+Cross-Coupling+from+Air-Stable+MIDA+Boronates&doi=10.1021%2Fja901416p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A General Solution for Unstable Boronic Acids: Slow-Release Cross-Coupling from Air-Stable MIDA Boronates</span></div><div class="casAuthors">Knapp, David M.; Gillis, Eric P.; Burke, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6961-6963</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Many boronic acids, including 2-heterocyclic, vinyl, and cyclopropyl derivs., are inherently unstable, which can limit their bench-top storage and/or efficient cross-coupling.  The authors herein report the 1st general soln. to this problem: in situ slow release of unstable boronic acids from the corresponding air-stable N-methyliminodiacetic acid (MIDA) boronates.  This remarkably general approach has transformed all three classes of these unstable boronic acids into shelf-stable and highly effective building blocks for cross-coupling with a wide range of aryl and heteroaryl chlorides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnIQpAbX2N_7Vg90H21EOLACvtfcHk0ljHj7QQEMudlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Cls7s%253D&md5=0865bc71ca79319e2116c23932c7ed55</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja901416p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja901416p%26sid%3Dliteratum%253Aachs%26aulast%3DKnapp%26aufirst%3DD.%2BM.%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DBurke%26aufirst%3DM.%2BD.%26atitle%3DA%2520General%2520Solution%2520for%2520Unstable%2520Boronic%2520Acids%253A%2520Slow-Release%2520Cross-Coupling%2520from%2520Air-Stable%2520MIDA%2520Boronates%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D6961%26epage%3D6963%26doi%3D10.1021%2Fja901416p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Dick, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woerly, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, M. D.</span><span> </span><span class="NLM_article-title">A General Solution for the 2-Pyridyl Problem</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2667</span><span class="NLM_x">–</span> <span class="NLM_lpage">2672</span><span class="refDoi"> DOI: 10.1002/anie.201108608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1002%2Fanie.201108608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=2667-2672&author=G.+R.+Dickauthor=E.+M.+Woerlyauthor=M.+D.+Burke&title=A+General+Solution+for+the+2-Pyridyl+Problem&doi=10.1002%2Fanie.201108608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A General Solution for the 2-Pyridyl Problem</span></div><div class="casAuthors">Dick, Graham R.; Woerly, Eric M.; Burke, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2667-2672, S2667/1-S2667/80</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The use of 2-pyridinyl N-methyliminodiacetic acid boronate in coupling reactions with aryl halides catalyzed by Cu(OAc)2 and XphosPdcycle to produce various 2-arylpyridines is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ5_1Q-2ZSa7Vg90H21EOLACvtfcHk0lj3tKe3jewnXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOqt7k%253D&md5=0b7fa5431edb9277382398f2925601fd</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fanie.201108608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201108608%26sid%3Dliteratum%253Aachs%26aulast%3DDick%26aufirst%3DG.%2BR.%26aulast%3DWoerly%26aufirst%3DE.%2BM.%26aulast%3DBurke%26aufirst%3DM.%2BD.%26atitle%3DA%2520General%2520Solution%2520for%2520the%25202-Pyridyl%2520Problem%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D2667%26epage%3D2672%26doi%3D10.1002%2Fanie.201108608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Sonoyama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezoe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanakura, Y.</span><span> </span><span class="NLM_article-title">Functional Cooperation among Ras, STAT5, and Phosphatidylinositol 3-Kinase Is Required for Full Oncogenic Activities of BCR/ABL in K562 Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">8076</span><span class="NLM_x">–</span> <span class="NLM_lpage">8082</span><span class="refDoi"> DOI: 10.1074/jbc.M111501200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1074%2Fjbc.M111501200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=8076-8082&author=J.+Sonoyamaauthor=I.+Matsumuraauthor=S.+Ezoeauthor=Y.+Satohauthor=X.+Zhangauthor=Y.+Kataokaauthor=E.+Takaiauthor=M.+Mizukiauthor=T.+Machiiauthor=H.+Wakaoauthor=Y.+Kanakura&title=Functional+Cooperation+among+Ras%2C+STAT5%2C+and+Phosphatidylinositol+3-Kinase+Is+Required+for+Full+Oncogenic+Activities+of+BCR%2FABL+in+K562+Cells&doi=10.1074%2Fjbc.M111501200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111501200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111501200%26sid%3Dliteratum%253Aachs%26aulast%3DSonoyama%26aufirst%3DJ.%26aulast%3DMatsumura%26aufirst%3DI.%26aulast%3DEzoe%26aufirst%3DS.%26aulast%3DSatoh%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DKataoka%26aufirst%3DY.%26aulast%3DTakai%26aufirst%3DE.%26aulast%3DMizuki%26aufirst%3DM.%26aulast%3DMachii%26aufirst%3DT.%26aulast%3DWakao%26aufirst%3DH.%26aulast%3DKanakura%26aufirst%3DY.%26atitle%3DFunctional%2520Cooperation%2520among%2520Ras%252C%2520STAT5%252C%2520and%2520Phosphatidylinositol%25203-Kinase%2520Is%2520Required%2520for%2520Full%2520Oncogenic%2520Activities%2520of%2520BCR%252FABL%2520in%2520K562%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D8076%26epage%3D8082%26doi%3D10.1074%2Fjbc.M111501200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Aichberger, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayerhofer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauth, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonneck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akgul, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derdak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickl, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacheck, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monia, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sillaber, C.</span><span> </span><span class="NLM_article-title">Identification of Mcl-1 as a BCR/ABL-Dependent Target in Chronic Myeloid Leukemia (CML): Evidence for Cooperative Antileukemic Effects of Imatinib and Mcl-1 Antisense Oligonucleotides</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3303</span><span class="NLM_x">–</span> <span class="NLM_lpage">3311</span><span class="refDoi"> DOI: 10.1182/blood-2004-02-0749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1182%2Fblood-2004-02-0749" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=3303-3311&author=K.+J.+Aichbergerauthor=M.+Mayerhoferauthor=M.-T.+Krauthauthor=H.+Skvaraauthor=S.+Florianauthor=K.+Sonneckauthor=C.+Akgulauthor=S.+Derdakauthor=W.+F.+Picklauthor=V.+Wacheckauthor=E.+Selzerauthor=B.+P.+Moniaauthor=R.+Morigglauthor=P.+Valentauthor=C.+Sillaber&title=Identification+of+Mcl-1+as+a+BCR%2FABL-Dependent+Target+in+Chronic+Myeloid+Leukemia+%28CML%29%3A+Evidence+for+Cooperative+Antileukemic+Effects+of+Imatinib+and+Mcl-1+Antisense+Oligonucleotides&doi=10.1182%2Fblood-2004-02-0749"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1182%2Fblood-2004-02-0749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2004-02-0749%26sid%3Dliteratum%253Aachs%26aulast%3DAichberger%26aufirst%3DK.%2BJ.%26aulast%3DMayerhofer%26aufirst%3DM.%26aulast%3DKrauth%26aufirst%3DM.-T.%26aulast%3DSkvara%26aufirst%3DH.%26aulast%3DFlorian%26aufirst%3DS.%26aulast%3DSonneck%26aufirst%3DK.%26aulast%3DAkgul%26aufirst%3DC.%26aulast%3DDerdak%26aufirst%3DS.%26aulast%3DPickl%26aufirst%3DW.%2BF.%26aulast%3DWacheck%26aufirst%3DV.%26aulast%3DSelzer%26aufirst%3DE.%26aulast%3DMonia%26aufirst%3DB.%2BP.%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DSillaber%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520Mcl-1%2520as%2520a%2520BCR%252FABL-Dependent%2520Target%2520in%2520Chronic%2520Myeloid%2520Leukemia%2520%2528CML%2529%253A%2520Evidence%2520for%2520Cooperative%2520Antileukemic%2520Effects%2520of%2520Imatinib%2520and%2520Mcl-1%2520Antisense%2520Oligonucleotides%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D3303%26epage%3D3311%26doi%3D10.1182%2Fblood-2004-02-0749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Ponte, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro-Fleury, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langonné, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hérault, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charbord, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenech, J.</span><span> </span><span class="NLM_article-title">Granulocyte-Colony-Stimulating Factor Stimulation of Bone Marrow Mesenchymal Stromal Cells Promotes CD34+ Cell Migration Via a Matrix Metalloproteinase-2-Dependent Mechanism</span> <span class="citation_source-journal">Stem Cells Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3162</span><span class="NLM_x">–</span> <span class="NLM_lpage">3172</span><span class="refDoi"> DOI: 10.1089/scd.2012.0048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1089%2Fscd.2012.0048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=3162-3172&author=A.+L.+Ponteauthor=T.+Ribeiro-Fleuryauthor=V.+Chabotauthor=F.+Gouilleuxauthor=A.+Langonn%C3%A9author=O.+H%C3%A9raultauthor=P.+Charbordauthor=J.+Domenech&title=Granulocyte-Colony-Stimulating+Factor+Stimulation+of+Bone+Marrow+Mesenchymal+Stromal+Cells+Promotes+CD34%2B+Cell+Migration+Via+a+Matrix+Metalloproteinase-2-Dependent+Mechanism&doi=10.1089%2Fscd.2012.0048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1089%2Fscd.2012.0048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fscd.2012.0048%26sid%3Dliteratum%253Aachs%26aulast%3DPonte%26aufirst%3DA.%2BL.%26aulast%3DRibeiro-Fleury%26aufirst%3DT.%26aulast%3DChabot%26aufirst%3DV.%26aulast%3DGouilleux%26aufirst%3DF.%26aulast%3DLangonn%25C3%25A9%26aufirst%3DA.%26aulast%3DH%25C3%25A9rault%26aufirst%3DO.%26aulast%3DCharbord%26aufirst%3DP.%26aulast%3DDomenech%26aufirst%3DJ.%26atitle%3DGranulocyte-Colony-Stimulating%2520Factor%2520Stimulation%2520of%2520Bone%2520Marrow%2520Mesenchymal%2520Stromal%2520Cells%2520Promotes%2520CD34%252B%2520Cell%2520Migration%2520Via%2520a%2520Matrix%2520Metalloproteinase-2-Dependent%2520Mechanism%26jtitle%3DStem%2520Cells%2520Dev.%26date%3D2012%26volume%3D21%26spage%3D3162%26epage%3D3172%26doi%3D10.1089%2Fscd.2012.0048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Moriggl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux-Gruart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jähne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berchtold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennighausen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux, F.</span><span> </span><span class="NLM_article-title">Deletion of the Carboxyl-Terminal Transactivation Domain of MGF-Stat5 Results in Sustained DNA Binding and a Dominant Negative Phenotype</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5691</span><span class="NLM_x">–</span> <span class="NLM_lpage">5700</span><span class="refDoi"> DOI: 10.1128/MCB.16.10.5691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1128%2FMCB.16.10.5691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=8816482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADyaK28XlvFamu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=5691-5700&author=R.+Morigglauthor=V.+Gouilleux-Gruartauthor=R.+J%C3%A4hneauthor=S.+Berchtoldauthor=C.+Gartmannauthor=X.+Liuauthor=L.+Hennighausenauthor=A.+Sotiropoulosauthor=B.+Gronerauthor=F.+Gouilleux&title=Deletion+of+the+Carboxyl-Terminal+Transactivation+Domain+of+MGF-Stat5+Results+in+Sustained+DNA+Binding+and+a+Dominant+Negative+Phenotype&doi=10.1128%2FMCB.16.10.5691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype</span></div><div class="casAuthors">Moriggl, Richard; Gouilleux-Gruart, Valerie; Jaehne, Ruth; Berchtold, Susanne; Gartmann, Christoph; Liu, Xiuwen; Hennighausen, Lothar; Sotiropoulos, Athanassia; Groner, Bernd; Gouilleux, Fabrice</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5691-5700</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Stat (signal transducer and activator of transcription) factors transmit cytokine, growth factor, and hormone responses.  Seven members of the Stat gene family are known.  MGF-Stat5a has been discovered as a mediator of the prolactin response in mammary epithelial cells.  Two closely related variants of Stat5, Stat5a and Stat5b, are encoded by distinct genes.  We examd. the functional properties of the carboxyl termini of these mols.  Wild-type Stat5a (794 amino acids) and the carboxyl-terminal deletion mutant Stat5aΔ772 supported prolactin-induced transcription of a β-casein promoter-reporter construct in COS7 cells; Stat5aΔ750 did not.  Upon prolactin activation, tyrosine phosphorylation and the specificity of DNA binding were indistinguishable among the three Sta5a variants.  Tyrosine dephosphorylation and the downregulation of the DNA-binding activity were delayed in the Stat5aΔ750 mutant.  The carboxyl-terminal transactivation domain of Stat5a, amino acids 722 to 794, can be confered to the DNA-binding domain of the yeast transcription factor GAL4.  Coexpression of Stat5a or Stat5b and of the carboxyl-terminal deletion mutants resulted in the suppression of transcriptional induction in COS or Ba/F3 cells.  We propose that Stat5aΔ750 and Stat5bΔ754 are lacking functional transactivation domains and exert their dominant neg. effects by blocking the DNA-binding site in Stat5-responsive gene promoters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4ZDVzvDn7z7Vg90H21EOLACvtfcHk0lif3MVFyETVdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFamu7g%253D&md5=f33088a2ce818e1e87d5f5cdb1822dba</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FMCB.16.10.5691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.16.10.5691%26sid%3Dliteratum%253Aachs%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DGouilleux-Gruart%26aufirst%3DV.%26aulast%3DJ%25C3%25A4hne%26aufirst%3DR.%26aulast%3DBerchtold%26aufirst%3DS.%26aulast%3DGartmann%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHennighausen%26aufirst%3DL.%26aulast%3DSotiropoulos%26aufirst%3DA.%26aulast%3DGroner%26aufirst%3DB.%26aulast%3DGouilleux%26aufirst%3DF.%26atitle%3DDeletion%2520of%2520the%2520Carboxyl-Terminal%2520Transactivation%2520Domain%2520of%2520MGF-Stat5%2520Results%2520in%2520Sustained%2520DNA%2520Binding%2520and%2520a%2520Dominant%2520Negative%2520Phenotype%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D5691%26epage%3D5700%26doi%3D10.1128%2FMCB.16.10.5691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Livak, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmittgen, T. D.</span><span> </span><span class="NLM_article-title">Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1006/meth.2001.1262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1006%2Fmeth.2001.1262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=11846609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFelt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=402-408&author=K.+J.+Livakauthor=T.+D.+Schmittgen&title=Analysis+of+Relative+Gene+Expression+Data+Using+Real-Time+Quantitative+PCR+and+the+2%E2%88%92%CE%94%CE%94CT+Method&doi=10.1006%2Fmeth.2001.1262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method</span></div><div class="casAuthors">Livak, Kenneth J.; Schmittgen, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-408</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The two most commonly used methods to analyze data from real-time, quant. PCR expts. are abs. quantification and relative quantification.  Abs. quantification dets. the input copy no., usually by relating the PCR signal to a std. curve.  Relative quantification relates the PCR signal of the target transcript in a treatment group to that of another sample such as an untreated control.  The 2-ΔΔCT method is a convenient way to analyze the relative changes in gene expression from real-time quant. PCR expts.  The purpose of this report is to present the derivation, assumptions, and applications of the 2-ΔΔCT method.  In addn., we present the derivation and applications of two variations of the 2-ΔΔCT method that may be useful in the anal. of real-time, quant. PCR data.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXNe1s-mDpprVg90H21EOLACvtfcHk0lgnhNOGGgKaew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFelt7s%253D&md5=f849383250ea43f7380ed540db8a64b1</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1006%2Fmeth.2001.1262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmeth.2001.1262%26sid%3Dliteratum%253Aachs%26aulast%3DLivak%26aufirst%3DK.%2BJ.%26aulast%3DSchmittgen%26aufirst%3DT.%2BD.%26atitle%3DAnalysis%2520of%2520Relative%2520Gene%2520Expression%2520Data%2520Using%2520Real-Time%2520Quantitative%2520PCR%2520and%2520the%25202%25E2%2588%2592%25CE%2594%25CE%2594CT%2520Method%26jtitle%3DMethods%26date%3D2001%26volume%3D25%26spage%3D402%26epage%3D408%26doi%3D10.1006%2Fmeth.2001.1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Janice
E. Sieser, Mark T. Maloney, Esmort Chisowa, Steven J. Brenek, Sebastien Monfette, John J. Salisbury, Nga M. Do, <span class="NLM_string-name hlFld-ContribAuthor">Robert A. Singer</span>. </span><span class="cited-content_cbyCitation_article-title">Ir-Catalyzed Borylation as an Efficient Route to a Nicotine Hapten. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2018,</strong> <em>22 </em>
                                    (4)
                                     , 527-534. <a href="https://doi.org/10.1021/acs.oprd.8b00053" title="DOI URL">https://doi.org/10.1021/acs.oprd.8b00053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.8b00053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.8b00053%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DIr-Catalyzed%252BBorylation%252Bas%252Ban%252BEfficient%252BRoute%252Bto%252Ba%252BNicotine%252BHapten%26aulast%3DSieser%26aufirst%3DJanice%2BE.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D14022018%26date%3D09042018%26date%3D04042018%26volume%3D22%26issue%3D4%26spage%3D527%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marion  Polomski</span>, <span class="hlFld-ContribAuthor ">Marie  Brachet‐Botineau</span>, <span class="hlFld-ContribAuthor ">Ludovic  Juen</span>, <span class="hlFld-ContribAuthor ">Marie‐Claude  Viaud‐Massuard</span>, <span class="hlFld-ContribAuthor ">Fabrice  Gouilleux</span>, <span class="hlFld-ContribAuthor ">Gildas  Prié</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (6)
                                     , 1034-1046. <a href="https://doi.org/10.1002/cmdc.202000841" title="DOI URL">https://doi.org/10.1002/cmdc.202000841</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000841%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DInhibitors%252BTargeting%252BSTAT5%252BSignaling%252Bin%252BMyeloid%252BLeukemias%25253A%252BNew%252BTetrahydroquinoline%252BDerivatives%252Bwith%252BImproved%252BAntileukemic%252BPotential%26aulast%3DPolomski%26aufirst%3DMarion%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D6%26spage%3D1034%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luyao  Long</span>, <span class="hlFld-ContribAuthor ">Yehuda G.  Assaraf</span>, <span class="hlFld-ContribAuthor ">Zi-Ning  Lei</span>, <span class="hlFld-ContribAuthor ">Hongwei  Peng</span>, <span class="hlFld-ContribAuthor ">Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Simei  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2020,</strong> <em>52 </em>, 100703. <a href="https://doi.org/10.1016/j.drup.2020.100703" title="DOI URL">https://doi.org/10.1016/j.drup.2020.100703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2020.100703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2020.100703%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DGenetic%252Bbiomarkers%252Bof%252Bdrug%252Bresistance%25253A%252BA%252Bcompass%252Bof%252Bprognosis%252Band%252Btargeted%252Btherapy%252Bin%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DLong%26aufirst%3DLuyao%26date%3D2020%26volume%3D52%26spage%3D100703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Brachet-Botineau</span>, <span class="hlFld-ContribAuthor ">Marion  Polomski</span>, <span class="hlFld-ContribAuthor ">Heidi A.  Neubauer</span>, <span class="hlFld-ContribAuthor ">Ludovic  Juen</span>, <span class="hlFld-ContribAuthor ">Damien  Hédou</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Viaud-Massuard</span>, <span class="hlFld-ContribAuthor ">Gildas  Prié</span>, <span class="hlFld-ContribAuthor ">Fabrice  Gouilleux</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (1)
                                     , 240. <a href="https://doi.org/10.3390/cancers12010240" title="DOI URL">https://doi.org/10.3390/cancers12010240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12010240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12010240%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DPharmacological%252BInhibition%252Bof%252BOncogenic%252BSTAT3%252Band%252BSTAT5%252BSignaling%252Bin%252BHematopoietic%252BCancers%26aulast%3DBrachet-Botineau%26aufirst%3DMarie%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D1%26spage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Christina  Wagner</span>, <span class="hlFld-ContribAuthor ">Elvin D.  de Araujo</span>, <span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">Heidi A.  Neubauer</span>, <span class="hlFld-ContribAuthor ">Marco  Herling</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Targeting Options for STAT3 and STAT5 in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (12)
                                     , 1930. <a href="https://doi.org/10.3390/cancers11121930" title="DOI URL">https://doi.org/10.3390/cancers11121930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11121930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11121930%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DDirect%252BTargeting%252BOptions%252Bfor%252BSTAT3%252Band%252BSTAT5%252Bin%252BCancer%26aulast%3DOrlova%26aufirst%3DAnna%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D12%26spage%3D1930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Brachet-Botineau</span>, <span class="hlFld-ContribAuthor ">Margaux  Deynoux</span>, <span class="hlFld-ContribAuthor ">Nicolas  Vallet</span>, <span class="hlFld-ContribAuthor ">Marion  Polomski</span>, <span class="hlFld-ContribAuthor ">Ludovic  Juen</span>, <span class="hlFld-ContribAuthor ">Olivier  Hérault</span>, <span class="hlFld-ContribAuthor ">Frédéric  Mazurier</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Viaud-Massuard</span>, <span class="hlFld-ContribAuthor ">Gildas  Prié</span>, <span class="hlFld-ContribAuthor ">Fabrice  Gouilleux</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (12)
                                     , 2043. <a href="https://doi.org/10.3390/cancers11122043" title="DOI URL">https://doi.org/10.3390/cancers11122043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11122043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11122043%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DA%252BNovel%252BInhibitor%252Bof%252BSTAT5%252BSignaling%252BOvercomes%252BChemotherapy%252BResistance%252Bin%252BMyeloid%252BLeukemia%252BCells%26aulast%3DBrachet-Botineau%26aufirst%3DMarie%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D12%26spage%3D2043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxiao  Jiang</span>, <span class="hlFld-ContribAuthor ">Yanhong  Cheng</span>, <span class="hlFld-ContribAuthor ">Chaojie  Hu</span>, <span class="hlFld-ContribAuthor ">Aimei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingli  Ren</span>, <span class="hlFld-ContribAuthor ">Xiucai  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5. </span><span class="cited-content_cbyCitation_journal-name">Leukemia & Lymphoma</span><span> <strong>2019,</strong> <em>60 </em>
                                    (7)
                                     , 1709-1720. <a href="https://doi.org/10.1080/10428194.2018.1543875" title="DOI URL">https://doi.org/10.1080/10428194.2018.1543875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10428194.2018.1543875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10428194.2018.1543875%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%2520%2526%2520Lymphoma%26atitle%3DMicroRNA-221%252Bsensitizes%252Bchronic%252Bmyeloid%252Bleukemia%252Bcells%252Bto%252Bimatinib%252Bby%252Btargeting%252BSTAT5%26aulast%3DJiang%26aufirst%3DXiaoxiao%26date%3D2019%26date%3D2018%26volume%3D60%26issue%3D7%26spage%3D1709%26epage%3D1720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Youming  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenghong  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional thiophosphinamide catalyzed highly enantioselective Michael addition of acetone to (E)-2-azido β-nitrostyrenes and the subsequent reductive cyclization. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (41)
                                     , 6071-6077. <a href="https://doi.org/10.1016/j.tet.2018.08.052" title="DOI URL">https://doi.org/10.1016/j.tet.2018.08.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.08.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.08.052%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DBifunctional%252Bthiophosphinamide%252Bcatalyzed%252Bhighly%252Benantioselective%252BMichael%252Baddition%252Bof%252Bacetone%252Bto%252B%252528E%252529-2-azido%252B%2525CE%2525B2-nitrostyrenes%252Band%252Bthe%252Bsubsequent%252Breductive%252Bcyclization%26aulast%3DZhang%26aufirst%3DHao%26date%3D2018%26volume%3D74%26issue%3D41%26spage%3D6071%26epage%3D6077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno  Oyallon</span>, <span class="hlFld-ContribAuthor ">Marie  Brachet-Botineau</span>, <span class="hlFld-ContribAuthor ">Cédric  Logé</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Mohamed  Souab</span>, <span class="hlFld-ContribAuthor ">Thomas  Robert</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bach</span>, <span class="hlFld-ContribAuthor ">Pascal  Berthelot</span>, <span class="hlFld-ContribAuthor ">Fabrice  Gouilleux</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Viaud-Massuard</span>, <span class="hlFld-ContribAuthor ">Caroline  Denevault-Sabourin</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>154 </em>, 101-109. <a href="https://doi.org/10.1016/j.ejmech.2018.04.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.04.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.04.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.04.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdesign%252Bof%252Bnovel%252Bquinoxaline-2-carboxylic%252Bacids%252Band%252Banalogues%252Bas%252BPim-1%252Binhibitors%26aulast%3DOyallon%26aufirst%3DBruno%26date%3D2018%26volume%3D154%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hit compound <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Previous Synthetic Route of Hit Compound <b>13</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Key Intermediates <b>6a</b> and <b>6b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) 3,3-dimethyl-acryloyl chloride, dry pyridine, 0 °C to rt, 5 h; (b) AlCl<sub>3</sub>, dry dichloromethane, 0 °C to rt, 1 h; (c) BH<sub>3</sub>·THF, dry toluene, 0 °C to reflux, 12 h; (d) NaH, BnBr, dry DMF, 0 °C to rt, 2 h; (e) CuI, 3,4,7,8-tetramethyl-1,10-phenanthroline, Cs<sub>2</sub>CO<sub>3</sub>, dry ethylene glycol, 130 °C, 72 h; (f) (1) IBX, DCE, 80 °C, 2 h; (2) filtration; (3) 4,4-dimethyl-1,2,3,4-tetrahydroquinoline or amine <b>3</b>, NaBH(AcO)<sub>3</sub>, rt, 3 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Hit Compound <b>13</b> and Its Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) CuCN, DMF, reflux, 6 h; (b) (1) cyclohexylmagnesium chloride, CuBr, dry THF, reflux, 2 h; (2) H<sub>2</sub>O, H<sub>2</sub>SO<sub>4</sub> 15%; (c) <i>t</i>-BuOK, DMSO, O<sub>2</sub>, rt, 3 h; (d) ethylene glycol, <i>p</i>-toluenesulfonic acid monohydrate, toluene, reflux, 6 h; (e) 0.1 M HCl, THF, rt, 5 h; (f) NaH, ethyl bromoacetate or methyl iodide, dry DMF, 0 °C to rt, 2 h; (g) LiOH, THF/H<sub>2</sub>O, 0 °C to rt, 2 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Analogues <b>16</b>, <b>17a</b>–<b>i</b>, and <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) <i>t</i>-BuOK, DMSO, O<sub>2</sub>, rt, 3 h; (b) corresponding boronic acid, K<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, DMF/H<sub>2</sub>O, 90 °C, 1–14 h; (c) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf), dry dioxane, 80 °C, 21 h; (d) 2-chloropyridine, K<sub>3</sub>PO<sub>4</sub>, PdCl<sub>2</sub>(dppf), dioxane/H<sub>2</sub>O, 100 °C, 4 h.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Growth kinetics of KU812 cells treated with 10 μM of each compound as indicated or DMSO as the control. (B) Growth kinetics of K562 cells treated with each compound or DMSO as the control as in A (<i>n</i> = 3 in triplicate; data are the mean ± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Growth kinetics of KU812 cells treated with 10 μM of each compound as indicated or DMSO as the control. (B) Growth kinetics of K562 cells treated with each compound or DMSO as the control as in A (<i>n</i> = 3 in triplicate; data are the mean ± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative flow cytometry histogram of KU812 cells cultured for 48 h with indicated compounds (10 μM) or control DMSO. Cells were stained with FITC-Annexin V and 7-AAD, and the percentages of apoptotic cells were then evaluated by flow cytometry (<i>n</i> = 3 in triplicate; data are the mean ± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) qRT-PCR analysis of <i>STAT5A</i> and <i>STAT5B</i> transcripts in KU812 cells treated or not with <b>17f</b> (10 μM) or DMSO as the control for 15 h. Results are presented as the fold changes in gene expression in <b>17f</b>-treated cells normalized to internal control genes (<i>GAPDH</i> and <i>ACTB</i>) and relative to control cells (normalized to 1) (<i>n</i> = 3 in triplicate; data are the mean ± SEM). (B) Protein extracts from KU812 and K562 cells treated with <b>17f</b> (+) or DMSO (−) for 12 h were analyzed by Western blotting to detect P-Y-STAT5 and STAT5 protein expression (<i>n</i> = 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) qRT-PCR analysis of <i>PIM1</i>, <i>CYCLIN D1</i>, <i>C-MYC</i>, and <i>MCL-1</i> expression in KU812 cells treated with <b>17f</b> (10 μM) or DMSO (control) for 15 h. Results are presented as the fold changes in <i>PIM1</i>, <i>CYCLIN D1</i>, <i>C-MYC</i>, and <i>MCL-1</i> gene expression in <b>17f</b> cells normalized to internal control genes (<i>GAPDH</i> and <i>ACTB</i>) and relative to untreated cells (normalized to 1) (<i>n</i> = 3 in triplicate; data are the mean ± SEM, *<i>p</i> < 0.05, and ***<i>p</i> < 0.001). (B) Expression of Pim1, Cyclin D1, and Mcl-1 proteins in KU812 cells treated with 10 μM <b>17f</b> (+) or DMSO (−) for 24 h. (C) KU812 cells transfected with a 6×(STAT5)-TK-luciferase reporter construct or a control TK-luciferase vector were treated with <b>17f</b> (10 μM) or DMSO (control) for 48 h. Luciferase activities were next determined as described in <a class="ref internalNav" href="#sec5_1_1" aria-label="Material and Methods">Material and Methods</a>. Luciferase activity (arbitrary units) in the histogram represents the relative luminescence unit (rlu) values/mg of proteins (<i>n</i> = 3 in triplicate; data are the mean ± SEM, ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Protein extracts from MV-4-11 and KG1a cells treated with <b>17f</b> (+) or DMSO (−) for 12 h were analyzed by Western blotting to detect P–Y<sup>694/699</sup>-STAT5 and STAT5 protein expression. (B) Growth kinetics of KG1a (left) and MV-4-11 (right) cells cultured in the absence (DMSO) or presence of <b>17f</b> (10 μM) were determined by MTT assays (<i>n</i> = 3 in triplicate; data are the mean ± SEM). (C) Representative flow cytometry histogram of KG1a and MV-4-11 cells cultured for 48 h with <b>17f</b> (10 μM) or DMSO (control). Cells were stained with FITC-Annexin V and 7-AAD, and the percentages of apoptotic cells were then evaluated by flow cytometry (<i>n</i> = 3 in triplicate; data are the mean ± SEM, *<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Protein extracts from KG1a, MV-4-11, and KU812 cells treated with <b>17f</b> (+) or DMSO (−) for 24 h were analyzed by Western blotting to detect the phosphorylated forms of STAT5, STAT3, Akt, and Erk1/2 and the total forms of these proteins (<i>n</i> = 2). Actin expression served as a loading control. Quantification of Western blot data is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/medium/jm-2017-003692_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Growth kinetics of HS-27a cells (left) and MSC (right) cultured in the absence (DMSO) or presence of <b>17f</b> (10 μM) were determined by MTT assays (<i>n</i> = 3 in triplicate; data are the mean ± SEM). (B) Extracts from HS-27a cells treated with <b>17f</b> (+) or DMSO (−) were analyzed by Western blotting to detect the phosphorylation and expression of STAT3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00369/20170721/images/large/jm-2017-003692_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00369&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i62">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bunting, K. D.</span><span> </span><span class="NLM_article-title">STAT5 Signaling in Normal and Pathologic Hematopoiesis</span> <span class="citation_source-journal">Front. Biosci., Landmark Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2807</span><span class="NLM_x">–</span> <span class="NLM_lpage">2820</span><span class="refDoi"> DOI: 10.2741/2274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.2741%2F2274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=17485261" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=2807-2820&author=K.+D.+Bunting&title=STAT5+Signaling+in+Normal+and+Pathologic+Hematopoiesis&doi=10.2741%2F2274"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2741%2F2274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F2274%26sid%3Dliteratum%253Aachs%26aulast%3DBunting%26aufirst%3DK.%2BD.%26atitle%3DSTAT5%2520Signaling%2520in%2520Normal%2520and%2520Pathologic%2520Hematopoiesis%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2007%26volume%3D12%26spage%3D2807%26epage%3D2820%26doi%3D10.2741%2F2274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mizuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halfter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüning, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratz-Albers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serve, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büchner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienast, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdel, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serve, H.</span><span> </span><span class="NLM_article-title">Flt3 Mutations from Patients with Acute Myeloid Leukemia Induce Transformation of 32D Cells Mediated by the Ras and STAT5 Pathways</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3907</span><span class="NLM_x">–</span> <span class="NLM_lpage">3914</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=11090077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVGnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2000&pages=3907-3914&author=M.+Mizukiauthor=R.+Fenskiauthor=H.+Halfterauthor=I.+Matsumuraauthor=R.+Schmidtauthor=C.+M%C3%BCllerauthor=W.+Gr%C3%BCningauthor=K.+Kratz-Albersauthor=S.+Serveauthor=C.+Steurauthor=T.+B%C3%BCchnerauthor=J.+Kienastauthor=Y.+Kanakuraauthor=W.+E.+Berdelauthor=H.+Serve&title=Flt3+Mutations+from+Patients+with+Acute+Myeloid+Leukemia+Induce+Transformation+of+32D+Cells+Mediated+by+the+Ras+and+STAT5+Pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways</span></div><div class="casAuthors">Mizuki, Masao; Fenski, Regina; Halfter, Hartmut; Matsumura, Itaru; Schmidt, Rainer; Muller, Carsten; Gruning, Wolfram; Kratz-Albers, Karsten; Serve, Susanne; Steur, Claudia; Buchner, Thomas; Kienast, Joachim; Kanakura, Yuzuru; Berdel, Wolfgang E.; Serve, Hubert</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3907-3914</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Somatic mutations of the receptor tyrosine kinase Flt3 consisting of internal tandem duplications (ITD) occur in 20% of patients with acute myeloid leukemia.  They are assocd. with a poor prognosis of the disease.  In this study, we characterized the oncogenic potential and signaling properties of Flt3 mutations.  We constructed chimeric mols. that consisted of the murine Flt3 backbone and a 510-base pair human Flt3 fragment, which contained either 4 different ITD mutants or the wild-type coding sequence.  Flt3 isoforms contg. ITD mutations (Flt3-ITD) induced factor-independent growth and resistance to radiation-induced apoptosis in 32D cells.  Cells contg. Flt3-ITD, but not those contg. wild-type Flt3 (Flt3-WT), formed colonies in methyl-cellulose.  Injection of 32D/Flt3-ITD induced rapid development of a leukemia-type disease in syngeneic mice.  Flt3-ITD mutations exhibited constitutive autophosphorylation of the immature form of the Flt3 receptor.  Anal. of the involved signal transduction pathways revealed that Flt3-ITD only slightly activated the MAP kinases Erk1 and 2 and the protein kinase B (Akt) in the absence of ligand and retained ligand-induced activation of these enzymes.  However, Flt3-ITD led to strong factor-independent activation of STAT5.  The relative importance of the STAT5 and Ras pathways for ITD-induced colony formation was assessed by transfection of dominant neg. (dn) forms of these proteins: transfection of dnSTAT5 inhibited colony formation by 50%.  Despite its weak constitutive activation by Flt3-ITD, dnRas also strongly inhibited Flt3-ITD-mediated colony formation.  Taken together, Flt3-ITD mutations induce factor-independent growth and leukemogenesis of 32D cells that are mediated by the Ras and STAT5 pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5yxxtxsjVJ7Vg90H21EOLACvtfcHk0ljAJkdqT1Q6ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVGnurs%253D&md5=d6a3335d36a309bf17c0cf3f6d4ca6ec</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMizuki%26aufirst%3DM.%26aulast%3DFenski%26aufirst%3DR.%26aulast%3DHalfter%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DI.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DGr%25C3%25BCning%26aufirst%3DW.%26aulast%3DKratz-Albers%26aufirst%3DK.%26aulast%3DServe%26aufirst%3DS.%26aulast%3DSteur%26aufirst%3DC.%26aulast%3DB%25C3%25BCchner%26aufirst%3DT.%26aulast%3DKienast%26aufirst%3DJ.%26aulast%3DKanakura%26aufirst%3DY.%26aulast%3DBerdel%26aufirst%3DW.%2BE.%26aulast%3DServe%26aufirst%3DH.%26atitle%3DFlt3%2520Mutations%2520from%2520Patients%2520with%2520Acute%2520Myeloid%2520Leukemia%2520Induce%2520Transformation%2520of%252032D%2520Cells%2520Mediated%2520by%2520the%2520Ras%2520and%2520STAT5%2520Pathways%26jtitle%3DBlood%26date%3D2000%26volume%3D96%26spage%3D3907%26epage%3D3914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Harir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedbichler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonneck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Lanneree, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerenyi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahiaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux-Gruart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gondry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benit, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusanter-Fourt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassoued, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux, F.</span><span> </span><span class="NLM_article-title">Oncogenic Kit Controls Neoplastic Mast Cell Growth through a Stat5/PI3-Kinase Signaling Cascade</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">2463</span><span class="NLM_x">–</span> <span class="NLM_lpage">2473</span><span class="refDoi"> DOI: 10.1182/blood-2007-09-115477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1182%2Fblood-2007-09-115477" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=2463-2473&author=N.+Harirauthor=C.+Boudotauthor=K.+Friedbichlerauthor=K.+Sonneckauthor=R.+Kondoauthor=S.+Martin-Lannereeauthor=L.+Kennerauthor=M.+Kerenyiauthor=S.+Yahiaouiauthor=V.+Gouilleux-Gruartauthor=J.+Gondryauthor=L.+Benitauthor=I.+Dusanter-Fourtauthor=K.+Lassouedauthor=P.+Valentauthor=R.+Morigglauthor=F.+Gouilleux&title=Oncogenic+Kit+Controls+Neoplastic+Mast+Cell+Growth+through+a+Stat5%2FPI3-Kinase+Signaling+Cascade&doi=10.1182%2Fblood-2007-09-115477"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-09-115477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-09-115477%26sid%3Dliteratum%253Aachs%26aulast%3DHarir%26aufirst%3DN.%26aulast%3DBoudot%26aufirst%3DC.%26aulast%3DFriedbichler%26aufirst%3DK.%26aulast%3DSonneck%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DR.%26aulast%3DMartin-Lanneree%26aufirst%3DS.%26aulast%3DKenner%26aufirst%3DL.%26aulast%3DKerenyi%26aufirst%3DM.%26aulast%3DYahiaoui%26aufirst%3DS.%26aulast%3DGouilleux-Gruart%26aufirst%3DV.%26aulast%3DGondry%26aufirst%3DJ.%26aulast%3DBenit%26aufirst%3DL.%26aulast%3DDusanter-Fourt%26aufirst%3DI.%26aulast%3DLassoued%26aufirst%3DK.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DGouilleux%26aufirst%3DF.%26atitle%3DOncogenic%2520Kit%2520Controls%2520Neoplastic%2520Mast%2520Cell%2520Growth%2520through%2520a%2520Stat5%252FPI3-Kinase%2520Signaling%2520Cascade%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D2463%26epage%3D2473%26doi%3D10.1182%2Fblood-2007-09-115477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Shuai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halpern, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ten Hoeve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Constitutive Activation of STAT5 by the BCR-ABL Oncogene in Chronic Myelogenous Leukemia</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=247-254&author=K.+Shuaiauthor=J.+Halpernauthor=J.+ten+Hoeveauthor=X.+Raoauthor=C.+L.+Sawyers&title=Constitutive+Activation+of+STAT5+by+the+BCR-ABL+Oncogene+in+Chronic+Myelogenous+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShuai%26aufirst%3DK.%26aulast%3DHalpern%26aufirst%3DJ.%26aulast%3Dten%2BHoeve%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DX.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DConstitutive%2520Activation%2520of%2520STAT5%2520by%2520the%2520BCR-ABL%2520Oncogene%2520in%2520Chronic%2520Myelogenous%2520Leukemia%26jtitle%3DOncogene%26date%3D1996%26volume%3D13%26spage%3D247%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">James, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Couédic, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staerk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garçon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raslova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennaceur-Griscelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeval, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vainchenker, W.</span><span> </span><span class="NLM_article-title">A Unique Clonal JAK2 Mutation Leading to Constitutive Signalling Causes Polycythaemia Vera</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span><span class="refDoi"> DOI: 10.1038/nature03546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1038%2Fnature03546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=15793561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsF2ltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=1144-1148&author=C.+Jamesauthor=V.+Ugoauthor=J.-P.+Le+Cou%C3%A9dicauthor=J.+Staerkauthor=F.+Delhommeauauthor=C.+Lacoutauthor=L.+Gar%C3%A7onauthor=H.+Raslovaauthor=R.+Bergerauthor=A.+Bennaceur-Griscelliauthor=J.+L.+Villevalauthor=S.+N.+Constantinescuauthor=N.+Casadevallauthor=W.+Vainchenker&title=A+Unique+Clonal+JAK2+Mutation+Leading+to+Constitutive+Signalling+Causes+Polycythaemia+Vera&doi=10.1038%2Fnature03546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera</span></div><div class="casAuthors">James, Chloe; Ugo, Valerie; Le Couedic, Jean-Pierre; Staerk, Judith; Delhommeau, Francois; Lacout, Catherine; Garcon, Loic; Raslova, Hana; Berger, Roland; Bennaceur-Griscelli, Annelise; Villeval, Jean Luc; Constantinescu, Stefan N.; Casadevall, Nicole; Vainchenker, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7037</span>),
    <span class="NLM_cas:pages">1144-1148</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Myeloproliferative disorders are clonal hematopoietic stem cell malignancies characterized by independency or hypersensitivity of hematopoietic progenitors to numerous cytokines.  The mol. basis of most myeloproliferative disorders is unknown.  On the basis of the model of chronic myeloid leukemia, it is expected that a constitutive tyrosine kinase activity could be at the origin of these diseases.  Polycythemia vera is an acquired myeloproliferative disorder, characterized by the presence of polycythemia diversely assocd. with thrombocytosis, leukocytosis and splenomegaly.  Polycythemia vera progenitors are hypersensitive to erythropoietin and other cytokines.  Here, the authors describe a clonal and recurrent mutation in the JH2 pseudo-kinase domain of the Janus kinase 2 (JAK2) gene in most (>80%) polycythemia vera patients.  The mutation, a valine-to-phenylalanine substitution at amino acid position 617, leads to constitutive tyrosine phosphorylation activity that promotes cytokine hypersensitivity and induces erythrocytosis in a mouse model.  As this mutation is also found in other myeloproliferative disorders, this unique mutation will permit a new mol. classification of these disorders and novel therapeutical approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy-6NigTwc97Vg90H21EOLACvtfcHk0ljlqNa48QdK0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsF2ltbk%253D&md5=9e9c223dd4e2da2ebf52d14edda85963</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature03546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03546%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DC.%26aulast%3DUgo%26aufirst%3DV.%26aulast%3DLe%2BCou%25C3%25A9dic%26aufirst%3DJ.-P.%26aulast%3DStaerk%26aufirst%3DJ.%26aulast%3DDelhommeau%26aufirst%3DF.%26aulast%3DLacout%26aufirst%3DC.%26aulast%3DGar%25C3%25A7on%26aufirst%3DL.%26aulast%3DRaslova%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DBennaceur-Griscelli%26aufirst%3DA.%26aulast%3DVilleval%26aufirst%3DJ.%2BL.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DCasadevall%26aufirst%3DN.%26aulast%3DVainchenker%26aufirst%3DW.%26atitle%3DA%2520Unique%2520Clonal%2520JAK2%2520Mutation%2520Leading%2520to%2520Constitutive%2520Signalling%2520Causes%2520Polycythaemia%2520Vera%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D1144%26epage%3D1148%26doi%3D10.1038%2Fnature03546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadleigh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wlodarska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelsperger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fröhling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Döhner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marynen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia, and Myeloid Metaplasia with Myelofibrosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1016/j.ccr.2005.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.ccr.2005.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=15837627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFSku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=387-397&author=R.+L.+Levineauthor=M.+Wadleighauthor=J.+Coolsauthor=B.+L.+Ebertauthor=G.+Wernigauthor=B.+J.+P.+Huntlyauthor=T.+J.+Boggonauthor=I.+Wlodarskaauthor=J.+J.+Clarkauthor=S.+Mooreauthor=J.+Adelspergerauthor=S.+Kooauthor=J.+C.+Leeauthor=S.+Gabrielauthor=T.+Mercherauthor=A.+D%E2%80%99Andreaauthor=S.+Fr%C3%B6hlingauthor=K.+D%C3%B6hnerauthor=P.+Marynenauthor=P.+Vandenbergheauthor=R.+A.+Mesaauthor=A.+Tefferiauthor=J.+D.+Griffinauthor=M.+J.+Eckauthor=W.+R.+Sellersauthor=M.+Meyersonauthor=T.+R.+Golubauthor=S.+J.+Leeauthor=D.+G.+Gilliland&title=Activating+Mutation+in+the+Tyrosine+Kinase+JAK2+in+Polycythemia+Vera%2C+Essential+Thrombocythemia%2C+and+Myeloid+Metaplasia+with+Myelofibrosis&doi=10.1016%2Fj.ccr.2005.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis</span></div><div class="casAuthors">Levine, Ross L.; Wadleigh, Martha; Cools, Jan; Ebert, Benjamin L.; Wernig, Gerlinde; Huntly, Brian J. P.; Boggon, Titus J.; Wlodarska, Iwona; Clark, Jennifer J.; Moore, Sandra; Adelsperger, Jennifer; Koo, Sumin; Lee, Jeffrey C.; Gabriel, Stacey; Mercher, Thomas; D'Andrea, Alan; Froehling, Stefan; Doehner, Konstanze; Marynen, Peter; Vandenberghe, Peter; Mesa, Ruben A.; Tefferi, Ayalew; Griffin, James D.; Eck, Michael J.; Sellers, William R.; Meyerson, Matthew; Golub, Todd R.; Lee, Stephanie J.; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-397</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors.  An internet-based protocol was used to collect clin. information and biol. specimens from patients with these diseases.  High-throughput DNA re-sequencing identified a recurrent somatic missense mutation JAK2V617F in granulocyte DNA samples of 121 of 164 PV patients, of which 41 had homozygous and 80 had heterozygous mutations.  Mol. and cytogenetic analyses demonstrated that homozygous mutations were due to duplication of the mutant allele.  JAK2V617F was also identified in granulocyte DNA samples from 37 of 115 ET and 16 of 46 MMM patients, but was not obsd. in 269 normal individuals.  In vitro anal. demonstrated that JAK2V617F is a constitutively active tyrosine kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXJNzUFm3Q3bVg90H21EOLACvtfcHk0li9-gQbNYr_3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFSku7o%253D&md5=2a3e893867b114e8749cd6f5e55990b7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DWadleigh%26aufirst%3DM.%26aulast%3DCools%26aufirst%3DJ.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%2BP.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DWlodarska%26aufirst%3DI.%26aulast%3DClark%26aufirst%3DJ.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DAdelsperger%26aufirst%3DJ.%26aulast%3DKoo%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DMercher%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%26aulast%3DFr%25C3%25B6hling%26aufirst%3DS.%26aulast%3DD%25C3%25B6hner%26aufirst%3DK.%26aulast%3DMarynen%26aufirst%3DP.%26aulast%3DVandenberghe%26aufirst%3DP.%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DActivating%2520Mutation%2520in%2520the%2520Tyrosine%2520Kinase%2520JAK2%2520in%2520Polycythemia%2520Vera%252C%2520Essential%2520Thrombocythemia%252C%2520and%2520Myeloid%2520Metaplasia%2520with%2520Myelofibrosis%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D387%26epage%3D397%26doi%3D10.1016%2Fj.ccr.2005.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ye, D.</span><span> </span><span class="NLM_article-title">STAT5 Signaling Is Required for the Efficient Induction and Maintenance of CML in Mice</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">4917</span><span class="NLM_x">–</span> <span class="NLM_lpage">4925</span><span class="refDoi"> DOI: 10.1182/blood-2005-10-4110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1182%2Fblood-2005-10-4110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=4917-4925&author=D.+Ye&title=STAT5+Signaling+Is+Required+for+the+Efficient+Induction+and+Maintenance+of+CML+in+Mice&doi=10.1182%2Fblood-2005-10-4110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-10-4110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-10-4110%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DD.%26atitle%3DSTAT5%2520Signaling%2520Is%2520Required%2520for%2520the%2520Efficient%2520Induction%2520and%2520Maintenance%2520of%2520CML%2520in%2520Mice%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D4917%26epage%3D4925%26doi%3D10.1182%2Fblood-2005-10-4110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hoelbl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelzl, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fajmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grebien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warsch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennighausen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beug, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexl, V.</span><span> </span><span class="NLM_article-title">Stat5 Is Indispensable for the Maintenance of Bcr/abl-Positive Leukaemia</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1002/emmm.201000062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1002%2Femmm.201000062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=20201032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1ersrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=98-110&author=A.+Hoelblauthor=C.+Schusterauthor=B.+Kovacicauthor=B.+Zhuauthor=M.+Wickreauthor=M.+A.+Hoelzlauthor=S.+Fajmannauthor=F.+Grebienauthor=W.+Warschauthor=G.+Stenglauthor=L.+Hennighausenauthor=V.+Poliauthor=H.+Beugauthor=R.+Morigglauthor=V.+Sexl&title=Stat5+Is+Indispensable+for+the+Maintenance+of+Bcr%2Fabl-Positive+Leukaemia&doi=10.1002%2Femmm.201000062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Stat5 is indispensable for the maintenance of Bcr/Abl-positive leukaemia</span></div><div class="casAuthors">Hoelbl, Andrea; Schuster, Christian; Kovacic, Boris; Zhu, Bingmei; Wickre, Mark; Hoelzl, Maria A.; Fajmann, Sabine; Grebien, Florian; Warsch, Wolfgang; Stengl, Gabriele; Hennighausen, Lothar; Poli, Valeria; Beug, Hartmut; Moriggl, Richard; Sexl, Veronika</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">98-110</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tumorigenesis caused by the Bcr/Abl oncoprotein is a multi-step process proceeding from initial to tumor-maintaining events and finally results in a complex tumor-supporting network.  A key to successful cancer therapy is the identification of crit. functional nodes in an oncogenic network required for disease maintenance.  So far, the transcription factors Stat3 and Stat5a/b were implicated in bcr/abl-induced initial transformation.  However, to qualify as a potential drug target, a signalling pathway must be required for the maintenance of the leukemic state.  Data on the roles of Stat3 or Stat5a/b in leukemia maintenance are elusive.  Here, we show that both, Stat3 and Stat5 are necessary for initial transformation.  However, Stat5- but not Stat3-deletion induces G0/G1 cell cycle arrest and apoptosis of imatinib-sensitive and imatinib-resistant stable leukemic cells in vitro.  Accordingly, Stat5-abrogation led to effective elimination of myeloid and lymphoid leukemia maintenance in vivo.  Hence, we identified Stat5 as a vulnerable point in the oncogenic network downstream of Bcr/Abl representing a case of non-oncogene addiction (NOA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj_LpUINLk77Vg90H21EOLACvtfcHk0lj_HhZPS6OOrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1ersrs%253D&md5=7bd1560e2d03dd45d12f2b5d814ba929</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Femmm.201000062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201000062%26sid%3Dliteratum%253Aachs%26aulast%3DHoelbl%26aufirst%3DA.%26aulast%3DSchuster%26aufirst%3DC.%26aulast%3DKovacic%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DWickre%26aufirst%3DM.%26aulast%3DHoelzl%26aufirst%3DM.%2BA.%26aulast%3DFajmann%26aufirst%3DS.%26aulast%3DGrebien%26aufirst%3DF.%26aulast%3DWarsch%26aufirst%3DW.%26aulast%3DStengl%26aufirst%3DG.%26aulast%3DHennighausen%26aufirst%3DL.%26aulast%3DPoli%26aufirst%3DV.%26aulast%3DBeug%26aufirst%3DH.%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DSexl%26aufirst%3DV.%26atitle%3DStat5%2520Is%2520Indispensable%2520for%2520the%2520Maintenance%2520of%2520Bcr%252Fabl-Positive%2520Leukaemia%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D98%26epage%3D110%26doi%3D10.1002%2Femmm.201000062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Jilani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottmann, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albitar, M.</span><span> </span><span class="NLM_article-title">Phosphorylation Levels of BCR-ABL, CrkL, AKT and STAT5 in Imatinib-Resistant Chronic Myeloid Leukemia Cells Implicate Alternative Pathway Usage as a Survival Strategy</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span><span class="refDoi"> DOI: 10.1016/j.leukres.2007.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.leukres.2007.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=17900686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlOhsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=643-649&author=I.+Jilaniauthor=H.+Kantarjianauthor=M.+Gorreauthor=J.+Cortesauthor=O.+Ottmannauthor=K.+Bhallaauthor=F.+J.+Gilesauthor=M.+Albitar&title=Phosphorylation+Levels+of+BCR-ABL%2C+CrkL%2C+AKT+and+STAT5+in+Imatinib-Resistant+Chronic+Myeloid+Leukemia+Cells+Implicate+Alternative+Pathway+Usage+as+a+Survival+Strategy&doi=10.1016%2Fj.leukres.2007.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy</span></div><div class="casAuthors">Jilani, Iman; Kantarjian, Hagop; Gorre, Mercedes; Cortes, Jorge; Ottmann, Oliver; Bhalla, Kapil; Giles, Francis J.; Albitar, Maher</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">643-649</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ex-vivo studies have suggested that imatinib-resistance in chronic myeloid leukemia (CML) patients occurs despite adequate suppression of BCR-ABL activity.  Whether BCR-ABL phosphorylation levels differ between imatinib-sensitive and -resistant patients is not known.  We compared the phosphorylation of BCR-ABL in 54 previously untreated CML patients and 62 imatinib-resistant CML patients with progressive disease.  Resistant patients had significantly lower levels of BCR-ABL, CrkL and AKT phosphorylation than previously untreated patients, but STAT5 phosphorylation showed no difference.  These observations suggest that imatinib- resistance is not necessarily dependent on higher activity in BCR-ABL-dependent pathways, but is likely due to the activation of other pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOetTZMc1sbbVg90H21EOLACvtfcHk0lj_HhZPS6OOrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlOhsbo%253D&md5=a33e302bef69b8e1b77d9daa926af098</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2007.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2007.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DJilani%26aufirst%3DI.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DGorre%26aufirst%3DM.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DOttmann%26aufirst%3DO.%26aulast%3DBhalla%26aufirst%3DK.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DAlbitar%26aufirst%3DM.%26atitle%3DPhosphorylation%2520Levels%2520of%2520BCR-ABL%252C%2520CrkL%252C%2520AKT%2520and%2520STAT5%2520in%2520Imatinib-Resistant%2520Chronic%2520Myeloid%2520Leukemia%2520Cells%2520Implicate%2520Alternative%2520Pathway%2520Usage%2520as%2520a%2520Survival%2520Strategy%26jtitle%3DLeuk.%2520Res.%26date%3D2008%26volume%3D32%26spage%3D643%26epage%3D649%26doi%3D10.1016%2Fj.leukres.2007.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Cumaraswamy, A. a.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resetca, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Inhibitors of Stat5 Protein Signalling</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span><span class="refDoi"> DOI: 10.1039/C1MD00175B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1039%2FC1MD00175B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=22-27&author=A.+a.+Cumaraswamyauthor=A.+Todicauthor=D.+Resetcaauthor=M.+D.+Mindenauthor=P.+T.+Gunning&title=Inhibitors+of+Stat5+Protein+Signalling&doi=10.1039%2FC1MD00175B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2FC1MD00175B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1MD00175B%26sid%3Dliteratum%253Aachs%26aulast%3DCumaraswamy%26aufirst%3DA.%2Ba.%26aulast%3DTodic%26aufirst%3DA.%26aulast%3DResetca%26aufirst%3DD.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DInhibitors%2520of%2520Stat5%2520Protein%2520Signalling%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D22%26epage%3D27%26doi%3D10.1039%2FC1MD00175B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Prost, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relouzat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spentchian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouzegdouh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saliba, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massonnet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beressi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeyen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggueneau, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maneglier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chomienne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrétien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousselot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leboulch, P.</span><span> </span><span class="NLM_article-title">Erosion of the Chronic Myeloid Leukaemia Stem Cell Pool by PPARγ Agonists</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">525</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span><span class="refDoi"> DOI: 10.1038/nature15248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1038%2Fnature15248" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=380-383&author=S.+Prostauthor=F.+Relouzatauthor=M.+Spentchianauthor=Y.+Ouzegdouhauthor=J.+Salibaauthor=G.+Massonnetauthor=J.+Beressiauthor=E.+Verhoeyenauthor=V.+Raggueneauauthor=B.+Maneglierauthor=S.+Castaigneauthor=C.+Chomienneauthor=S.+Chr%C3%A9tienauthor=P.+Rousselotauthor=P.+Leboulch&title=Erosion+of+the+Chronic+Myeloid+Leukaemia+Stem+Cell+Pool+by+PPAR%CE%B3+Agonists&doi=10.1038%2Fnature15248"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature15248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature15248%26sid%3Dliteratum%253Aachs%26aulast%3DProst%26aufirst%3DS.%26aulast%3DRelouzat%26aufirst%3DF.%26aulast%3DSpentchian%26aufirst%3DM.%26aulast%3DOuzegdouh%26aufirst%3DY.%26aulast%3DSaliba%26aufirst%3DJ.%26aulast%3DMassonnet%26aufirst%3DG.%26aulast%3DBeressi%26aufirst%3DJ.%26aulast%3DVerhoeyen%26aufirst%3DE.%26aulast%3DRaggueneau%26aufirst%3DV.%26aulast%3DManeglier%26aufirst%3DB.%26aulast%3DCastaigne%26aufirst%3DS.%26aulast%3DChomienne%26aufirst%3DC.%26aulast%3DChr%25C3%25A9tien%26aufirst%3DS.%26aulast%3DRousselot%26aufirst%3DP.%26aulast%3DLeboulch%26aufirst%3DP.%26atitle%3DErosion%2520of%2520the%2520Chronic%2520Myeloid%2520Leukaemia%2520Stem%2520Cell%2520Pool%2520by%2520PPAR%25CE%25B3%2520Agonists%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D380%26epage%3D383%26doi%3D10.1038%2Fnature15248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Warsch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundschober, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gille, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerny-Reiterer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigan, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelbl-Kovacic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexl, V.</span><span> </span><span class="NLM_article-title">STAT5 Triggers BCR-ABL1 Mutation by Mediating ROS Production in Chronic Myeloid Leukaemia</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1687</span><span class="refDoi"> DOI: 10.18632/oncotarget.806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.18632%2Foncotarget.806" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1669-1687&author=W.+Warschauthor=E.+Grundschoberauthor=A.+Bergerauthor=L.+Gilleauthor=S.+Cerny-Reitererauthor=A.-S.+Tiganauthor=A.+Hoelbl-Kovacicauthor=P.+Valentauthor=R.+Morigglauthor=V.+Sexl&title=STAT5+Triggers+BCR-ABL1+Mutation+by+Mediating+ROS+Production+in+Chronic+Myeloid+Leukaemia&doi=10.18632%2Foncotarget.806"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.806%26sid%3Dliteratum%253Aachs%26aulast%3DWarsch%26aufirst%3DW.%26aulast%3DGrundschober%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DGille%26aufirst%3DL.%26aulast%3DCerny-Reiterer%26aufirst%3DS.%26aulast%3DTigan%26aufirst%3DA.-S.%26aulast%3DHoelbl-Kovacic%26aufirst%3DA.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DSexl%26aufirst%3DV.%26atitle%3DSTAT5%2520Triggers%2520BCR-ABL1%2520Mutation%2520by%2520Mediating%2520ROS%2520Production%2520in%2520Chronic%2520Myeloid%2520Leukaemia%26jtitle%3DOncotarget%26date%3D2012%26volume%3D3%26spage%3D1669%26epage%3D1687%26doi%3D10.18632%2Foncotarget.806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span> </span><span class="NLM_article-title">Inhibition of STAT5: A Therapeutic Option in BCR-ABL1-Driven Leukemia</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">9564</span><span class="NLM_x">–</span> <span class="NLM_lpage">9576</span><span class="refDoi"> DOI: 10.18632/oncotarget.2465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.18632%2Foncotarget.2465" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=9564-9576&author=A.+Bergerauthor=V.+Sexlauthor=P.+Valentauthor=R.+Moriggl&title=Inhibition+of+STAT5%3A+A+Therapeutic+Option+in+BCR-ABL1-Driven+Leukemia&doi=10.18632%2Foncotarget.2465"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2465%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DSexl%26aufirst%3DV.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DMoriggl%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520STAT5%253A%2520A%2520Therapeutic%2520Option%2520in%2520BCR-ABL1-Driven%2520Leukemia%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D9564%26epage%3D9576%26doi%3D10.18632%2Foncotarget.2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Nelson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Natan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gashin, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klitgaard, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addorio, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, D. A.</span><span> </span><span class="NLM_article-title">The STAT5 Inhibitor Pimozide Decreases Survival of Chronic Myelogenous Leukemia Cells Resistant to Kinase Inhibitors</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">3421</span><span class="NLM_x">–</span> <span class="NLM_lpage">3429</span><span class="refDoi"> DOI: 10.1182/blood-2009-11-255232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1182%2Fblood-2009-11-255232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=3421-3429&author=E.+A.+Nelsonauthor=S.+R.+Walkerauthor=E.+Weisbergauthor=M.+Bar-Natanauthor=R.+Barrettauthor=L.+B.+Gashinauthor=S.+Terrellauthor=J.+L.+Klitgaardauthor=L.+Santoauthor=M.+R.+Addorioauthor=B.+L.+Ebertauthor=J.+D.+Griffinauthor=D.+A.+Frank&title=The+STAT5+Inhibitor+Pimozide+Decreases+Survival+of+Chronic+Myelogenous+Leukemia+Cells+Resistant+to+Kinase+Inhibitors&doi=10.1182%2Fblood-2009-11-255232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-11-255232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-11-255232%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DE.%2BA.%26aulast%3DWalker%26aufirst%3DS.%2BR.%26aulast%3DWeisberg%26aufirst%3DE.%26aulast%3DBar-Natan%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DR.%26aulast%3DGashin%26aufirst%3DL.%2BB.%26aulast%3DTerrell%26aufirst%3DS.%26aulast%3DKlitgaard%26aufirst%3DJ.%2BL.%26aulast%3DSanto%26aufirst%3DL.%26aulast%3DAddorio%26aufirst%3DM.%2BR.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26atitle%3DThe%2520STAT5%2520Inhibitor%2520Pimozide%2520Decreases%2520Survival%2520of%2520Chronic%2520Myelogenous%2520Leukemia%2520Cells%2520Resistant%2520to%2520Kinase%2520Inhibitors%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26spage%3D3421%26epage%3D3429%26doi%3D10.1182%2Fblood-2009-11-255232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cumaraswamy, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geletu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laister, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muench, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1202</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span><span class="refDoi"> DOI: 10.1021/ml500165r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500165r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1202-1206&author=A.+A.+Cumaraswamyauthor=A.+M.+Lewisauthor=M.+Geletuauthor=A.+Todicauthor=D.+B.+Diazauthor=X.+R.+Chengauthor=C.+E.+Brownauthor=R.+C.+Laisterauthor=D.+Muenchauthor=K.+Kermanauthor=H.+L.+Grimesauthor=M.+D.+Mindenauthor=P.+T.+Gunning&title=Nanomolar-Potency+Small+Molecule+Inhibitor+of+STAT5+Protein&doi=10.1021%2Fml500165r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fml500165r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500165r%26sid%3Dliteratum%253Aachs%26aulast%3DCumaraswamy%26aufirst%3DA.%2BA.%26aulast%3DLewis%26aufirst%3DA.%2BM.%26aulast%3DGeletu%26aufirst%3DM.%26aulast%3DTodic%26aufirst%3DA.%26aulast%3DDiaz%26aufirst%3DD.%2BB.%26aulast%3DCheng%26aufirst%3DX.%2BR.%26aulast%3DBrown%26aufirst%3DC.%2BE.%26aulast%3DLaister%26aufirst%3DR.%2BC.%26aulast%3DMuench%26aufirst%3DD.%26aulast%3DKerman%26aufirst%3DK.%26aulast%3DGrimes%26aufirst%3DH.%2BL.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DNanomolar-Potency%2520Small%2520Molecule%2520Inhibitor%2520of%2520STAT5%2520Protein%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1202%26epage%3D1206%26doi%3D10.1021%2Fml500165r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Possinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeffler, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elstner, E.</span><span> </span><span class="NLM_article-title">Growth Inhibition and Apoptosis in Human Philadelphia Chromosome-Positive Lymphoblastic Leukemia Cell Lines by Treatment with the Dual PPARα/γ Ligand TZD18</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">3683</span><span class="NLM_x">–</span> <span class="NLM_lpage">3692</span><span class="refDoi"> DOI: 10.1182/blood-2005-05-2103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1182%2Fblood-2005-05-2103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=3683-3692&author=H.+Liuauthor=C.+Zangauthor=M.+H.+Fennerauthor=D.+Liuauthor=K.+Possingerauthor=H.+P.+Koefflerauthor=E.+Elstner&title=Growth+Inhibition+and+Apoptosis+in+Human+Philadelphia+Chromosome-Positive+Lymphoblastic+Leukemia+Cell+Lines+by+Treatment+with+the+Dual+PPAR%CE%B1%2F%CE%B3+Ligand+TZD18&doi=10.1182%2Fblood-2005-05-2103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-05-2103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-05-2103%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZang%26aufirst%3DC.%26aulast%3DFenner%26aufirst%3DM.%2BH.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DPossinger%26aufirst%3DK.%26aulast%3DKoeffler%26aufirst%3DH.%2BP.%26aulast%3DElstner%26aufirst%3DE.%26atitle%3DGrowth%2520Inhibition%2520and%2520Apoptosis%2520in%2520Human%2520Philadelphia%2520Chromosome-Positive%2520Lymphoblastic%2520Leukemia%2520Cell%2520Lines%2520by%2520Treatment%2520with%2520the%2520Dual%2520PPAR%25CE%25B1%252F%25CE%25B3%2520Ligand%2520TZD18%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D3683%26epage%3D3692%26doi%3D10.1182%2Fblood-2005-05-2103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Saiki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatta, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horie, T.</span><span> </span><span class="NLM_article-title">Pioglitazone Inhibits the Growth of Human Leukemia Cell Lines and Primary Leukemia Cells While Sparing Normal Hematopoietic Stem Cells</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span><span class="refDoi"> DOI: 10.3892/ijo.29.2.437</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.3892%2Fijo.29.2.437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=16820887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=437-443&author=M.+Saikiauthor=Y.+Hattaauthor=T.+Yamazakiauthor=T.+Itohauthor=Y.+Enomotoauthor=J.+Takeuchiauthor=U.+Sawadaauthor=S.+Aizawaauthor=T.+Horie&title=Pioglitazone+Inhibits+the+Growth+of+Human+Leukemia+Cell+Lines+and+Primary+Leukemia+Cells+While+Sparing+Normal+Hematopoietic+Stem+Cells&doi=10.3892%2Fijo.29.2.437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells</span></div><div class="casAuthors">Saiki, Minoru; Hatta, Yoshihiro; Yamazaki, Tetsuo; Itoh, Takeyoshi; Enomoto, Yuko; Takeuchi, Jin; Sawada, Umihiko; Aizawa, Shin; Horie, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">437-443</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) compose a subfamily of nuclear hormone receptors functioning as transcriptional regulators.  Originally, the PPARγ ligand known as thiazolidinedione (TZD) was used for the treatment of diabetic patients.  However, recent studies have shown that TZD also has an antitumor effect that inhibits cell growth in several types of human malignant neoplasms, including leukemia cell lines.  Since pioglitazone is the only TZD currently available in clinics in Japan and the role of TZD in normal human hematopoietic cells or primary leukemia cells has not been previously reported, the authors investigated the effect of pioglitazone on human normal hematopoietic progenitor cells, primary leukemia cells, and leukemia cell lines (HL60, K562, U937, HEL, CEM, Jurkat, and NALM1).  Pioglitazone inhibited the proliferation of leukemia cells in a dose-dependent manner.  The viable cell nos. of HL60, K562, and Jurkat leukemia cell lines were profoundly reduced when the cells were cocultured with pioglitazone.  Colony formation in the leukemia cell lines as well as the primary leukemia cells was significantly inhibited to 20-71% and 1-25% of that in control cultures by the addn. of 100 and 300 μM of pioglitazone, resp.  However, the CFU-E and CFU-GM colonies of cells obtained from healthy volunteers were not altered in the presence of 100 μM of pioglitazone.  Pioglitazone (300 μM) induced slight decrease of CFU-E and CFU-GM.  BFU-E was more sensitive to pioglitazone than CFU-E and CFU-GM.  Pioglitazone-induced growth inhibition in HL60 cells was assocd. with cell cycle arrest at the G1 phase, as has been reported for another TZD, troglitazone.  Similar levels of PPARγ protein were obsd. in both leukemia and normal bone marrow cells by Western blotting, suggesting that the expression of PPARγ protein was not assocd. with the inhibitory potency of pioglitazone.  In conclusion, the authors' results suggest that pioglitazone may offer a new therapeutic approach to aid in the treatment of leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-S6WHssFOu7Vg90H21EOLACvtfcHk0lj6PUF55PY69w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKls7w%253D&md5=cd73257e9d9c3d272572a64f94abd2cc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3892%2Fijo.29.2.437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.29.2.437%26sid%3Dliteratum%253Aachs%26aulast%3DSaiki%26aufirst%3DM.%26aulast%3DHatta%26aufirst%3DY.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DEnomoto%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DJ.%26aulast%3DSawada%26aufirst%3DU.%26aulast%3DAizawa%26aufirst%3DS.%26aulast%3DHorie%26aufirst%3DT.%26atitle%3DPioglitazone%2520Inhibits%2520the%2520Growth%2520of%2520Human%2520Leukemia%2520Cell%2520Lines%2520and%2520Primary%2520Leukemia%2520Cells%2520While%2520Sparing%2520Normal%2520Hematopoietic%2520Stem%2520Cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2006%26volume%3D29%26spage%3D437%26epage%3D443%26doi%3D10.3892%2Fijo.29.2.437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bertz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wächter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Possinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillip Koeffler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elstner, E.</span><span> </span><span class="NLM_article-title">Compound 48, a Novel Dual PPAR α/γ Ligand, Inhibits the Growth of Human CML Cell Lines and Enhances the Anticancer-Effects of Imatinib</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1016/j.leukres.2008.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.leukres.2008.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=19131110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVajsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=686-692&author=J.+Bertzauthor=C.+Zangauthor=H.+Liuauthor=M.+W%C3%A4chterauthor=K.+Possingerauthor=H.+Phillip+Koefflerauthor=E.+Elstner&title=Compound+48%2C+a+Novel+Dual+PPAR+%CE%B1%2F%CE%B3+Ligand%2C+Inhibits+the+Growth+of+Human+CML+Cell+Lines+and+Enhances+the+Anticancer-Effects+of+Imatinib&doi=10.1016%2Fj.leukres.2008.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Compound 48, a novel dual PPAR α/γ ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib</span></div><div class="casAuthors">Bertz, Janina; Zang, Chuanbing; Liu, Hongyu; Waechter, Marlies; Possinger, Kurt; Phillip Koeffler, H.; Elstner, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">686-692</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Compd. 48 (C48) is a novel dual ligand for peroxisome proliferator-activated receptor α and γ (PPARα/γ).  Culture of imatinib-sensitive and -resistant CML cell lines with C48 resulted in a strong growth inhibition which assocd. with G0/G1 cell cycle arrest.  However, it showed no obvious toxicity to normal CD34+ hematopoietic stem cells.  Decrease of pSTATs and pAKT were noticed suggesting that interference of AKT and STATs signaling may be the mechanisms for the effects of PPARα/γ ligands.  Of more clin. importance, this ligand strongly enhanced the anticancer-effects of imatinib.  Overall, our data suggest that the PPARα/γ ligands may have potentials in the treatment of CML in an adjuvant setting either before or after the development of imatinib resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Dt8rO5BcXbVg90H21EOLACvtfcHk0lgA2QhkUEH0YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVajsr8%253D&md5=41da2590344c7c152e04d2d82f4e127c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2008.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2008.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DBertz%26aufirst%3DJ.%26aulast%3DZang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DW%25C3%25A4chter%26aufirst%3DM.%26aulast%3DPossinger%26aufirst%3DK.%26aulast%3DPhillip%2BKoeffler%26aufirst%3DH.%26aulast%3DElstner%26aufirst%3DE.%26atitle%3DCompound%252048%252C%2520a%2520Novel%2520Dual%2520PPAR%2520%25CE%25B1%252F%25CE%25B3%2520Ligand%252C%2520Inhibits%2520the%2520Growth%2520of%2520Human%2520CML%2520Cell%2520Lines%2520and%2520Enhances%2520the%2520Anticancer-Effects%2520of%2520Imatinib%26jtitle%3DLeuk.%2520Res.%26date%3D2009%26volume%3D33%26spage%3D686%26epage%3D692%26doi%3D10.1016%2Fj.leukres.2008.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Prost, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Dantec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augé, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derdouch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auregan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Déglon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relouzat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubertin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillere, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusanter-Fourt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirszenbaum, M.</span><span> </span><span class="NLM_article-title">Human and Simian Immunodeficiency Viruses Deregulate Early Hematopoiesis through a Nef/PPARγ/STAT5 Signaling Pathway in Macaques</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1765</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span><span class="refDoi"> DOI: 10.1172/JCI33037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1172%2FJCI33037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1765-1775&author=S.+Prostauthor=M.+Le+Dantecauthor=S.+Aug%C3%A9author=R.+Le+Grandauthor=S.+Derdouchauthor=G.+Aureganauthor=N.+D%C3%A9glonauthor=F.+Relouzatauthor=A.+Aubertinauthor=B.+Maillereauthor=I.+Dusanter-Fourtauthor=M.+Kirszenbaum&title=Human+and+Simian+Immunodeficiency+Viruses+Deregulate+Early+Hematopoiesis+through+a+Nef%2FPPAR%CE%B3%2FSTAT5+Signaling+Pathway+in+Macaques&doi=10.1172%2FJCI33037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1172%2FJCI33037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI33037%26sid%3Dliteratum%253Aachs%26aulast%3DProst%26aufirst%3DS.%26aulast%3DLe%2BDantec%26aufirst%3DM.%26aulast%3DAug%25C3%25A9%26aufirst%3DS.%26aulast%3DLe%2BGrand%26aufirst%3DR.%26aulast%3DDerdouch%26aufirst%3DS.%26aulast%3DAuregan%26aufirst%3DG.%26aulast%3DD%25C3%25A9glon%26aufirst%3DN.%26aulast%3DRelouzat%26aufirst%3DF.%26aulast%3DAubertin%26aufirst%3DA.%26aulast%3DMaillere%26aufirst%3DB.%26aulast%3DDusanter-Fourt%26aufirst%3DI.%26aulast%3DKirszenbaum%26aufirst%3DM.%26atitle%3DHuman%2520and%2520Simian%2520Immunodeficiency%2520Viruses%2520Deregulate%2520Early%2520Hematopoiesis%2520through%2520a%2520Nef%252FPPAR%25CE%25B3%252FSTAT5%2520Signaling%2520Pathway%2520in%2520Macaques%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D1765%26epage%3D1775%26doi%3D10.1172%2FJCI33037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Seargent, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, J. H.</span><span> </span><span class="NLM_article-title">GW9662, a Potent Antagonist of PPARγ, Inhibits Growth of Breast Tumour Cells and Promotes the Anticancer Effects of the PPARγ Agonist Rosiglitazone, Independently of PPARγ Activation</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1038%2Fsj.bjp.0705973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=15533890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFWmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=933-937&author=J.+M.+Seargentauthor=E.+A.+Yatesauthor=J.+H.+Gill&title=GW9662%2C+a+Potent+Antagonist+of+PPAR%CE%B3%2C+Inhibits+Growth+of+Breast+Tumour+Cells+and+Promotes+the+Anticancer+Effects+of+the+PPAR%CE%B3+Agonist+Rosiglitazone%2C+Independently+of+PPAR%CE%B3+Activation&doi=10.1038%2Fsj.bjp.0705973"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activation</span></div><div class="casAuthors">Seargent, Jill M.; Yates, Elisabeth A.; Gill, Jason H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">933-937</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor gamma (PPARγ), a member of the nuclear receptor superfamily, is activated by several compds., including the thiazolidinediones.  In addn. to being a therapeutic target for obesity, hypolipidemia and diabetes, perturbation of PPARγ signaling is now believed to be a strategy for treatment of several cancers, including breast.  Although differential expression of PPARγ is obsd. in tumors compared to normal tissues and PPARγ agonists have been shown to inhibit tumor cell growth and survival, the interdependence of these observations is unclear.  This study demonstrated that the potent, irreversible and selective PPARγ antagonist GW9662 prevented activation of PPARγ and inhibited growth of human mammary tumor cell lines.  Controversially, GW9662 prevented rosiglitazone-mediated PPARγ activation, but enhanced rather than reversed rosiglitazone-induced growth inhibition.  As such, these data support the existence of PPARγ-independent pathways and question the central belief that PPARγ ligands mediate their anticancer effects via activation of PPARγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7aiVWefjYtLVg90H21EOLACvtfcHk0lgPx-axZtLOkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFWmtw%253D%253D&md5=b75a4db57a7ac03225406d11314c37d7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705973%26sid%3Dliteratum%253Aachs%26aulast%3DSeargent%26aufirst%3DJ.%2BM.%26aulast%3DYates%26aufirst%3DE.%2BA.%26aulast%3DGill%26aufirst%3DJ.%2BH.%26atitle%3DGW9662%252C%2520a%2520Potent%2520Antagonist%2520of%2520PPAR%25CE%25B3%252C%2520Inhibits%2520Growth%2520of%2520Breast%2520Tumour%2520Cells%2520and%2520Promotes%2520the%2520Anticancer%2520Effects%2520of%2520the%2520PPAR%25CE%25B3%2520Agonist%2520Rosiglitazone%252C%2520Independently%2520of%2520PPAR%25CE%25B3%2520Activation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D933%26epage%3D937%26doi%3D10.1038%2Fsj.bjp.0705973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulp, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">PPARγ-Independent Antitumor Effects of Thiazolidinediones</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1016/j.canlet.2008.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.canlet.2008.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=18790559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFKjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=119-124&author=S.+Weiauthor=J.+Yangauthor=S.+Leeauthor=S.+K.+Kulpauthor=C.+Chen&title=PPAR%CE%B3-Independent+Antitumor+Effects+of+Thiazolidinediones&doi=10.1016%2Fj.canlet.2008.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">PPARγ-independent antitumor effects of thiazolidinediones</span></div><div class="casAuthors">Wei, Shuo; Yang, Jian; Lee, Su-Lin; Kulp, Samuel K.; Chen, Ching-Shih</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-124</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The thiazolidinedione (TZD) family of PPARγ agonists, esp. troglitazone and ciglitazone, induce cell cycle arrest, differentiation, and apoptosis in cancer cells.  Mounting evidence indicates that TZDs interfere with multiple signaling mechanisms independently of PPARγ activation, which affect many aspects of cellular functions governing cell cycle progression and survival of cancer cells.  Here, we review the "off-target" mechanisms that underlie the antitumor effects of TZDs with emphasis on 3 key pathways, namely, inhibition of Bcl-2/Bcl-xL function, proteasomal degrdn. of cell cycle- and apoptosis-regulatory proteins, and transcriptional repression of androgen receptor (AR) through Sp1 degrdn.  Relative to tumor cells, nonmalignant cells are resistant to these PPARγ-independent antitumor effects, which underscores the translational potential of these agents.  Furthermore, dissocn. of these antitumor effects from their PPARγ agonist activity provides a rationale for using TZDs as scaffolds for lead optimization to develop a novel class of antitumor agents with a unique mode of mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6Y4tzRlwErVg90H21EOLACvtfcHk0lgPx-axZtLOkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFKjsL8%253D&md5=fc56d3c6acc3500d8afc0b8d77b67248</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKulp%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DPPAR%25CE%25B3-Independent%2520Antitumor%2520Effects%2520of%2520Thiazolidinediones%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D276%26spage%3D119%26epage%3D124%26doi%3D10.1016%2Fj.canlet.2008.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Parmenon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennuyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinot-Bouchez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutin, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dacquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktorza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viaud-Massuard, M.-C.</span><span> </span><span class="NLM_article-title">4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline-Based PPARα/γ Agonists. Part I: Synthesis and Pharmacological Evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1617</span><span class="NLM_x">–</span> <span class="NLM_lpage">1622</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.bmcl.2008.01.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=18255290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1Ckt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1617-1622&author=C.+Parmenonauthor=J.+Guillardauthor=D.-H.+Caignardauthor=N.+Hennuyerauthor=B.+Staelsauthor=V.+Audinot-Bouchezauthor=J.-A.+Boutinauthor=C.+Dacquetauthor=A.+Ktorzaauthor=M.-C.+Viaud-Massuard&title=4%2C4-Dimethyl-1%2C2%2C3%2C4-Tetrahydroquinoline-Based+PPAR%CE%B1%2F%CE%B3+Agonists.+Part+I%3A+Synthesis+and+Pharmacological+Evaluation&doi=10.1016%2Fj.bmcl.2008.01.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARα/γ agonists. Part I: Synthesis and pharmacological evaluation</span></div><div class="casAuthors">Parmenon, Cecile; Guillard, Jerome; Caignard, Daniel-Henri; Hennuyer, Nathalie; Staels, Bart; Audinot-Bouchez, Valerie; Boutin, Jean-Albert; Dacquet, Catherine; Ktorza, Alain; Viaud-Massuard, Marie-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1617-1622</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 4,4-dimethyl-1,2,3,4-tetrahydroquinolines, e.g. I (R = H, Me), was synthesized and studied as human PPARγ selective agonists and dual PPARα/γ agonists for potential treatment of type-2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp08HKGqPuCVLVg90H21EOLACvtfcHk0lj_8P0ISsTPwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1Ckt70%253D&md5=93ad385b32df02483e5cd41d979000de</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.067%26sid%3Dliteratum%253Aachs%26aulast%3DParmenon%26aufirst%3DC.%26aulast%3DGuillard%26aufirst%3DJ.%26aulast%3DCaignard%26aufirst%3DD.-H.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DAudinot-Bouchez%26aufirst%3DV.%26aulast%3DBoutin%26aufirst%3DJ.-A.%26aulast%3DDacquet%26aufirst%3DC.%26aulast%3DKtorza%26aufirst%3DA.%26aulast%3DViaud-Massuard%26aufirst%3DM.-C.%26atitle%3D4%252C4-Dimethyl-1%252C2%252C3%252C4-Tetrahydroquinoline-Based%2520PPAR%25CE%25B1%252F%25CE%25B3%2520Agonists.%2520Part%2520I%253A%2520Synthesis%2520and%2520Pharmacological%2520Evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1617%26epage%3D1622%26doi%3D10.1016%2Fj.bmcl.2008.01.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Parmenon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennuyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinot-Bouchez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutin, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dacquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktorza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viaud-Massuard, M.-C.</span><span> </span><span class="NLM_article-title">4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline-Based PPARα/γ Agonists. Part. II: Synthesis and Pharmacological Evaluation of Oxime and Acidic Head Group Structural Variations</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2683</span><span class="NLM_x">–</span> <span class="NLM_lpage">2687</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2Fj.bmcl.2009.03.143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2683-2687&author=C.+Parmenonauthor=J.+Guillardauthor=D.-H.+Caignardauthor=N.+Hennuyerauthor=B.+Staelsauthor=V.+Audinot-Bouchezauthor=J.-A.+Boutinauthor=C.+Dacquetauthor=A.+Ktorzaauthor=M.-C.+Viaud-Massuard&title=4%2C4-Dimethyl-1%2C2%2C3%2C4-Tetrahydroquinoline-Based+PPAR%CE%B1%2F%CE%B3+Agonists.+Part.+II%3A+Synthesis+and+Pharmacological+Evaluation+of+Oxime+and+Acidic+Head+Group+Structural+Variations&doi=10.1016%2Fj.bmcl.2009.03.143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.143%26sid%3Dliteratum%253Aachs%26aulast%3DParmenon%26aufirst%3DC.%26aulast%3DGuillard%26aufirst%3DJ.%26aulast%3DCaignard%26aufirst%3DD.-H.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DAudinot-Bouchez%26aufirst%3DV.%26aulast%3DBoutin%26aufirst%3DJ.-A.%26aulast%3DDacquet%26aufirst%3DC.%26aulast%3DKtorza%26aufirst%3DA.%26aulast%3DViaud-Massuard%26aufirst%3DM.-C.%26atitle%3D4%252C4-Dimethyl-1%252C2%252C3%252C4-Tetrahydroquinoline-Based%2520PPAR%25CE%25B1%252F%25CE%25B3%2520Agonists.%2520Part.%2520II%253A%2520Synthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Oxime%2520and%2520Acidic%2520Head%2520Group%2520Structural%2520Variations%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2683%26epage%3D2687%26doi%3D10.1016%2Fj.bmcl.2009.03.143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Garcia-Bates, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson-Haidaris, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sime, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, R. P.</span><span> </span><span class="NLM_article-title">Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies</span> <span class="citation_source-journal">PPAR Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1155/2008/834612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1155%2F2008%2F834612" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=1-18&author=T.+M.+Garcia-Batesauthor=G.+M.+Lehmannauthor=P.+J.+Simpson-Haidarisauthor=S.+H.+Bernsteinauthor=P.+J.+Simeauthor=R.+P.+Phipps&title=Role+of+Peroxisome+Proliferator-Activated+Receptor+Gamma+and+Its+Ligands+in+the+Treatment+of+Hematological+Malignancies&doi=10.1155%2F2008%2F834612"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1155%2F2008%2F834612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2008%252F834612%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Bates%26aufirst%3DT.%2BM.%26aulast%3DLehmann%26aufirst%3DG.%2BM.%26aulast%3DSimpson-Haidaris%26aufirst%3DP.%2BJ.%26aulast%3DBernstein%26aufirst%3DS.%2BH.%26aulast%3DSime%26aufirst%3DP.%2BJ.%26aulast%3DPhipps%26aufirst%3DR.%2BP.%26atitle%3DRole%2520of%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520Gamma%2520and%2520Its%2520Ligands%2520in%2520the%2520Treatment%2520of%2520Hematological%2520Malignancies%26jtitle%3DPPAR%2520Res.%26date%3D2008%26volume%3D2008%26spage%3D1%26epage%3D18%26doi%3D10.1155%2F2008%2F834612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kodomari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span> </span><span class="NLM_article-title">Graphite as an Effective Catalyst for Friedel–Crafts Acylation</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">1567</span><span class="NLM_x">–</span> <span class="NLM_lpage">1568</span><span class="refDoi"> DOI: 10.1039/a703947f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1039%2Fa703947f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=1567-1568&issue=16&author=M.+Kodomariauthor=Y.+Suzukiauthor=K.+Yoshida&title=Graphite+as+an+Effective+Catalyst+for+Friedel%E2%80%93Crafts+Acylation&doi=10.1039%2Fa703947f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fa703947f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa703947f%26sid%3Dliteratum%253Aachs%26aulast%3DKodomari%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DK.%26atitle%3DGraphite%2520as%2520an%2520Effective%2520Catalyst%2520for%2520Friedel%25E2%2580%2593Crafts%2520Acylation%26jtitle%3DChem.%2520Commun.%26date%3D1997%26issue%3D16%26spage%3D1567%26epage%3D1568%26doi%3D10.1039%2Fa703947f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Niu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span> </span><span class="NLM_article-title">Copper(I)-Catalyzed Aryl Bromides To Form Intermolecular and Intramolecular Carbon–Oxygen Bonds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">5075</span><span class="NLM_x">–</span> <span class="NLM_lpage">5078</span><span class="refDoi"> DOI: 10.1021/jo900600m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo900600m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVOmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=5075-5078&author=J.+Niuauthor=P.+Guoauthor=J.+Kangauthor=Z.+Liauthor=J.+Xuauthor=S.+Hu&title=Copper%28I%29-Catalyzed+Aryl+Bromides+To+Form+Intermolecular+and+Intramolecular+Carbon%E2%80%93Oxygen+Bonds&doi=10.1021%2Fjo900600m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I)-Catalyzed Aryl Bromides To Form Intermolecular and Intramolecular Carbon-Oxygen Bonds</span></div><div class="casAuthors">Niu, Jiajia; Guo, Pengran; Kang, Juntao; Li, Zhigang; Xu, Jingwei; Hu, Shaojing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5075-5078</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A highly efficient Cu-catalyzed C-O bond-forming reaction of alc. and aryl bromides has been developed.  This transformation was realized through the use of copper(I) iodide as a catalyst, 8-hydroxyquinoline as a ligand, and K3PO4 as a base.  A variety of functionalized substrates were found to react under these reaction conditions to provide products in good to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXe9h4hZl2HLVg90H21EOLACvtfcHk0liaqNReRWeKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVOmsbo%253D&md5=b80aea2e47f5e3b9c9c9cef81794966f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo900600m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900600m%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DS.%26atitle%3DCopper%2528I%2529-Catalyzed%2520Aryl%2520Bromides%2520To%2520Form%2520Intermolecular%2520and%2520Intramolecular%2520Carbon%25E2%2580%2593Oxygen%2520Bonds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D5075%26epage%3D5078%26doi%3D10.1021%2Fjo900600m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Altman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtor, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">An Improved Cu-Based Catalyst System for the Reactions of Alcohols with Aryl Halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1021/jo702024p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo702024p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOgsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=284-286&author=R.+A.+Altmanauthor=A.+Shafirauthor=A.+Choiauthor=P.+A.+Lichtorauthor=S.+L.+Buchwald&title=An+Improved+Cu-Based+Catalyst+System+for+the+Reactions+of+Alcohols+with+Aryl+Halides&doi=10.1021%2Fjo702024p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An Improved Cu-Based Catalyst System for the Reactions of Alcohols with Aryl Halides</span></div><div class="casAuthors">Altman, Ryan A.; Shafir, Alexandr; Choi, Alice; Lichtor, Phillip A.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">284-286</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of 3,4,7,8-tetramethyl-1,10-phenanthroline (Me4Phen) as a ligand improves the Cu-catalyzed cross-coupling reactions of aryl iodides and bromides with primary and secondary aliph., benzylic, allylic, and propargylic alcs to give products, e.g., I, in good yields.  Most importantly, by employing this catalyst system, the need to use an excessive quantity of the alc. coupling partner is alleviated.  The relatively mild conditions, short reaction times, and moderately low catalyst loading allow for a wide array of functional groups to be tolerated on both the electrophilic and nucleophilic coupling partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy2UxAcp1pOrVg90H21EOLACvtfcHk0liNROekvF4TzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOgsrjF&md5=a99d7184c0f34e2ca688ba0796c95b70</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo702024p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo702024p%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DR.%2BA.%26aulast%3DShafir%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DA.%26aulast%3DLichtor%26aufirst%3DP.%2BA.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DAn%2520Improved%2520Cu-Based%2520Catalyst%2520System%2520for%2520the%2520Reactions%2520of%2520Alcohols%2520with%2520Aryl%2520Halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D284%26epage%3D286%26doi%3D10.1021%2Fjo702024p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">More, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finney, N. S.</span><span> </span><span class="NLM_article-title">A Simple and Advantageous Protocol for the Oxidation of Alcohols with O-Iodoxybenzoic Acid (IBX)</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3001</span><span class="NLM_x">–</span> <span class="NLM_lpage">3003</span><span class="refDoi"> DOI: 10.1021/ol026427n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol026427n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVSgtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=3001-3003&author=J.+D.+Moreauthor=N.+S.+Finney&title=A+Simple+and+Advantageous+Protocol+for+the+Oxidation+of+Alcohols+with+O-Iodoxybenzoic+Acid+%28IBX%29&doi=10.1021%2Fol026427n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple and Advantageous Protocol for the Oxidation of Alcohols with o-Iodoxybenzoic Acid (IBX)</span></div><div class="casAuthors">More, Jesse D.; Finney, Nathaniel S.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3001-3003</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Both primary and secondary alcs. were oxidized into the corresponding aldehydes in excellent yields (90-100%) by heating a soln. of an alc. with suspended 2-iodoxybenzoic acid (IBX) followed by filtration of insol. byproducts and solvent removal.  The IBX oxidant can be recycled and reused.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEUdN6GyHKIrVg90H21EOLACvtfcHk0liNROekvF4TzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVSgtbo%253D&md5=c7ff04157bc298d4fce92906f321ba96</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fol026427n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol026427n%26sid%3Dliteratum%253Aachs%26aulast%3DMore%26aufirst%3DJ.%2BD.%26aulast%3DFinney%26aufirst%3DN.%2BS.%26atitle%3DA%2520Simple%2520and%2520Advantageous%2520Protocol%2520for%2520the%2520Oxidation%2520of%2520Alcohols%2520with%2520O-Iodoxybenzoic%2520Acid%2520%2528IBX%2529%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D3001%26epage%3D3003%26doi%3D10.1021%2Fol026427n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. D.</span><span> </span><span class="NLM_article-title">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3849</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span><span class="refDoi"> DOI: 10.1021/jo960057x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+Amination+of+Aldehydes+and+Ketones+with+Sodium+Triacetoxyborohydride.+Studies+on+Direct+and+Indirect+Reductive+Amination+Procedures&doi=10.1021%2Fjo960057x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0ljt7QFygjhQ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520Amination%2520of%2520Aldehydes%2520and%2520Ketones%2520with%2520Sodium%2520Triacetoxyborohydride.%2520Studies%2520on%2520Direct%2520and%2520Indirect%2520Reductive%2520Amination%2520Procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862%26doi%3D10.1021%2Fjo960057x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Dhar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klucik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madler, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivey, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacheis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birckbichler, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benbrook, D. M.</span><span> </span><span class="NLM_article-title">Synthesis, Structure–Activity Relationships, and RARγ–Ligand Interactions of Nitrogen Heteroarotinoids</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3602</span><span class="NLM_x">–</span> <span class="NLM_lpage">3614</span><span class="refDoi"> DOI: 10.1021/jm9900974</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9900974" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3602-3614&author=A.+Dharauthor=S.+Liuauthor=J.+Klucikauthor=K.+D.+Berlinauthor=M.+M.+Madlerauthor=S.+Luauthor=R.+T.+Iveyauthor=D.+Zacheisauthor=C.+W.+Brownauthor=E.+C.+Nelsonauthor=P.+J.+Birckbichlerauthor=D.+M.+Benbrook&title=Synthesis%2C+Structure%E2%80%93Activity+Relationships%2C+and+RAR%CE%B3%E2%80%93Ligand+Interactions+of+Nitrogen+Heteroarotinoids&doi=10.1021%2Fjm9900974"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm9900974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9900974%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DKlucik%26aufirst%3DJ.%26aulast%3DBerlin%26aufirst%3DK.%2BD.%26aulast%3DMadler%26aufirst%3DM.%2BM.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DIvey%26aufirst%3DR.%2BT.%26aulast%3DZacheis%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DC.%2BW.%26aulast%3DNelson%26aufirst%3DE.%2BC.%26aulast%3DBirckbichler%26aufirst%3DP.%2BJ.%26aulast%3DBenbrook%26aufirst%3DD.%2BM.%26atitle%3DSynthesis%252C%2520Structure%25E2%2580%2593Activity%2520Relationships%252C%2520and%2520RAR%25CE%25B3%25E2%2580%2593Ligand%2520Interactions%2520of%2520Nitrogen%2520Heteroarotinoids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3602%26epage%3D3614%26doi%3D10.1021%2Fjm9900974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Weiberth, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. S.</span><span> </span><span class="NLM_article-title">Copper(I)-Activated Addition of Grignard Reagents to Nitriles. Synthesis of Ketimines, Ketones, and Amines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3901</span><span class="NLM_x">–</span> <span class="NLM_lpage">3904</span><span class="refDoi"> DOI: 10.1021/jo00226a033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00226a033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADyaL2sXlsFCjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1987&pages=3901-3904&author=F.+J.+Weiberthauthor=S.+S.+Hall&title=Copper%28I%29-Activated+Addition+of+Grignard+Reagents+to+Nitriles.+Synthesis+of+Ketimines%2C+Ketones%2C+and+Amines&doi=10.1021%2Fjo00226a033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I)-activated addition of Grignard reagents to nitriles.  Synthesis of ketimines, ketones, and amines</span></div><div class="casAuthors">Weiberth, Franz J.; Hall, Stan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3901-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The nucleophilic addn. of Grignard reagents to nitriles, esp. when using sterically demanding components, is effectively catalyzed by copper(I) salts.  Alkyl and arom. nitriles and a selection of Grignard reagents were employed to prep. sterically hindered ketimines after addn., ketones after a tandem addn.-hydrolysis procedure, and branched primary amines after a tandem addn.-redn. sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSk9wHfpw5mLVg90H21EOLACvtfcHk0ljt7QFygjhQ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlsFCjs7c%253D&md5=dcb9d089a8d4b275553ae770f089a9f7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo00226a033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00226a033%26sid%3Dliteratum%253Aachs%26aulast%3DWeiberth%26aufirst%3DF.%2BJ.%26aulast%3DHall%26aufirst%3DS.%2BS.%26atitle%3DCopper%2528I%2529-Activated%2520Addition%2520of%2520Grignard%2520Reagents%2520to%2520Nitriles.%2520Synthesis%2520of%2520Ketimines%252C%2520Ketones%252C%2520and%2520Amines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1987%26volume%3D52%26spage%3D3901%26epage%3D3904%26doi%3D10.1021%2Fjo00226a033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Haddach, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deaton-rewolinski, M. V.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">An Efficient Method for the N-Debenzylation of Aromatic Heterocycles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)02192-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2FS0040-4039%2801%2902192-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtlSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=399-402&author=A.+A.+Haddachauthor=M.+V.+Deaton-rewolinski&title=An+Efficient+Method+for+the+N-Debenzylation+of+Aromatic+Heterocycles&doi=10.1016%2FS0040-4039%2801%2902192-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient method for the N-debenzylation of aromatic heterocycles</span></div><div class="casAuthors">Haddach, Aubrey A.; Kelleman, Audrey; Deaton-Rewolinski, Melissa V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-402</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The treatment of N-benzylated heterocycles with K tert-butoxide/DMSO and O at room temp. cleanly affords N-debenzylated products in high yield.  This procedure can be used on a variety of functionalized N-contg. heterocycles such as imidazoles, benzimidazoles, pyrazoles, indazoles, carbazoles, and indoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxH_1cyKPnwLVg90H21EOLACvtfcHk0liaQwK0QU6-Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtlSg&md5=d58503d132cc29a1d75ba44ab13040c1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2902192-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252902192-X%26sid%3Dliteratum%253Aachs%26aulast%3DHaddach%26aufirst%3DA.%2BA.%26aulast%3DDeaton-rewolinski%26aufirst%3DM.%2BV.%26atitle%3DAn%2520Efficient%2520Method%2520for%2520the%2520N-Debenzylation%2520of%2520Aromatic%2520Heterocycles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D399%26epage%3D402%26doi%3D10.1016%2FS0040-4039%2801%2902192-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Liang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, N.</span><span> </span><span class="NLM_article-title">Highly Efficient C-H Hydroxylation of Carbonyl Compounds with Oxygen under Mild Conditions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">548</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span><span class="refDoi"> DOI: 10.1002/anie.201308698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1002%2Fanie.201308698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVClsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=548-552&author=Y.+F.+Liangauthor=N.+Jiao&title=Highly+Efficient+C-H+Hydroxylation+of+Carbonyl+Compounds+with+Oxygen+under+Mild+Conditions&doi=10.1002%2Fanie.201308698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Efficient C-H Hydroxylation of Carbonyl Compounds with Oxygen under Mild Conditions</span></div><div class="casAuthors">Liang, Yu-Feng; Jiao, Ning</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">548-552</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A transition-metal-free Cs2CO3-catalyzed α-hydroxylation of carbonyl compds. with O2 as the oxygen source is described.  E.g., in presence of Cs2CO3, P(OEt)3, and O2 in DMSO, α-hydroxylation of 2-methyl-1-tetralone gave 99% I.  This reaction provides an efficient approach to tertiary α-hydroxy carbonyl compds., which are highly valued chems. and widely used in the chem. and pharmaceutical industry.  The simple conditions and the use of mol. oxygen as both the oxidant and the oxygen source make this protocol very environmentally friendly and practical.  This transformation is highly efficient and highly selective for tertiary C(sp3)-H bond cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwv4f5czbDALVg90H21EOLACvtfcHk0liaQwK0QU6-Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVClsLvP&md5=996c3e3c8b7176daaf378db12273801e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.201308698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201308698%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%2BF.%26aulast%3DJiao%26aufirst%3DN.%26atitle%3DHighly%2520Efficient%2520C-H%2520Hydroxylation%2520of%2520Carbonyl%2520Compounds%2520with%2520Oxygen%2520under%2520Mild%2520Conditions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D548%26epage%3D552%26doi%3D10.1002%2Fanie.201308698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lucas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehdi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bélanger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breau, L.</span><span> </span><span class="NLM_article-title">Expedient Synthesis of Symmetric Aryl Ketones and of Ambient-Temperature Molten Salts of Imidazole</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span><span class="refDoi"> DOI: 10.1055/s-2000-6416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1055%2Fs-2000-6416" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2000&publication_year=2000&pages=1253-1258&author=P.+Lucasauthor=N.+Mehdiauthor=H.+A.+Hoauthor=D.+B%C3%A9langerauthor=L.+Breau&title=Expedient+Synthesis+of+Symmetric+Aryl+Ketones+and+of+Ambient-Temperature+Molten+Salts+of+Imidazole&doi=10.1055%2Fs-2000-6416"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-6416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-6416%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DP.%26aulast%3DMehdi%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DH.%2BA.%26aulast%3DB%25C3%25A9langer%26aufirst%3DD.%26aulast%3DBreau%26aufirst%3DL.%26atitle%3DExpedient%2520Synthesis%2520of%2520Symmetric%2520Aryl%2520Ketones%2520and%2520of%2520Ambient-Temperature%2520Molten%2520Salts%2520of%2520Imidazole%26jtitle%3DSynthesis%26date%3D2000%26volume%3D2000%26spage%3D1253%26epage%3D1258%26doi%3D10.1055%2Fs-2000-6416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demnitz, F. W. J.</span><span> </span><span class="NLM_article-title">An Efficient, Rapid and Highly Selective Preparation of the Wieland-Miescher Ketone-9-Ethylene Ketal</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1016/S0040-4039(96)02334-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1016%2FS0040-4039%2896%2902334-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=389-390&author=P.+Ciceriauthor=F.+W.+J.+Demnitz&title=An+Efficient%2C+Rapid+and+Highly+Selective+Preparation+of+the+Wieland-Miescher+Ketone-9-Ethylene+Ketal&doi=10.1016%2FS0040-4039%2896%2902334-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2896%2902334-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252896%252902334-9%26sid%3Dliteratum%253Aachs%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDemnitz%26aufirst%3DF.%2BW.%2BJ.%26atitle%3DAn%2520Efficient%252C%2520Rapid%2520and%2520Highly%2520Selective%2520Preparation%2520of%2520the%2520Wieland-Miescher%2520Ketone-9-Ethylene%2520Ketal%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D389%26epage%3D390%26doi%3D10.1016%2FS0040-4039%2896%2902334-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Devine, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodring, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leed, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciotti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5537</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5522-5537&author=W.+Devineauthor=J.+L.+Woodringauthor=U.+Swaminathanauthor=E.+Amataauthor=G.+Patelauthor=J.+Erathauthor=N.+E.+Roncalauthor=P.+J.+Leeauthor=S.+E.+Leedauthor=A.+Rodriguezauthor=K.+Mensa-Wilmotauthor=R.+J.+Sciottiauthor=M.+P.+Pollastri&title=Protozoan+Parasite+Growth+Inhibitors+Discovered+by+Cross-Screening+Yield+Potent+Scaffolds+for+Lead+Discovery&doi=10.1021%2Facs.jmedchem.5b00515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Protozoan parasite growth inhibitors discovered by cross-screening yield potent scaffolds for lead discovery</span></div><div class="casAuthors">Devine, William; Woodring, Jennifer L.; Swaminathan, Uma; Amata, Emanuele; Patel, Gautam; Erath, Jessey; Roncal, Norma E.; Lee, Patricia J.; Leed, Susan E.; Rodriguez, Ana; Mensa-Wilmot, Kojo; Sciotti, Richard J.; Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5522-5537</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tropical protozoal infections are a significant cause of morbidity and mortality worldwide; four in particular (human African trypanosomiasis (HAT), Chagas disease, cutaneous leishmaniasis, and malaria) have an estd. combined burden of over 87 million disability-adjusted life years.  New drugs are needed for each of these diseases.  Building on the previous identification of NEU-617 as a potent and nontoxic inhibitor of proliferation for the HAT pathogen (Trypanosoma brucei), the authors have now tested this class of analogs against other protozoal species: T. cruzi (Chagas disease), Leishmania major (cutaneous leishmaniasis), and Plasmodium falciparum (malaria).  Based on hits identified in this screening campaign, the authors describe the prepn. of several replacements for the quinazoline scaffold and report these inhibitors' biol. activities against these parasites.  In doing this, the authors have identified several potent proliferation inhibitors for each pathogen, such as NEU-924, I, for T. cruzi and NEU-1017, II, for L. major and P. falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbrXR55ZLJ7Vg90H21EOLACvtfcHk0liq7WhYHiMGQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bN&md5=76fef909165981d8e542d28a5ee59c12</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00515%26sid%3Dliteratum%253Aachs%26aulast%3DDevine%26aufirst%3DW.%26aulast%3DWoodring%26aufirst%3DJ.%2BL.%26aulast%3DSwaminathan%26aufirst%3DU.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DG.%26aulast%3DErath%26aufirst%3DJ.%26aulast%3DRoncal%26aufirst%3DN.%2BE.%26aulast%3DLee%26aufirst%3DP.%2BJ.%26aulast%3DLeed%26aufirst%3DS.%2BE.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DProtozoan%2520Parasite%2520Growth%2520Inhibitors%2520Discovered%2520by%2520Cross-Screening%2520Yield%2520Potent%2520Scaffolds%2520for%2520Lead%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5522%26epage%3D5537%26doi%3D10.1021%2Facs.jmedchem.5b00515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Knapp, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, M. D.</span><span> </span><span class="NLM_article-title">A General Solution for Unstable Boronic Acids: Slow-Release Cross-Coupling from Air-Stable MIDA Boronates</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">6961</span><span class="NLM_x">–</span> <span class="NLM_lpage">6963</span><span class="refDoi"> DOI: 10.1021/ja901416p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja901416p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Cls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=6961-6963&author=D.+M.+Knappauthor=E.+P.+Gillisauthor=M.+D.+Burke&title=A+General+Solution+for+Unstable+Boronic+Acids%3A+Slow-Release+Cross-Coupling+from+Air-Stable+MIDA+Boronates&doi=10.1021%2Fja901416p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A General Solution for Unstable Boronic Acids: Slow-Release Cross-Coupling from Air-Stable MIDA Boronates</span></div><div class="casAuthors">Knapp, David M.; Gillis, Eric P.; Burke, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6961-6963</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Many boronic acids, including 2-heterocyclic, vinyl, and cyclopropyl derivs., are inherently unstable, which can limit their bench-top storage and/or efficient cross-coupling.  The authors herein report the 1st general soln. to this problem: in situ slow release of unstable boronic acids from the corresponding air-stable N-methyliminodiacetic acid (MIDA) boronates.  This remarkably general approach has transformed all three classes of these unstable boronic acids into shelf-stable and highly effective building blocks for cross-coupling with a wide range of aryl and heteroaryl chlorides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnIQpAbX2N_7Vg90H21EOLACvtfcHk0lggaCRa3cjoyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Cls7s%253D&md5=0865bc71ca79319e2116c23932c7ed55</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja901416p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja901416p%26sid%3Dliteratum%253Aachs%26aulast%3DKnapp%26aufirst%3DD.%2BM.%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DBurke%26aufirst%3DM.%2BD.%26atitle%3DA%2520General%2520Solution%2520for%2520Unstable%2520Boronic%2520Acids%253A%2520Slow-Release%2520Cross-Coupling%2520from%2520Air-Stable%2520MIDA%2520Boronates%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D6961%26epage%3D6963%26doi%3D10.1021%2Fja901416p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Dick, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woerly, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, M. D.</span><span> </span><span class="NLM_article-title">A General Solution for the 2-Pyridyl Problem</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2667</span><span class="NLM_x">–</span> <span class="NLM_lpage">2672</span><span class="refDoi"> DOI: 10.1002/anie.201108608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1002%2Fanie.201108608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=2667-2672&author=G.+R.+Dickauthor=E.+M.+Woerlyauthor=M.+D.+Burke&title=A+General+Solution+for+the+2-Pyridyl+Problem&doi=10.1002%2Fanie.201108608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A General Solution for the 2-Pyridyl Problem</span></div><div class="casAuthors">Dick, Graham R.; Woerly, Eric M.; Burke, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2667-2672, S2667/1-S2667/80</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The use of 2-pyridinyl N-methyliminodiacetic acid boronate in coupling reactions with aryl halides catalyzed by Cu(OAc)2 and XphosPdcycle to produce various 2-arylpyridines is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ5_1Q-2ZSa7Vg90H21EOLACvtfcHk0lhqzmbOXgjX5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOqt7k%253D&md5=0b7fa5431edb9277382398f2925601fd</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fanie.201108608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201108608%26sid%3Dliteratum%253Aachs%26aulast%3DDick%26aufirst%3DG.%2BR.%26aulast%3DWoerly%26aufirst%3DE.%2BM.%26aulast%3DBurke%26aufirst%3DM.%2BD.%26atitle%3DA%2520General%2520Solution%2520for%2520the%25202-Pyridyl%2520Problem%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D2667%26epage%3D2672%26doi%3D10.1002%2Fanie.201108608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Sonoyama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezoe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanakura, Y.</span><span> </span><span class="NLM_article-title">Functional Cooperation among Ras, STAT5, and Phosphatidylinositol 3-Kinase Is Required for Full Oncogenic Activities of BCR/ABL in K562 Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">8076</span><span class="NLM_x">–</span> <span class="NLM_lpage">8082</span><span class="refDoi"> DOI: 10.1074/jbc.M111501200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1074%2Fjbc.M111501200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=8076-8082&author=J.+Sonoyamaauthor=I.+Matsumuraauthor=S.+Ezoeauthor=Y.+Satohauthor=X.+Zhangauthor=Y.+Kataokaauthor=E.+Takaiauthor=M.+Mizukiauthor=T.+Machiiauthor=H.+Wakaoauthor=Y.+Kanakura&title=Functional+Cooperation+among+Ras%2C+STAT5%2C+and+Phosphatidylinositol+3-Kinase+Is+Required+for+Full+Oncogenic+Activities+of+BCR%2FABL+in+K562+Cells&doi=10.1074%2Fjbc.M111501200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111501200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111501200%26sid%3Dliteratum%253Aachs%26aulast%3DSonoyama%26aufirst%3DJ.%26aulast%3DMatsumura%26aufirst%3DI.%26aulast%3DEzoe%26aufirst%3DS.%26aulast%3DSatoh%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DKataoka%26aufirst%3DY.%26aulast%3DTakai%26aufirst%3DE.%26aulast%3DMizuki%26aufirst%3DM.%26aulast%3DMachii%26aufirst%3DT.%26aulast%3DWakao%26aufirst%3DH.%26aulast%3DKanakura%26aufirst%3DY.%26atitle%3DFunctional%2520Cooperation%2520among%2520Ras%252C%2520STAT5%252C%2520and%2520Phosphatidylinositol%25203-Kinase%2520Is%2520Required%2520for%2520Full%2520Oncogenic%2520Activities%2520of%2520BCR%252FABL%2520in%2520K562%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D8076%26epage%3D8082%26doi%3D10.1074%2Fjbc.M111501200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Aichberger, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayerhofer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauth, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonneck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akgul, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derdak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickl, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacheck, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monia, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sillaber, C.</span><span> </span><span class="NLM_article-title">Identification of Mcl-1 as a BCR/ABL-Dependent Target in Chronic Myeloid Leukemia (CML): Evidence for Cooperative Antileukemic Effects of Imatinib and Mcl-1 Antisense Oligonucleotides</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3303</span><span class="NLM_x">–</span> <span class="NLM_lpage">3311</span><span class="refDoi"> DOI: 10.1182/blood-2004-02-0749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1182%2Fblood-2004-02-0749" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=3303-3311&author=K.+J.+Aichbergerauthor=M.+Mayerhoferauthor=M.-T.+Krauthauthor=H.+Skvaraauthor=S.+Florianauthor=K.+Sonneckauthor=C.+Akgulauthor=S.+Derdakauthor=W.+F.+Picklauthor=V.+Wacheckauthor=E.+Selzerauthor=B.+P.+Moniaauthor=R.+Morigglauthor=P.+Valentauthor=C.+Sillaber&title=Identification+of+Mcl-1+as+a+BCR%2FABL-Dependent+Target+in+Chronic+Myeloid+Leukemia+%28CML%29%3A+Evidence+for+Cooperative+Antileukemic+Effects+of+Imatinib+and+Mcl-1+Antisense+Oligonucleotides&doi=10.1182%2Fblood-2004-02-0749"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1182%2Fblood-2004-02-0749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2004-02-0749%26sid%3Dliteratum%253Aachs%26aulast%3DAichberger%26aufirst%3DK.%2BJ.%26aulast%3DMayerhofer%26aufirst%3DM.%26aulast%3DKrauth%26aufirst%3DM.-T.%26aulast%3DSkvara%26aufirst%3DH.%26aulast%3DFlorian%26aufirst%3DS.%26aulast%3DSonneck%26aufirst%3DK.%26aulast%3DAkgul%26aufirst%3DC.%26aulast%3DDerdak%26aufirst%3DS.%26aulast%3DPickl%26aufirst%3DW.%2BF.%26aulast%3DWacheck%26aufirst%3DV.%26aulast%3DSelzer%26aufirst%3DE.%26aulast%3DMonia%26aufirst%3DB.%2BP.%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DSillaber%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520Mcl-1%2520as%2520a%2520BCR%252FABL-Dependent%2520Target%2520in%2520Chronic%2520Myeloid%2520Leukemia%2520%2528CML%2529%253A%2520Evidence%2520for%2520Cooperative%2520Antileukemic%2520Effects%2520of%2520Imatinib%2520and%2520Mcl-1%2520Antisense%2520Oligonucleotides%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D3303%26epage%3D3311%26doi%3D10.1182%2Fblood-2004-02-0749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Ponte, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro-Fleury, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langonné, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hérault, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charbord, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenech, J.</span><span> </span><span class="NLM_article-title">Granulocyte-Colony-Stimulating Factor Stimulation of Bone Marrow Mesenchymal Stromal Cells Promotes CD34+ Cell Migration Via a Matrix Metalloproteinase-2-Dependent Mechanism</span> <span class="citation_source-journal">Stem Cells Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3162</span><span class="NLM_x">–</span> <span class="NLM_lpage">3172</span><span class="refDoi"> DOI: 10.1089/scd.2012.0048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1089%2Fscd.2012.0048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=3162-3172&author=A.+L.+Ponteauthor=T.+Ribeiro-Fleuryauthor=V.+Chabotauthor=F.+Gouilleuxauthor=A.+Langonn%C3%A9author=O.+H%C3%A9raultauthor=P.+Charbordauthor=J.+Domenech&title=Granulocyte-Colony-Stimulating+Factor+Stimulation+of+Bone+Marrow+Mesenchymal+Stromal+Cells+Promotes+CD34%2B+Cell+Migration+Via+a+Matrix+Metalloproteinase-2-Dependent+Mechanism&doi=10.1089%2Fscd.2012.0048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1089%2Fscd.2012.0048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fscd.2012.0048%26sid%3Dliteratum%253Aachs%26aulast%3DPonte%26aufirst%3DA.%2BL.%26aulast%3DRibeiro-Fleury%26aufirst%3DT.%26aulast%3DChabot%26aufirst%3DV.%26aulast%3DGouilleux%26aufirst%3DF.%26aulast%3DLangonn%25C3%25A9%26aufirst%3DA.%26aulast%3DH%25C3%25A9rault%26aufirst%3DO.%26aulast%3DCharbord%26aufirst%3DP.%26aulast%3DDomenech%26aufirst%3DJ.%26atitle%3DGranulocyte-Colony-Stimulating%2520Factor%2520Stimulation%2520of%2520Bone%2520Marrow%2520Mesenchymal%2520Stromal%2520Cells%2520Promotes%2520CD34%252B%2520Cell%2520Migration%2520Via%2520a%2520Matrix%2520Metalloproteinase-2-Dependent%2520Mechanism%26jtitle%3DStem%2520Cells%2520Dev.%26date%3D2012%26volume%3D21%26spage%3D3162%26epage%3D3172%26doi%3D10.1089%2Fscd.2012.0048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Moriggl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux-Gruart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jähne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berchtold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennighausen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux, F.</span><span> </span><span class="NLM_article-title">Deletion of the Carboxyl-Terminal Transactivation Domain of MGF-Stat5 Results in Sustained DNA Binding and a Dominant Negative Phenotype</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5691</span><span class="NLM_x">–</span> <span class="NLM_lpage">5700</span><span class="refDoi"> DOI: 10.1128/MCB.16.10.5691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1128%2FMCB.16.10.5691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=8816482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADyaK28XlvFamu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=5691-5700&author=R.+Morigglauthor=V.+Gouilleux-Gruartauthor=R.+J%C3%A4hneauthor=S.+Berchtoldauthor=C.+Gartmannauthor=X.+Liuauthor=L.+Hennighausenauthor=A.+Sotiropoulosauthor=B.+Gronerauthor=F.+Gouilleux&title=Deletion+of+the+Carboxyl-Terminal+Transactivation+Domain+of+MGF-Stat5+Results+in+Sustained+DNA+Binding+and+a+Dominant+Negative+Phenotype&doi=10.1128%2FMCB.16.10.5691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype</span></div><div class="casAuthors">Moriggl, Richard; Gouilleux-Gruart, Valerie; Jaehne, Ruth; Berchtold, Susanne; Gartmann, Christoph; Liu, Xiuwen; Hennighausen, Lothar; Sotiropoulos, Athanassia; Groner, Bernd; Gouilleux, Fabrice</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5691-5700</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Stat (signal transducer and activator of transcription) factors transmit cytokine, growth factor, and hormone responses.  Seven members of the Stat gene family are known.  MGF-Stat5a has been discovered as a mediator of the prolactin response in mammary epithelial cells.  Two closely related variants of Stat5, Stat5a and Stat5b, are encoded by distinct genes.  We examd. the functional properties of the carboxyl termini of these mols.  Wild-type Stat5a (794 amino acids) and the carboxyl-terminal deletion mutant Stat5aΔ772 supported prolactin-induced transcription of a β-casein promoter-reporter construct in COS7 cells; Stat5aΔ750 did not.  Upon prolactin activation, tyrosine phosphorylation and the specificity of DNA binding were indistinguishable among the three Sta5a variants.  Tyrosine dephosphorylation and the downregulation of the DNA-binding activity were delayed in the Stat5aΔ750 mutant.  The carboxyl-terminal transactivation domain of Stat5a, amino acids 722 to 794, can be confered to the DNA-binding domain of the yeast transcription factor GAL4.  Coexpression of Stat5a or Stat5b and of the carboxyl-terminal deletion mutants resulted in the suppression of transcriptional induction in COS or Ba/F3 cells.  We propose that Stat5aΔ750 and Stat5bΔ754 are lacking functional transactivation domains and exert their dominant neg. effects by blocking the DNA-binding site in Stat5-responsive gene promoters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4ZDVzvDn7z7Vg90H21EOLACvtfcHk0lgRstZLjc7j2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFamu7g%253D&md5=f33088a2ce818e1e87d5f5cdb1822dba</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FMCB.16.10.5691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.16.10.5691%26sid%3Dliteratum%253Aachs%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DGouilleux-Gruart%26aufirst%3DV.%26aulast%3DJ%25C3%25A4hne%26aufirst%3DR.%26aulast%3DBerchtold%26aufirst%3DS.%26aulast%3DGartmann%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHennighausen%26aufirst%3DL.%26aulast%3DSotiropoulos%26aufirst%3DA.%26aulast%3DGroner%26aufirst%3DB.%26aulast%3DGouilleux%26aufirst%3DF.%26atitle%3DDeletion%2520of%2520the%2520Carboxyl-Terminal%2520Transactivation%2520Domain%2520of%2520MGF-Stat5%2520Results%2520in%2520Sustained%2520DNA%2520Binding%2520and%2520a%2520Dominant%2520Negative%2520Phenotype%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D5691%26epage%3D5700%26doi%3D10.1128%2FMCB.16.10.5691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Livak, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmittgen, T. D.</span><span> </span><span class="NLM_article-title">Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1006/meth.2001.1262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=10.1006%2Fmeth.2001.1262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=11846609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFelt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=402-408&author=K.+J.+Livakauthor=T.+D.+Schmittgen&title=Analysis+of+Relative+Gene+Expression+Data+Using+Real-Time+Quantitative+PCR+and+the+2%E2%88%92%CE%94%CE%94CT+Method&doi=10.1006%2Fmeth.2001.1262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method</span></div><div class="casAuthors">Livak, Kenneth J.; Schmittgen, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-408</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The two most commonly used methods to analyze data from real-time, quant. PCR expts. are abs. quantification and relative quantification.  Abs. quantification dets. the input copy no., usually by relating the PCR signal to a std. curve.  Relative quantification relates the PCR signal of the target transcript in a treatment group to that of another sample such as an untreated control.  The 2-ΔΔCT method is a convenient way to analyze the relative changes in gene expression from real-time quant. PCR expts.  The purpose of this report is to present the derivation, assumptions, and applications of the 2-ΔΔCT method.  In addn., we present the derivation and applications of two variations of the 2-ΔΔCT method that may be useful in the anal. of real-time, quant. PCR data.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXNe1s-mDpprVg90H21EOLACvtfcHk0lg9dDcRvXp9ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFelt7s%253D&md5=f849383250ea43f7380ed540db8a64b1</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1006%2Fmeth.2001.1262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmeth.2001.1262%26sid%3Dliteratum%253Aachs%26aulast%3DLivak%26aufirst%3DK.%2BJ.%26aulast%3DSchmittgen%26aufirst%3DT.%2BD.%26atitle%3DAnalysis%2520of%2520Relative%2520Gene%2520Expression%2520Data%2520Using%2520Real-Time%2520Quantitative%2520PCR%2520and%2520the%25202%25E2%2588%2592%25CE%2594%25CE%2594CT%2520Method%26jtitle%3DMethods%26date%3D2001%26volume%3D25%26spage%3D402%26epage%3D408%26doi%3D10.1006%2Fmeth.2001.1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i57"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00369">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33828"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00369">10.1021/acs.jmedchem.7b00369</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_001.csv">CSV</a>)</p></li><li><p class="inline">Additional figures illustrating the inhibition of STAT5 phosphorylation of hit <b>13</b>, cell growth inhibition data, apoptosis experiments, dose–response curve for EC<sub>50</sub> calculation, quantification of Western Blot data, and NMR spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_001.csv">jm7b00369_si_001.csv (1.98 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00369/suppl_file/jm7b00369_si_002.pdf">jm7b00369_si_002.pdf (4.1 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00369&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00369%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00369" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0b0253a9f1228","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
